12e8:L   (ALA109) to   (ASN210)  2E8 FAB FRAGMENT  |   IMMUNOGLOBULIN 
12e8:M   (ALA109) to   (ASN210)  2E8 FAB FRAGMENT  |   IMMUNOGLOBULIN 
3rkd:L   (ALA109) to   (ASN210)  HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   HEPATITIS E VIRUS CAPSID PROTEIN, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1a0q:L   (ALA109) to   (ASN212)  29G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE  |   CATALYTIC ANTIBODY, ESTERASE 
1n8z:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB  |   TYROSIN KINASE RECEPTOR, CELL SURFACE RECEPTOR, TRANSFERASE 
4wcy:L   (ALA113) to   (ASN216)  FAB FRAGMENT OF MOUSE AZ130 MONOCLONAL ANTIBODY  |   MONOCLONAL ANTIBODY, EPSTEIN-BARR VIRUS (EBV), ZEBRA PROTEIN, IMMUNE SYSTEM 
1a3l:L   (ALA109) to   (ASN212)  CATALYSIS OF A DISFAVORED REACTION: AN ANTIBODY EXO DIELS- ALDERASE-TSA-INHIBITOR COMPLEX AT 1.95 A RESOLUTION  |   DIELS-ALDER, DISFAVORED REACTION, CATALYTIC ANTIBODY, IMMUNOGLOBULIN 
1a3r:L   (ALA109) to   (ASN212)  FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)  |   IMMUNOGLOBULIN, ANTIBODY, RHINOVIRUS, NEUTRALIZATION, CONTINUOUS EPITOPE, COMPLEX (IMMUNOGLOBULIN/VIRAL PEPTIDE), VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1nak:L   (ALA109) to   (ASN212)  IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3e8u:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION  |   FAB 106.3, IGG1, BRAIN NATRIURETIC PEPTIDE (BNP), IMMUNE SYSTEM 
1a4k:L   (THR109) to   (PHE209)  DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE  |   IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE 
1a4k:A   (THR109) to   (SER208)  DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE  |   IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE 
2ajs:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH HEPTAETHYLENE GLYCOL  |   CATALYTIC ANTIBODY, FAB, COCAINE, HYDROLYTIC, HEPTAETHYLENE GLYCOL, IMMUNE SYSTEM 
2aju:L   (ALA109) to   (ASN210)  CYRSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB'  |   CATALYTIC ANTIBODY, FAB, COCAINE, HYDROLYTIC, IMMUNE SYSTEM 
2ajv:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH COCAINE  |   CATALYTIC ANTIBODY, FAB, COCAINE, HYDROLYTIC, IMMUNE SYSTEM 
2ajy:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER AND BENZOIC ACID  |   CATALYTIC ANTIBODY, FAB, ECGONINE METHYL ESTER, BENZOIC ACID, HYDROLYTIC, IMMUNE SYSTEM 
2ajz:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER  |   CATALYTIC ANTIBODY, FAB, ECGONINE METHYL ESTER, HYDROLYTIC, IMMUNE SYSTEM 
2ak1:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH BENZOIC ACID  |   CATALYTIC ANTIBODY, FAB, BENZOIC ACID, HYDROLYTIC, IMMUNE SYSTEM 
1nby:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A  |   ANTIBODY, LYSOZYME, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX 
4wfe:D   (ALA108) to   (ASN211)  HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
4wfe:F   (ALA108) to   (ASN211)  HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
1nbz:A   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K97A  |   ANTIBODY, LYSOZYME, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX 
4wff:D   (ALA108) to   (ASN211)  HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
4wff:F   (ALA108) to   (ASN211)  HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
4wfg:D   (ALA108) to   (ASN211)  HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
4wfg:F   (ALA108) to   (ASN211)  HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
1nc4:A   (PRO112) to   (PRO211)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA  |   ANTIBODY-DOTA COMPLEX, RARE EARTH, DOTA, METAL CHELATE, GADOLINIUM, GAMMA TURN, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM 
4wfh:D   (ALA108) to   (ASN211)  HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
4wfh:F   (ALA108) to   (ASN211)  HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
1ncb:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE  |   HYDROLASE(O-GLYCOSYL) 
1ncc:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE  |   HYDROLASE(O-GLYCOSYL) 
1ncd:L   (ALA109) to   (ASN210)  REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX  |   HYDROLASE(O-GLYCOSYL) 
1ncw:L   (ALA109) to   (ASN210)  CATIONIC CYCLIZATION ANTIBODY 4C6 IN COMPLEX WITH BENZOIC ACID  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1nd0:A   (ALA109) to   (ARG211)  CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1nd0:C   (ALA109) to   (ARG211)  CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1nd0:E   (ALA109) to   (ARG211)  CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1nd0:G   (ALA109) to   (ARG211)  CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1a6t:C   (ALA109) to   (ARG211)  FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE  |   IMMUNOGLOBULIN, NEUTRALIZES HUMAN RHINOVIRUS, IGG1 
1ndg:A   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-8 COMPLEXED WITH ITS ANTIGEN LYSOZYME  |   ANTIBODY; LYSOZYME; MUTANT; HYHEL-8, IMMUNE SYSTEM/HYDROLASE COMPLEX 
4gw5:A   (THR109) to   (ASN210)  CQYN MEDITOPE - CETUXIMAB FAB  |   IGG, IMMUNE SYSTEM, EGFR 
4gw5:C   (THR109) to   (SER208)  CQYN MEDITOPE - CETUXIMAB FAB  |   IGG, IMMUNE SYSTEM, EGFR 
1ndm:A   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-26 COMPLEXED WITH LYSOZYME  |   ANTIBODY; LYSOZYME; MUTANT; HYHEL-26, IMMUNE SYSTEM/HYDROLASE COMPLEX 
4wht:J   (ALA113) to   (ARG215)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:B   (ALA113) to   (ASN214)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:L   (ALA113) to   (ASN214)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:R   (ALA113) to   (ASN214)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:V   (ALA113) to   (ARG215)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4why:H   (ALA113) to   (ARG215)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P21 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4why:J   (ALA113) to   (ARG215)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P21 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4why:L   (ALA113) to   (ASN216)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P21 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4why:N   (ALA113) to   (ASN214)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P21 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
2arj:L   (ALA109) to   (ARG211)  CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB  |   PROTEIN-PROTEIN COMPLEX, ANTIBODY FAB, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN 
2arj:A   (ALA109) to   (ARG211)  CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB  |   PROTEIN-PROTEIN COMPLEX, ANTIBODY FAB, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN 
1ngw:L   (THR109) to   (ARG211)  CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN  |   ANTIBODY, IMMUNOGLOBULIN, ANTIGEN BINDING FRAGMENT, IMMUNE SYSTEM 
1ngx:A   (THR109) to   (SER208)  CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND  |   ANTIBODY, IMMUNOGLOBULIN, ANTIGEN BINDING FRAGMENT (FAB), IMMUNE SYSTEM 
1ngx:L   (THR109) to   (SER208)  CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND  |   ANTIBODY, IMMUNOGLOBULIN, ANTIGEN BINDING FRAGMENT (FAB), IMMUNE SYSTEM 
1ngy:A   (THR109) to   (ARG211)  CHIMERIC MATURE FAB 7G12-APO  |   ANTIBODY, IMMUNOGLOBULIN, ANTIGEN BINDING FRAGMENT (FAB), IMMUNE SYSTEM 
2ojz:L   (SER109) to   (ASN210)  ANTI-DNA ANTIBODY ED10  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
2ojz:M   (SER109) to   (ASN212)  ANTI-DNA ANTIBODY ED10  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1acy:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV- 1  |   COMPLEX(ANTIBODY/HIV-1 FRAGMENT) 
1ad9:L   (THR108) to   (SER207)  IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01  |   IMMUNOGLOBULIN, FAB FRAGMENT 
1ad9:A   (THR108) to   (SER207)  IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01  |   IMMUNOGLOBULIN, FAB FRAGMENT 
2omb:C   (PRO114) to   (PRO213)  BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(1)21 CRYSTAL FORM  |   IMMUNOGLOBULIN LIGHT CHAIN, IMMUNE SYSTEM 
3eff:C   (THR111) to   (ASN212)  THE CRYSTAL STRUCTURE OF FULL-LENGTH KCSA IN ITS CLOSED CONFORMATION  |   FULL LENGTH KCSA, BULGE HELIX, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE- GATED CHANNEL, MEMBRANE PROTEIN 
1ahw:A   (ALA109) to   (ASN210)  A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)  |   BLOOD COAGULATION, TISSUE FACTOR, FAB, COMPLEX, ANTIBODY, COMPLEX (IMMUNOGLOBULIN/TISSUE FACTOR) 
1ahw:D   (ALA109) to   (ASN212)  A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)  |   BLOOD COAGULATION, TISSUE FACTOR, FAB, COMPLEX, ANTIBODY, COMPLEX (IMMUNOGLOBULIN/TISSUE FACTOR) 
1nld:L   (ALA109) to   (ARG211)  FAB FRAGMENT OF A NEUTRALIZING ANTIBODY DIRECTED AGAINST AN EPITOPE OF GP41 FROM HIV-1  |   FAB FRAGMENT, IMMUNOGLOBULIN 
3rvt:C   (ALA109) to   (ARG211)  STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP  |   IGG, ANTIBODY, DER F 1, DER P 1, IMMUNE SYSTEM 
3rvw:C   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1  |   ALLERGEN-ANTIBODY COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3rvx:C   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1  |   DER P 1, ALLERGEN-ANTIBODY COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
2b2x:L   (ALA113) to   (ARG215)  VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB  |   COMPUTATIONAL DESIGN, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM 
2b2x:M   (ALA113) to   (ARG215)  VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB  |   COMPUTATIONAL DESIGN, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM 
4h20:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE AND COMPUTATIONAL MODELING OF THE FAB FRAGMENT FROM THE PROTECTIVE ANTI-RICIN MONOCLONAL ANTIBODY RAC18  |   IG, ANTI RICIN ANTIBODY FAB FRAGMENT, RICIN A CHAIN, EXTRACELLULAR, BLOODSTREAM, IMMUNE SYSTEM 
2oqj:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
2oqj:D   (THR109) to   (ASN210)  CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
2oqj:G   (THR109) to   (SER208)  CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
2oqj:J   (THR109) to   (GLY212)  CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
2orb:L   (ALA109) to   (ASN212)  THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT  |   ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, LONG CDR H3, IMMUNE SYSTEM 
2orb:M   (ALA109) to   (ASN210)  THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT  |   ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, LONG CDR H3, IMMUNE SYSTEM 
3ejy:D   (ALA108) to   (ALA211)  STRUCTURE OF E203H MUTANT OF E.COLI CL-/H+ ANTIPORTER, CLC-EC1  |   MEMBRANE PROTEIN, CL-/H+ EXCHANGER, ANTIPORT, CELL INNER MEMBRANE, CELL MEMBRANE, CHLORIDE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE, TRANSPORT, IMMUNE SYSTEM-PROTON TRANSPORT COMPLEX 
3ejy:F   (ALA108) to   (ARG210)  STRUCTURE OF E203H MUTANT OF E.COLI CL-/H+ ANTIPORTER, CLC-EC1  |   MEMBRANE PROTEIN, CL-/H+ EXCHANGER, ANTIPORT, CELL INNER MEMBRANE, CELL MEMBRANE, CHLORIDE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE, TRANSPORT, IMMUNE SYSTEM-PROTON TRANSPORT COMPLEX 
3ejz:D   (ALA108) to   (ALA211)  STRUCTURE OF E203V MUTANT E.COLI CL-/H+ EXCHANGER, CLC-EC1  |   MEMBRANE PROTEIN, CL-/H+ EXCHANGER, ANTIPORT, CELL INNER MEMBRANE, CELL MEMBRANE, CHLORIDE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE, TRANSPORT, IMMUNE SYSTEM-PROTON TRANSPORT COMPLEX 
3ejz:F   (ALA108) to   (ALA211)  STRUCTURE OF E203V MUTANT E.COLI CL-/H+ EXCHANGER, CLC-EC1  |   MEMBRANE PROTEIN, CL-/H+ EXCHANGER, ANTIPORT, CELL INNER MEMBRANE, CELL MEMBRANE, CHLORIDE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE, TRANSPORT, IMMUNE SYSTEM-PROTON TRANSPORT COMPLEX 
1nsn:L   (ALA109) to   (ASN210)  THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN, STAPHYLOCOCCAL NUCLEASE, COMPLEX (IMMUNOGLOBULIN/HYDROLASE) COMPLEX 
4h88:L   (ALA109) to   (ASN212)  STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230  |   C-TERM MOUSE PRION PROTEIN, POM1 FAB, IMMUNE SYSTEM 
3eo0:A   (THR110) to   (SER209)  STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008  |   CYTOKINE NEUTRALIZING ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM 
3eo0:C   (THR110) to   (ASN211)  STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008  |   CYTOKINE NEUTRALIZING ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM 
3eo9:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB  |   EFALIZUMAB, FAB, ANTIBODY, IMMUNE SYSTEM 
1axs:A   (THR109) to   (ARG211)  MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN  |   OXY-COPE, CATALYTIC ANTIBODY, FAB FRAGMENT 
3eot:L   (ALA110) to   (ASN213)  CRYSTAL STRUCTURE OF LAC031, AN ENGINEERED ANTI-VLA1 FAB  |   ANTIBODY, FAB, VLA-1, DOMAIN SWAP, PROTEN ENGINEERING, IMMUNE SYSTEM 
1axt:L   (ALA109) to   (ARG211)  IMMUNE VERSUS NATURAL SELECTION: ANTIBODY ALDOLASES WITH THE RATES OF NATURAL ENZYMES  |   IMMUNOGLOBULIN, ANTIBODY FAB', CATALYST, ALDOLASE REACTION 
4wv1:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE FGFR2 D2 DOMAIN IN COMPLEX WITH FAB 2B.1.3  |   FGFR2, FAB, COMPLEX, ANTIBODY, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
4wv1:D   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE FGFR2 D2 DOMAIN IN COMPLEX WITH FAB 2B.1.3  |   FGFR2, FAB, COMPLEX, ANTIBODY, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
1b2w:L   (THR109) to   (ASN210)  COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY  |   ANTIBODY ENGINEERING, HUMANIZED AND CHIMERIC ANTIBODY, FAB, THREE- DIMENSIONAL STRYCTURE, GAMMA-INTERFERON, IMMUNE SYSTEM 
4hcr:L   (THR114) to   (SER213)  CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659  |   IMMUNOGLOBULIN SUPERFAMILY, ROLLING AND FIRM ADHESION, INTEGRIN ALPHA4BETA7, IMMUNE SYSTEM 
1b4j:L   (THR109) to   (ARG211)  COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY  |   ANTIBODY ENGINEERING, HUMANIZED AND CHIMERIC ANTIBODIES, FAB, X-RAY STRUCTURES, GAMMA-INTERFERON 
4wy7:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF RECOMBINANT 4E10 EXPRESSED IN ESCHERICHIA COLI WITH EPITOPE BOUND  |   BROAD NEUTRALIZING ANTOBODY, RECOMBINANT FAB, EPITOPE, IMMUNE SYSTEM 
1b6d:A   (THR109) to   (SER208)  BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER  |   IMMUNOGLOBULIN, KAPPA LIGHT-CHAIN DIMER 
2p8l:A   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN  |   NMAB 2F5, HIV-1, GP41 EPITOPE, VIRAL PROTEIN 
2p8m:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN IN NEW CRYSTAL FORM  |   NMAB 2F5, HIV-1, GP41 EPITOPE, VIRAL PROTEIN 
2p8p:A   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASLW[N-AC]  |   NMAB 2F5, HIV-1, GP41 EPITOPE, VIRAL PROTEIN 
4hha:A   (THR109) to   (SER208)  ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5 WITH EPITOPE PEPTIDE AD-2S1  |   FAB FRAGMENT, ANTIBODY, IMMUNE SYSTEM 
4x0k:L   (GLY109) to   (SER208)  ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE  |   ANTIBODY FRAGMENT, CRYSTALLIZATION CHAPERONE, FAB FRAGMENT, IMMUNE SYSTEM 
4hih:A   (THR109) to   (SER208)  ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE.  |   IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM 
4hii:A   (THR109) to   (ARG211)  ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE  |   IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM 
4hii:C   (THR109) to   (SER208)  ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE  |   IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM 
4hij:A   (THR109) to   (ARG211)  ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND L-RHAMNOSE- (1-2)-ALPHA-D-GALACTOSE-(3-O)-PHOSPHATE-2-GLYCEROL  |   IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM 
4hij:C   (THR109) to   (ARG211)  ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND L-RHAMNOSE- (1-2)-ALPHA-D-GALACTOSE-(3-O)-PHOSPHATE-2-GLYCEROL  |   IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM 
3s34:L   (THR109) to   (SER208)  STRUCTURE OF THE 1121B FAB FRAGMENT  |   VEGF RECEPTOR DOMAIN 3, IMMUNE SYSTEM 
3s36:L   (THR109) to   (ASN210)  STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES  |   ANTIBODY, KDR, VEGF RECEPTOR, CANCER, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
3s37:L   (THR109) to   (SER208)  STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES  |   ANTIBODY, KDR, VEGF RECEPTOR, CANCER, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
4hj0:Q   (PRO112) to   (ALA210)  CRYSTAL STRUCTURE OF THE HUMAN GIPR ECD IN COMPLEX WITH GIPG013 FAB AT 3-A RESOLUTION  |   GLUCAGON RECEPTOR SUB-FAMILY RECOGNITION FOLD, IMMUNE SYSTEM 
1bfo:A   (ALA109) to   (ASN212)  CAMPATH-1G IGG2B RAT MONOCLONAL FAB  |   ANTIBODY, FAB, CAMPATH-1G, CD52 
1bfo:C   (ALA109) to   (ASN212)  CAMPATH-1G IGG2B RAT MONOCLONAL FAB  |   ANTIBODY, FAB, CAMPATH-1G, CD52 
1bfo:E   (ALA109) to   (ASN212)  CAMPATH-1G IGG2B RAT MONOCLONAL FAB  |   ANTIBODY, FAB, CAMPATH-1G, CD52 
1bfo:G   (ALA109) to   (ASN212)  CAMPATH-1G IGG2B RAT MONOCLONAL FAB  |   ANTIBODY, FAB, CAMPATH-1G, CD52 
4hjj:L   (THR223) to   (ASN324)  STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE  |   DFAB COMPLEX, IL-18, DUAL VARIABLE DOMAIN IMMUNOGLOBULIN, IMMUNE SYSTEM 
4hk0:D   (PRO111) to   (PRO210)  UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE  |   FAB FRAGMENT, IMMUNE SYSTEM 
3eyf:A   (THR110) to   (ASN211)  CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE  |   CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM 
3eys:L   (ALA114) to   (ASN217)  PFA1 FAB FRAGMENT COMPLEXED WITH PYRO-GLU3-A-BETA (3-8)  |   FAB, AMYLOID, ALZHEIMER'S, PROTEIN-PEPTIDE COMPLEX, IMMUNE SYSTEM 
3eyu:L   (ALA114) to   (ASN217)  PFA1 FAB FRAGMENT COMPLEXED WITH ROR2(518-525)  |   FAB, AMYLOID, ALZHEIMER'S, PROTEIN-PEPTIDE COMPLEX, IMMUNE SYSTEM 
4hkz:A   (THR109) to   (SER208)  TRASTUZUMAB FAB COMPLEXED WITH PROTEIN L AND PROTEIN A FRAGMENTS  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CANCER THERAPEUTIC 
4hlz:J   (ALA111) to   (ARG213)  CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPES, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENTS, H2N2 SUBTYPE, INFLUENZA VACCINES, AVIAN FLU, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3f12:A   (GLY102) to   (ARG212)  GERMLINE V-GENES SCULPT THE BINDING SITE OF A FAMILY OF ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS  |   HUMAN CYTOMEGALOVIRUS, ANTIBODY, GERMLINE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
2bmk:L   (ALA109) to   (GLU213)  FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE  |   CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, HAPTEN, PHOSPHOPYRIDOXYL-L-LYSINE, IMMUNE SYSTEM 
1bog:A   (ALA109) to   (ASN212)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-HOMOLOGOUS PEPTIDE  |   POLYSPECIFICITY, CROSS REACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1, COMPLEX (ANTIBODY/PEPTIDE) 
2bob:B   (ALA109) to   (ASN210)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)  |   IMMUNE SYSTEM/TRANSPORT PROTEIN, COMPLEX (ANTIBODY/ION CHANNEL), POTASSIUM CHANNEL, ION TRANSPORT, IONIC CHANNEL, PROTEIN- ANTIBODY FAB COMPLEX 
2boc:B   (ALA109) to   (ASN212)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)  |   IMMUNE SYSTEM/TRANSPORT PROTEIN, COMPLEX (ANTIBODY/ION CHANNEL), POTASSIUM CHANNEL, ION TRANSPORT, IONIC CHANNEL, PROTEIN- ANTIBODY FAB COMPLEX 
3f58:L   (ALA109) to   (ARG211)  IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120 (MN ISOLATE); H315S MUTATION  |   IMMUNOGLOBULIN, FAB, HIV-1, GP120, V3, IMMUNE SYSTEM 
1bql:L   (ALA107) to   (ARG209)  STRUCTURE OF AN ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME  |   ANTIBODY/ANTIGEN COMPLEX, HYHEL-5, ANTI-LYSOZYME, BOBWHITE QUAIL 
3f5w:B   (ALA109) to   (ASN212)  KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 32 A OPENING AT T112  |   POTASSIUM CHANNEL, KCSA, OPEN, INACTIVATED, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX 
2brr:L   (ALA109) to   (ASN210)  COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)  |   IMMUNE SYSTEM, FAB FRAGMENT, ANTI-PORA ANTIBODY, P1.4 ANTIBODY, ANTIGEN, PORIN, TRANSMEMBRANE, ANTIBODY/ANTIGEN COMPLEX 
2brr:X   (ALA109) to   (ASN210)  COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)  |   IMMUNE SYSTEM, FAB FRAGMENT, ANTI-PORA ANTIBODY, P1.4 ANTIBODY, ANTIGEN, PORIN, TRANSMEMBRANE, ANTIBODY/ANTIGEN COMPLEX 
3s88:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF SUDAN EBOLAVIRUS GLYCOPROTEIN (STRAIN GULU) BOUND TO 16F6  |   GLYCOSYLATION, VIRAL MEMBRANE, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3f7y:B   (ALA109) to   (ASN212)  KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 17 A OPENING AT T112  |   KCSA, OPEN, INACTIVATION, POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX 
4x7s:L   (THR113) to   (SER212)  STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1  |   ANTIBODY FAB FRAGMENT, ANTI-IGE ANTIBODY, ANTI-INFLAMMATORY, IMMUNE SYSTEM 
4x80:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF MURINE 7B4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5  |   MONOCLONAL, IMMUNE SYSTEM 
4hs6:A   (THR109) to   (ASN210)  HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362  |   IMMUNE SYSTEM 
3fb6:B   (ALA109) to   (ASN212)  KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112  |   KCSA, OPEN, INACTIVATION, POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX 
4hs8:L   (THR109) to   (ASN210)  HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY HU5B3.V3  |   IMMUNE SYSTEM 
3fb8:B   (ALA109) to   (ASN212)  KCSA POTASSIUM CHANNEL IN THE OPEN-CONDUCTIVE STATE WITH 20 A OPENING AT T112 IN THE PRESENCE OF RB+ ION  |   KCSA, OPEN, INACTIVATION, POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX 
4xak:E   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD  |   MERS-COV RBD, ANTIBODY M336, NEUTRALIZATION, IMMUNE SYSTEM 
4ht1:L   (THR113) to   (ASN214)  HUMAN TWEAK IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY  |   ANTIBODY FAB, TNF HOMOLOGY DOMAIN, CYTOKINE, TWEAK RECEPTOR, MEMBRANE BOUND, EXTRACELLULAR THD DOMAIN, IMMUNE SYSTEM 
4xaw:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH PHOSPHATIDIC ACID (08:0 PA)  |   HIV-1 GP41 MPER, 4E10 FAB, LIPID MEMBRANE, IMMUNE SYSTEM 
4xbe:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SPHINGOMYELIN (02:0 SM (D18:1/2:0)).  |   HIV-1 GP41 MPER, 4E10 FAB, MEMBRANE LIPID, IMMUNE SYSTEM 
4xbg:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xbg:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xbg:D   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xbg:F   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xbg:I   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xbg:K   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPID, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xbp:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)  |   HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM 
4xbp:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)  |   HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM 
4xbp:D   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)  |   HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM 
4xbp:F   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)  |   HUMAN 4E10 FAB ANTI HIV-1 GP41, MEMBRANE LIPIDS, PHOSPHATIDYLETHANOLAMINE, IMMUNE SYSTEM 
3fct:A   (THR109) to   (GLU213)  MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN  |   METAL CHELATASE, CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM 
3fct:C   (THR109) to   (ASN212)  MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN  |   METAL CHELATASE, CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM 
4xc1:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SN-GLYCEROL 3- PHOSPHATE  |   HIV-1 GP41 MPER, 4E10 FAB, LIPID MEMBRANE, IMMUNE SYSTEM 
4hwb:L   (THR106) to   (SER205)  CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA 1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT  |   FAB, FNIII, CYTOKINE SIGNALING, IMMUNE SYSTEM 
4hwe:L   (THR106) to   (SER205)  CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT  |   FAB, FNIII, IMMUNE SYSTEM 
1c12:A   (ALA109) to   (ASN210)  INSIGHT IN ODORANT PERCEPTION: THE CRYSTAL STRUCTURE AND BINDING CHARACTERISTICS OF ANTIBODY FRAGMENTS DIRECTED AGAINST THE MUSK ODORANT TRASEOLIDE  |   ANTIBODY-ANTIGEN COMPLEX, SCFV FRAGMENT, CDRH3, MUSK ODORANT, ODORANT SPECIFICITY, IMMUNE SYSTEM 
1c1e:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN  |   CATALYTIC ANTIBODY, DIELS-ALDER, IMMUNOGLOBULIN, IMMUNE SYSTEM 
4xcc:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); I422 SPACE GROUP  |   4E10 FAB ANTI HIV-1 GP41, LIPID MEMBRANE, IMMUNE SYSTEM, PHOSPHATIDYLCHOLINE 
4hxa:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF 13D9 FAB  |   ANTIBODY, FAB, IMMUNE SYSTEM, CARBOHYDRATE, COMPLEMENTARITY DETERMINING REGIONS 
4hxb:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF 6B9 FAB  |   ANTIBODY, FAB, COMPLEMENTARITY DETERMINING REGIONS, CARBOHYDRATE- BINDING, IMMUNE SYSTEM 
4xce:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP  |   4E10 FAB ANTI HIV-1 GP41, PHOSPHATIDYLCHOLINE, MEMBRANE LIPID, IMMUNE SYSTEM 
4xce:D   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP  |   4E10 FAB ANTI HIV-1 GP41, PHOSPHATIDYLCHOLINE, MEMBRANE LIPID, IMMUNE SYSTEM 
4xcf:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH PHOSPHATIDYLCHOLINE (03:0 PC)  |   4E10 FAB ANTI HIV-1 GP41, PHOSPHATIDYLCHOLINE, MEMBRANE LIPID, IMMUNE SYSTEM 
4xcn:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xcn:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xcn:D   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xcn:F   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
4xcn:K   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
3sdy:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3se9:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG04 IN COMPLEX WITH HIV-1 GP120  |   HIV, GP120, ANTIBODY, VRC-PG04, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4hzl:B   (ALA114) to   (ASN215)  NEUTRALIZING ANTIBODY MAB#8 IN COMPLEX WITH THE EPITOPE II OF HCV E2 ENVELOPE PROTEIN  |   IG DOMAIN, NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
1c5b:L   (THR109) to   (ASN210)  DECARBOXYLASE CATALYTIC ANTIBODY 21D8 UNLIGANDED FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, DECARBOXYLASE, UNLIGANDED, IMMUNE SYSTEM 
1c5c:L   (THR109) to   (ASN210)  DECARBOXYLASE CATALYTIC ANTIBODY 21D8-HAPTEN COMPLEX  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, DECARBOXYLASE, HAPTEN COMPLEX, IMMUNE SYSTEM 
4i18:L   (THR112) to   (ASN213)  CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT  |   IMMUNOGLOBULIN FOLD, PROLACTIN BINDING, RECEPTOR SIGNALING, CYTOKINE, SIGNALING PROTEIN 
4i18:B   (THR112) to   (SER211)  CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT  |   IMMUNOGLOBULIN FOLD, PROLACTIN BINDING, RECEPTOR SIGNALING, CYTOKINE, SIGNALING PROTEIN 
4xgz:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xgz:F   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xgz:I   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xgz:K   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xgz:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xgz:N   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xgz:P   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xgz:R   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xgz:T   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xgz:X   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
2c1p:A   (ALA109) to   (ASN212)  FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE  |   FAB FRAGMENT, ENANTIOSELECTIVE, FINROZOLE, IMMUNE SYSTEM, ANTIBODY, ENANTIOSELECTIVE ANTIBODY, IMMUNOGLOBULIN DOMAIN 
2c1p:L   (ALA109) to   (ASN212)  FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE  |   FAB FRAGMENT, ENANTIOSELECTIVE, FINROZOLE, IMMUNE SYSTEM, ANTIBODY, ENANTIOSELECTIVE ANTIBODY, IMMUNOGLOBULIN DOMAIN 
4i2x:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117  |   PROTEIN-FAB COMPLEX, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, SIGNAL REGULATORY PROTEIN, CD47, CELL SURFACE, IMMUNE SYSTEM 
4i2x:C   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117  |   PROTEIN-FAB COMPLEX, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, SIGNAL REGULATORY PROTEIN, CD47, CELL SURFACE, IMMUNE SYSTEM 
4i3r:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221  |   ANTIBODY AFFINITY, ANTIBODY SPECIFICITY, BINDING SITES, HIV INFECTIONS, ANTIBODIES, HIV ENVELOPE PROTEIN GP120, AIDS VACCINES, AMINO ACID SEQUENCE, ANTIGENS, EPITOPES, HIV ANTIBODIES, CD4, SOMATIC MUTATION, SEQUENCE ENGINEERING, COMPLEMENTARITY DETERMINING REGIONS, IMMUNOGLOBULIN FAB FRAGMENTS, SERA, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2pr4:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5  |   NMAB 2F5, GP41, HIV, VIRAL PROTEIN 
1om3:L   (THR109) to   (SER208)  FAB 2G12 UNLIGANDED  |   FAB 2G12, THREE-DIMENSIONAL DOMAIN SWAP, IMMUNE SYSTEM 
1om3:M   (THR109) to   (SER208)  FAB 2G12 UNLIGANDED  |   FAB 2G12, THREE-DIMENSIONAL DOMAIN SWAP, IMMUNE SYSTEM 
3skj:L   (THR109) to   (GLY212)  STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY  |   FAB, RECEPTOR, IG FOLD, EPHRIN RECEPTOR, ANTIBODY, ANTIGEN, EXTRA- CELLULAR, IMMUNE SYSTEM 
1cf8:L   (ALA109) to   (ASN210)  CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS  |   CATALYTIC ANTIBODY, TERPENOID SYNTHASE, CARBOCATION, CYCLIZATION CASCADE 
3fmg:L   (ALA109) to   (ARG211)  STRUCTURE OF ROTAVIRUS OUTER CAPSID PROTEIN VP7 TRIMER IN COMPLEX WITH A NEUTRALIZING FAB  |   ANTIBODY-ANTIGEN COMPLEX, CALCIUM DEPENDENT TRIMER, ANTIPARALLEL BETA-SANDWICH, JELLY ROLL, ALPHA-BETA-ALPHA SANDWICH, ROSSMANN FOLD, CAPSID PROTEIN, ENDOPLASMIC RETICULUM, GLYCOPROTEIN, MEMBRANE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM 
1cfn:A   (ALA109) to   (ASN212)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-RELATED PEPTIDE  |   POLYSPECIFICITY, CROSS REACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1 
1cfq:A   (ALA109) to   (ASN212)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41  |   POLYSPECIFICITY, CROSS REACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1 
1cfs:A   (ALA109) to   (ASN210)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED PEPTIDE  |   POLYSPECIFICITY, CROSS REACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1 
1cft:A   (ALA109) to   (ASN212)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED D-PEPTIDE  |   POLYSPECIFICITY, CROSS REACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1 
2pw1:A   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWNSL  |   HIV-1, 2F5, GP41, NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
2pw2:A   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWKSL  |   HIV-1, GP41, 2F5, NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
3fo0:L   (THR114) to   (ARG216)  CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3fo1:L   (THR114) to   (SER213)  CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3fo1:A   (THR114) to   (SER213)  CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
1op3:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN  |   DOMAIN-SWAPPED FAB 2G12; ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
1op3:K   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN  |   DOMAIN-SWAPPED FAB 2G12; ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
3fo2:L   (THR114) to   (ARG216)  CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3fo2:A   (THR114) to   (SER213)  CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, ACID BASE CATALYSIS, PROTON TRANSFER, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
1op5:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2  |   DOMAIN-SWAPPED FAB 2G12 MAN9GLCNAC2 ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
1opg:L   (ALA109) to   (ARG211)  OPG2 FAB FRAGMENT  |   CELL ADHESION MOLECULE, IMMUNOGLOBULIN 
4i77:L   (THR109) to   (SER208)  LEBRIKIZUMAB FAB BOUND TO IL-13  |   IMMUNOGLOBULIN, IMMUNE SYSTEM RECOGNITION, IMMUNE SYSTEM-CYTOKINE COMPLEX 
1ck0:L   (ALA108) to   (ARG210)  ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, UNLIGANDED FORM  |   IMMUNOGLOBULIN 
1ors:A   (ALA109) to   (ASN212)  X-RAY STRUCTURE OF THE KVAP POTASSIUM CHANNEL VOLTAGE SENSOR IN COMPLEX WITH AN FAB  |   POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, VOLTAGE SENSOR, KVAP, FAB COMPLEX, MEMBRANE PROTEIN 
1cl7:L   (ALA109) to   (ARG211)  ANTI HIV1 PROTEASE FAB  |   FAB FRAGMENT, CROSS-REACTIVITY, HIV1 PROTEASE, ENZYME INHIBITION, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1cly:L   (THR109) to   (PHE209)  IGG FAB (HUMAN IGG1, KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER  |   IMMUNOGLOBULIN, IMMUNOGLOBULIN C REGION, GLYCOPROTEIN, ANTIB 
4i9w:D   (ALA108) to   (ASN211)  HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE  |   POTASSIUM ION CHANNEL, METAL TRANSPORT 
4i9w:F   (ALA108) to   (ASN211)  HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE  |   POTASSIUM ION CHANNEL, METAL TRANSPORT 
1ots:F   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX  |   CLC CHLORIDE CHANNEL, FAB COMPLEX, MEMBRANE PROTEIN 
1otu:D   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX  |   ION CHANNEL, CLC CHLORIDE CHANNEL, FAB COMPLEX, MEMBRANE PROTEIN 
1otu:F   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX  |   ION CHANNEL, CLC CHLORIDE CHANNEL, FAB COMPLEX, MEMBRANE PROTEIN 
1cr9:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4  |   ANTI-PRION ANTIBODY, FAB 3F4, IMMUNE SYSTEM 
1ct8:A   (ALA109) to   (ASN210)  CATALYTIC ANTIBODY 7C8 COMPLEX  |   ABZYME TRANSITION STATE ANALOG, IMMUNE SYSTEM 
4xmk:L   (THR108) to   (SER207)  CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE  |   HIV-1 GP120, MONOCLONAL ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4xmk:M   (THR108) to   (ARG210)  CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE  |   HIV-1 GP120, MONOCLONAL ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4xmk:N   (THR108) to   (SER207)  CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE  |   HIV-1 GP120, MONOCLONAL ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3stl:B   (ALA109) to   (ASN212)  KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND  |   CADMIUM, TRANSMEMBRANE PROTEIN, ION CHANNEL, KCSA POTASSIUM CHANNEL, INACTIVATION, MEMBRANE PROTEIN 
3stz:B   (ALA109) to   (ASN212)  KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL  |   TRANSMEMBRANE PROTEIN, ION CHANNEL, KCSA POTASSIUM CHANNEL, INACTIVATION, SPIN-LABEL, MEMBRANE PROTEIN 
2q76:A   (ALA109) to   (ASN210)  MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT  |   ANTIBODY, FAB FRAGMENT, LYSOZYME, AFFINITY MATURATION, VH- VL INTERFACE., IMMUNE SYSTEM 
2q76:C   (ALA109) to   (ARG211)  MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT  |   ANTIBODY, FAB FRAGMENT, LYSOZYME, AFFINITY MATURATION, VH- VL INTERFACE., IMMUNE SYSTEM 
2q8a:L   (ALA109) to   (ASN210)  STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY  |   ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM 
2q8b:L   (ALA109) to   (ASN212)  STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY  |   ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM 
3fzu:D   (THR109) to   (ARG211)  IGG1 FAB CHARACTERIZED BY H/D EXCHANGE  |   IGG1 FAB, IMMUNE SYSTEM 
4xnm:L   (PRO108) to   (PRO207)  ANTIBODY INFLUENZA H5 COMPLEX  |   ANTIBODY, INFLUENZA, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4xnm:A   (PRO108) to   (PRO207)  ANTIBODY INFLUENZA H5 COMPLEX  |   ANTIBODY, INFLUENZA, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4xnq:L   (PRO108) to   (ALA206)  ANTIBODY HEMAGGLUTININ COMPLEXES  |   ANTIBODY, HEMAGGLUTININ, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4xnu:L   (ALA110) to   (ARG212)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH NISOXETINE  |   INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX 
3sy0:A   (ALA108) to   (ASN209)  S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX  |   ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, KDO, IMMUNE SYSTEM 
1d5i:L   (THR109) to   (SER208)  UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY  |   IMMUNE SYSTEM 
4xp5:L   (ALA110) to   (ARG212)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO COCAINE ANALOGUE-RTI55  |   INTEGRAL MEMBRANE PROTEIN, MEMBRANE PROTEIN-TRANSPORT PROTEIN COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX 
4xp6:L   (ALA110) to   (ASN211)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO PSYCHOSTIMULANT METHAMPHETAMINE  |   INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANPORT PROTEIN-INHIBITOR COMPLEX 
4xpg:L   (ALA110) to   (ASN211)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO BETA-CFT OR WIN35428  |   ALL ALPHA-HELICAL INTEGRAL MEMBRANE PROTEIN, TRANSPORT PROTEIN- INHIBITOR COMPLEX 
4xph:L   (ALA110) to   (ARG212)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO 3,4DICHLOROPHENETHYLAMINE  |   INTEGRAL MEMBRANE PROTEIN, NEUROTRANSMITTER TRANSPORTER, PROTEIN TRANSPORT-INHIBITOR COMPLEX 
1d6v:L   (THR109) to   (SER208)  CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION  |   IMMUNE SYSTEM 
1p7k:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)  |   FAB, ANTIBODY, ANTI-DNA ANTIBODY, AUTOANTIBODY, LUPUS, HEPES, IMMUNE SYSTEM 
4xpt:L   (ALA110) to   (ARG212)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS D121G/S426M AND EL2 DELETION OF 162-201 IN COMPLEX WITH SUBSTRATE ANALOGUE 3,4 DICHLOROPHEN ETHYLAMINE  |   INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX, PROTEIN TRANSPORT-INHIBITOR COMPLEX 
1dbj:L   (ALA109) to   (SER208)  MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY  |   IMMUNOGLOBULIN 
1dbm:L   (ALA109) to   (ARG211)  MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY  |   IMMUNOGLOBULIN 
2ck0:L   (ALA108) to   (ARG210)  ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE  |   IMMUNOGLOBULIN 
4xrc:A   (PRO108) to   (PRO207)  ANTIBODY HEMAGGLUTININ COMPLEXES  |   ANTIBODY, HEMAGGLUTININ, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3g5v:A   (ALA109) to   (ASN210)  ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR  |   ANTIBODY, IMMUNE SYSTEM 
3g5y:A   (ALA109) to   (ARG211)  ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR  |   ANTIBODY, IMMUNE SYSTEM 
3g5x:A   (ALA109) to   (ASN212)  ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR  |   ANTIBODY, IMMUNE SYSTEM 
3g5x:C   (ALA109) to   (ASN212)  ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR  |   ANTIBODY, IMMUNE SYSTEM 
3g6j:G   (THR109) to   (ASN210)  C3B IN COMPLEX WITH A C3B SPECIFIC FAB  |   COMPLEMENT, C3B, FAB, ANTIBODY:ANTIGEN, AGE-RELATED MACULAR DEGENERATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, COMPLEMENT ALTERNATE PATHWAY, COMPLEMENT PATHWAY, DISEASE MUTATION, GLYCOPROTEIN, IMMUNE RESPONSE, INFLAMMATORY RESPONSE, INNATE IMMUNITY, PHOSPHOPROTEIN, SECRETED, THIOESTER BOND, IMMUNE SYSTEM 
2cmr:L   (THR108) to   (SER207)  CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX  |   IMMUNE SYSTEM, IMMUNOGLOBULIN COMPLEX, NEUTRALIZATION, IMMUNOGLOBULIN, ENVELOPE PROTEIN, HIV, GP41, AIDS, MHC I, MEMBRANE, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN 
4ioi:A   (THR109) to   (SER208)  MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CANCER IMMUNOTHERAPY 
3t2n:L   (PRO110) to   (PRO209)  HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY  |   TYPE II TRANSMEMBRANE SERINE PROTEASE, SRCR DOMAIN, SUBSTRATES INCLUDE PRO-HEPSIN, PRO-HGF, LAMININ-332, TRANSMEMBRANE, HYDROLASE 
3t2n:M   (PRO110) to   (ALA208)  HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY  |   TYPE II TRANSMEMBRANE SERINE PROTEASE, SRCR DOMAIN, SUBSTRATES INCLUDE PRO-HEPSIN, PRO-HGF, LAMININ-332, TRANSMEMBRANE, HYDROLASE 
3gb7:B   (ALA109) to   (ASN212)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+  |   ION-CHANNEL, ION SELECTIVITY, POTASSIUM TRANSPORT, LITHIUM BLOCK, MEMBRANE PROTEIN, INTEGRAL MEMBRANE PROTEIN, VOLTAGE-GATED POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL 
1dn0:C   (THR110) to   (SER209)  STRUCTURE OF THE FAB FRAGMENT FROM A HUMAN IGM COLD AGGLUTININ  |   FAB, IGM, ANTIBODY, COLD AGGLUTININ, HUMAN, IMMUNE SYSTEM 
3t3m:L   (ALA109) to   (ASN212)  A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS  |   INTEGRIN, CELL ADHESION, BLOOD CLOTTING, FIBRINOGEN, PLATELET 
3t3p:L   (ALA109) to   (ASN210)  A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS  |   INTEGRIN, CELL ADHESION, BLOOD CLOTTING, FIBRINOGEN, PLATELET 
4xvu:D   (THR112) to   (SER211)  STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1  |   MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX 
4xvu:J   (THR112) to   (ASN213)  STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1  |   MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX 
4xvu:L   (THR112) to   (ASN213)  STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1  |   MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX 
4xwo:F   (THR112) to   (ASN213)  STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22  |   MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX 
4xwo:J   (THR112) to   (ASN213)  STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22  |   MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX 
4xwo:L   (THR112) to   (ARG214)  STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22  |   MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX 
2qqn:L   (THR109) to   (ASN210)  NEUROPILIN-1 B1 DOMAIN IN COMPLEX WITH A VEGF-BLOCKING FAB  |   VEGF RECEPTOR, SEMAPHORIN RECEPTOR, PHAGE-DERIVED ANTIBODY, ANGIOGENESIS, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, HEPARAN SULFATE, MEMBRANE, NEUROGENESIS, PROTEOGLYCAN, SECRETED, TRANSMEMBRANE, HORMONE, SIGNALING PROTEIN 
1plg:L   (ALA114) to   (ASN215)  EVIDENCE FOR THE EXTENDED HELICAL NATURE OF POLYSACCHARIDE EPITOPES. THE 2.8 ANGSTROMS RESOLUTION STRUCTURE AND THERMODYNAMICS OF LIGAND BINDING OF AN ANTIGEN BINDING FRAGMENT SPECIFIC FOR ALPHA-(2->8)- POLYSIALIC ACID  |   IMMUNOGLOBULIN 
2qr0:A   (THR109) to   (ARG211)  STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS  |   VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM 
2qr0:G   (THR109) to   (ARG211)  STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS  |   VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM 
2qr0:K   (THR109) to   (ARG211)  STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS  |   VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM 
2qr0:M   (THR109) to   (ARG211)  STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS  |   VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM 
2qr0:S   (THR109) to   (ARG211)  STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS  |   VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM 
2qr0:W   (THR109) to   (ARG211)  STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS  |   VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM 
4xxd:A   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB  |   FAB, AMYLOID-BETA, IMMUNE SYSTEM 
4xxd:D   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB  |   FAB, AMYLOID-BETA, IMMUNE SYSTEM 
1dqj:A   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE ANTI-LYSOZYME ANTIBODY HYHEL-63 COMPLEXED WITH HEN EGG WHITE LYSOZYME  |   ANTIBODY, PROTEIN-PROTEIN COMPLEX, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM/HYDROLASE COMPLEX 
1dqq:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63  |   ANTI-LYSOZYME ANTIBODY, HYHEL-63, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM 
1dqq:C   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63  |   ANTI-LYSOZYME ANTIBODY, HYHEL-63, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM 
3ggw:A   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A CARBOHYDRATE-MIMETIC PEPTIDE  |   PEPTIDE-CARBOHYDRATE MIMICRY, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM 
3ggw:C   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A CARBOHYDRATE-MIMETIC PEPTIDE  |   PEPTIDE-CARBOHYDRATE MIMICRY, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM 
3t77:A   (ALA108) to   (ASN209)  S25-2- A(2-4)KDO DISACCHARIDE COMPLEX  |   ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, KDO, IMMUNE SYSTEM 
2d03:L   (ALA115) to   (ASN218)  CRYSTAL STRUCTURE OF THE G91S MUTANT OF THE NNA7 FAB  |   ANTIBODY, IMMUNE SYSTEM 
3gk8:L   (ALA109) to   (ASN210)  X-RAY CRYSTAL STRUCTURE OF THE FAB FROM MAB 14, MOUSE ANTIBODY AGAINST CANINE PARVOVIRUS  |   ANTIBODY FRAGMENT FROM NEUTRALIZING MONOCLONAL ANTIBODY AGAINST CANINE PARVOVIRUS, IMMUNE SYSTEM 
4xzu:B   (ALA108) to   (ASN211)  CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY  |   IMMUNOGLOBULIN, BLOOD COAGULATION, ANTIBODY, DISCOIDIN, IMMUNE SYSTEM 
3gnm:L   (ALA114) to   (ASN215)  THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT  |   ANTIBODY, IMMUNOGLOBULIN, JAA-F11, THOMPSON-FRIEDENREICH ANTIGEN, IMMUNE SYSTEM 
4j1u:E   (SER114) to   (ARG216)  CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT  |   ANTIBODY MATURATION, ANTIBODY STABILITY, CLONAL SELECTION, IMMUNE SYSTEM 
1e4w:L   (ALA109) to   (ASN212)  CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT  |   IMMUNE SYSTEM, COMPLEX (ANTIBODY/ANTIGEN), CROSS-REACTIVITY, PROTEIN-PEPTIDE RECOGNITION 
2r1w:A   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES  |   FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION, SECRETED, IMMUNE SYSTEM 
2r1x:A   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES  |   FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
1e4x:L   (ALA109) to   (ASN210)  CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT  |   IMMUNE SYSTEM, COMPLEX (ANTIBODY/ANTIGEN), CROSS-REACTIVITY, PROTEIN-PEPTIDE RECOGNITION 
1e4x:M   (ALA109) to   (ASN212)  CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT  |   IMMUNE SYSTEM, COMPLEX (ANTIBODY/ANTIGEN), CROSS-REACTIVITY, PROTEIN-PEPTIDE RECOGNITION 
2r1y:A   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES  |   FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
2r2b:A   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES  |   FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
2r2e:A   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES  |   FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
2r2h:A   (ALA108) to   (ASN209)  STRUCTURE OF S25-2 IN COMPLEX WITH KO  |   FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
3tcl:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04  |   IG, IMMUNOGLOBULIN, IMMUNE SYSTEM 
3tcl:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04  |   IG, IMMUNOGLOBULIN, IMMUNE SYSTEM 
3grw:L   (THR109) to   (SER208)  FGFR3 IN COMPLEX WITH A FAB  |   FGFR3, FAB, PROTEIN-PROTEIN COMPLEX, RECEPTOR TYROSINE KINASE, ATP- BINDING, IMMUNOGLOBULIN DOMAIN, KINASE, MEMBRANE, NUCLEOTIDE- BINDING, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
2dd8:L   (PRO110) to   (ALA209)  CRYSTAL STRUCTURE OF SARS-COV SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING ANTIBODY  |   SARS, S PROTEIN, ANTIBODY, EPITOPES, VACCINES, INHIBITORS, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
1e6j:L   (ALA107) to   (ASN210)  CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5  |   HIV CAPSID PROTEIN (P24), P24, FAB, HIV-1, VIRUS ASSEMBLY, CAPSID, CA, ANTIGEN, ANTIBODY, PROTEIN-PROTEIN INTERACTIONS, VIRAL PROTEIN 
1e6o:L   (ALA107) to   (ASN210)  CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24  |   IMMUNOGLOBULIN, FAB, ANTIBODY, ANTIGEN, HIV-1, P24, CA 
4j8r:A   (ALA107) to   (ARG209)  STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT  |   IMMUNOGLOBULIN FOLD, FAB, ANTIBODY, OCTAPEPTIDE REPEAT, MOUSE PRION PROTEIN, IMMUNE SYSTEM 
4j8r:C   (ALA107) to   (ALA210)  STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT  |   IMMUNOGLOBULIN FOLD, FAB, ANTIBODY, OCTAPEPTIDE REPEAT, MOUSE PRION PROTEIN, IMMUNE SYSTEM 
1q72:L   (ALA109) to   (GLY212)  ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE  |   ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM 
2dqt:L   (ALA109) to   (ASN210)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG  |   CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM 
2dqu:L   (ALA109) to   (ASN210)  CRYSTAL FORM II: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG  |   CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM 
4jdv:B   (THR105) to   (SER204)  CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB  |   IG FOLD, ANTI HIV ANTIBODY, IMMUNE SYSTEM 
4jdv:L   (THR105) to   (SER204)  CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB  |   IG FOLD, ANTI HIV ANTIBODY, IMMUNE SYSTEM 
1q9k:A   (ALA108) to   (ASN211)  S25-2 FAB UNLIGANDED 1  |   ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1q9l:A   (ALA108) to   (ASN209)  S25-2 FAB UNLIGANDED 2  |   ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1q9l:C   (ALA108) to   (ASN211)  S25-2 FAB UNLIGANDED 2  |   ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1q9o:C   (ALA108) to   (ASN211)  S45-18 FAB UNLIGANDED  |   ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1q9w:C   (ALA108) to   (ASN211)  S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX  |   ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CABOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, KDO, PROTEIN-CARBOHYDRATE COMPLEX, IMMUNE SYSTEM 
2r9h:D   (ALA108) to   (ALA211)  CRYSTAL STRUCTURE OF Q207C MUTANT OF CLC-EC1 IN COMPLEX WITH FAB  |   CLC, ANTIPORTER, TRANSPORTER, EXCHANGER, DISULFIDE, CROSSLINK, MEMBRANE PROTEIN, CHLORIDE, INNER MEMBRANE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE 
3tnm:L   (PRO109) to   (PRO208)  CRYSTAL STRUCTURE OF A32 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY  |   ADCC, NON-NEUTRALIZING, ANTI-HIV-1 ENV ANTIBODY A32, CD4I ANTIBODY, FAB, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, IMMUNE SYSTEM 
4jfx:A   (THR109) to   (GLY212)  STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE  |   IMMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4jfx:L   (THR109) to   (ASN210)  STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE  |   IMMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4jfy:A   (THR109) to   (ARG211)  APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD  |   IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4jfy:L   (THR109) to   (GLY212)  APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD  |   IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
1egj:L   (GLY109) to   (ARG211)  DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY  |   CYTOKINE RECEPTOR COMPLEXED TO AN ANTIBODY, IMMUNE SYSTEM 
4ybl:L   (PRO109) to   (PRO208)  CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC MEDIATING ANTI-HIV-1 ANTIBODY A32  |   ADCC, NON-NEUTRALIZING, ANTI-HIV-1 ENV ANTIBODY A32, CD4I ANTIBODY, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4ybl:C   (PRO109) to   (PRO208)  CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC MEDIATING ANTI-HIV-1 ANTIBODY A32  |   ADCC, NON-NEUTRALIZING, ANTI-HIV-1 ENV ANTIBODY A32, CD4I ANTIBODY, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2rcs:L   (THR109) to   (GLY212)  IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY  |   GERMLINE ANTIBODY, FAB, CATALYTIC ANTIBODY, AFFINITY MATURATION 
1qbl:L   (ALA109) to   (ASN210)  FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION  |   IMMUNOGLOBULIN, IGG1 KAPPA, ANTIBODY, FAB FRAGMENT, ANTI- CYTOCHROME C ANTIBODY 
1qbm:L   (ALA109) to   (ASN210)  FAB E8B ANTIBODY, X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN, IGG1 KAPPA, ANTIBODY, FAB FRAGMENT, ANTI- CYTOCHROME C ANTIBODY 
4yc2:C   (PRO109) to   (PRO208)  CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 FROM E. COLI IN COMPLEX WITH THE ANTIBODY A32.  |   ADCC, NON-NEUTRALIZING, ANTI-HIV-1 ENV ANTIBODY A32, CD4I ANTIBODY, CLADE A/E 93TH057, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1ejo:L  (ALA2113) to  (ASN2214)  FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G-H LOOP FROM FMDV.  |   FMDV, ANTIGENIC-ANTIBODY INTERACTIONS, RGD MOTIF, G-H LOOP OF VP1., IMMUNE SYSTEM 
2dwd:B   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+  |   POTASSIUM CHANNEL, MEMBRANE PROTEIN, TETRABUTYLAMMONIUM, K+, KCSA 
4ydk:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC16.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120  |   ANTIBODY, HIV-1, IMMUNE SYSTEM 
4ydl:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120  |   ANTIBODY, HIV-1, IMMUNE SYSTEM 
4ydl:C   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120  |   ANTIBODY, HIV-1, IMMUNE SYSTEM 
4ydv:L   (THR109) to   (ASN210)  STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS  |   IGG, HIV, ANTIBODY, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM 
4ydv:A   (THR109) to   (ASN210)  STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS  |   IGG, HIV, ANTIBODY, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM 
3tt1:L   (ALA113) to   (ARG215)  CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB  |   LEUT FOLD, TRANSPORTER, PLASMA MEMBRANE, TRANSPORT PROTEIN 
3tt1:M   (ALA113) to   (ARG215)  CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB  |   LEUT FOLD, TRANSPORTER, PLASMA MEMBRANE, TRANSPORT PROTEIN 
3tt3:L   (ALA113) to   (ASN216)  CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB  |   LEUT FOLD, TRANSPORTER, PLASMA MEMBRANE, TRANSPORT PROTEIN 
1emt:L   (ALA109) to   (ASN210)  FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY  |   ANTI-FULLERENE ANTIBODY, NANOTUBES, IMMUNE SYSTEM 
4jkp:L   (THR105) to   (SER204)  RESTRICTING HIV-1 PATHWAYS FOR ESCAPE USING RATIONALLY-DESIGNED ANTI- HIV-1 ANTIBODIES  |   IGG, ANTIBODY, GP120, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1qkz:L   (ALA109) to   (ASN212)  FAB FRAGMENT (MN14C11.6) IN COMPLEX WITH A PEPTIDE ANTIGEN DERIVED FROM NEISSERIA MENINGITIDIS P1.7 SEROSUBTYPE ANTIGEN AND DOMAIN II FROM STREPTOCOCCAL PROTEIN G  |   IMMUNE SYSTEM, FAB, PORA, NEISSERIA MENINGITIDIS, PORIN 
4jlr:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB  |   ANTIBODY, DESIGNED IMMUNOGEN, SPECIFIC BINDING, RSV F PROTEIN, IMMUNE SYSTEM 
4jlr:B   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB  |   ANTIBODY, DESIGNED IMMUNOGEN, SPECIFIC BINDING, RSV F PROTEIN, IMMUNE SYSTEM 
1qlr:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ  |   IMMUNOGLOBULIN, AUTOANTIBODY, COLD AGGLUTININ, HUMAN IGM FAB FRAGMENT 
1qlr:C   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ  |   IMMUNOGLOBULIN, AUTOANTIBODY, COLD AGGLUTININ, HUMAN IGM FAB FRAGMENT 
4jm2:B   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4jm4:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF PGT 135 FAB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4jn2:A   (THR115) to   (SER214)  AN ANTIDOTE FOR DABIGATRAN  |   IGG FRAGMENT BINDING DABIGATRAN, DABIGATRAN, IMMUNE SYSTEM-INHIBITOR COMPLEX 
4jn2:L   (THR115) to   (SER214)  AN ANTIDOTE FOR DABIGATRAN  |   IGG FRAGMENT BINDING DABIGATRAN, DABIGATRAN, IMMUNE SYSTEM-INHIBITOR COMPLEX 
4jpi:L   (SER111) to   (SER210)  CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB  |   ANTI-HIV-1, GP120, CD4 BINDING SITE-TARGETING, VRC01 BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
4ygv:B   (THR114) to   (SER213)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4ygv:L   (THR114) to   (SER213)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4yhi:B   (THR114) to   (ASN215)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4yhi:L   (THR114) to   (ASN215)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4yhk:L   (THR114) to   (SER213)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4yhl:L   (THR114) to   (SER213)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4yhm:L   (THR114) to   (SER213)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4jr9:L   (ALA108) to   (ARG210)  CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK  |   TRANSPORTER, IMMUNOGLOBULIN, MAJOR FACILITATOR SUPERFAMILY, EXCHANGER, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4yhn:B   (THR114) to   (SER213)  DABIGATRAN REVERSAL AGENT  |   ANTIBODIES, IMMUNE SYSTEM 
4yhn:L   (THR114) to   (SER213)  DABIGATRAN REVERSAL AGENT  |   ANTIBODIES, IMMUNE SYSTEM 
4yho:L   (THR114) to   (SER213)  REVERSAL AGENT FOR DABIGATRAN  |   ANTIBODY, DABIGATRAN, PRADAXA, ANTIDOTE, REVERSAL AGENT, IMMUNE SYSTEM 
4yhp:B   (THR110) to   (ARG212)  CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE  |   ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM 
4yhp:F   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE  |   ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM 
1f11:A   (ALA109) to   (ASN210)  F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY  |   IMMUNOGLOBULIN, ANTIBODY, FAB, HEPATITIS B, PRES2, IMMUNE SYSTEM 
1f11:C   (ALA109) to   (ARG211)  F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY  |   IMMUNOGLOBULIN, ANTIBODY, FAB, HEPATITIS B, PRES2, IMMUNE SYSTEM 
4jre:C   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND  |   TRANSPORTER, IMMUNOGLOBULIN, MAJOR FACILITATOR SUPERFAMILY, EXCHANGER, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4yhy:C   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF 309M3-B IN COMPLEX WITH TRIMETHYLATED LYS  |   ANTIBODY, FAB, TRIMETHYLATED LYS, IMMUNE SYSTEM 
4yhy:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF 309M3-B IN COMPLEX WITH TRIMETHYLATED LYS  |   ANTIBODY, FAB, TRIMETHYLATED LYS, IMMUNE SYSTEM 
4yhz:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF 304M3-B FAB IN COMPLEX WITH H3K4ME3 PEPTIDE  |   ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K4ME3, IMMUNE SYSTEM 
3tyg:L   (PRO109) to   (PRO211)  CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH A GLYCOSYLATED ENGINEERED GP120 OUTER DOMAIN WITH MINIV3 (EODMV3)  |   GP120, HIV-1, ENV, FAB, HIV-1 NEUTRALIZING ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN 
4yk4:Y   (THR109) to   (SER208)  HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006  |   INFLUENZA, ANTIBODY, COMPLEX, HEMAGGLUTININ, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1f3d:L   (ALA109) to   (ASN212)  CATALYTIC ANTIBODY 4B2 IN COMPLEX WITH ITS AMIDINIUM HAPTEN.  |   CATALYTIC ANTIBODY, AMIDINIUM, HAPTENIC CHARGE, IMMUNE SYSTEM 
1f3d:J   (ALA109) to   (ASN210)  CATALYTIC ANTIBODY 4B2 IN COMPLEX WITH ITS AMIDINIUM HAPTEN.  |   CATALYTIC ANTIBODY, AMIDINIUM, HAPTENIC CHARGE, IMMUNE SYSTEM 
3u0t:C   (THR109) to   (ASN210)  FAB-ANTIBODY COMPLEX  |   ANTIBODY FAB, IMMUNOTHERAPEUTIC, IMMUNE SYSTEM 
3u0t:A   (THR109) to   (ASN210)  FAB-ANTIBODY COMPLEX  |   ANTIBODY FAB, IMMUNOTHERAPEUTIC, IMMUNE SYSTEM 
3u1s:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN FAB PGT145, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY  |   IGG, BROADLY NEUTRALIZING ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM 
1f58:L   (ALA109) to   (ALA212)  IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 24-RESIDUE PEPTIDE (RESIDUES 308-333 OF HIV-1 GP120 (MN ISOLATE) WITH ALA TO AIB SUBSTITUTION AT POSITION 323  |   IMMUNOGLOBULIN, FAB, HIV-1, GP120, V3, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
3u4b:L   (THR109) to   (ASN210)  CH04H/CH02L FAB P4  |   IGG, IMMUNOGLOBULIN, IMMUNE SYSTEM, HIV-1, V1V2-DIRECTED 
3u4e:L   (PRO109) to   (PRO208)  CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45  |   NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM 
1qyg:L   (ALA109) to   (GLY212)  ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE  |   ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM 
1f8t:L   (ALA109) to   (ASN210)  FAB (LNKB-2) OF MONOCLONAL ANTIBODY, CRYSTAL STRUCTURE  |   MONOCLONAL ANTIBODY, ANTIGEN-BINDING FRAGMENT, INTERLEUKIN- 2, X-RAY ANALYSIS, CRYSTAL, IMMUNE SYSTEM 
1f90:L   (ALA109) to   (ARG211)  FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE  |   MONOCLONAL ANTIBODY, ANTIGEN-BINDING FRAGMENT, INTERLEUKIN- 2, ANTIGENIC PEPTIDE, IMMUNE SYSTEM 
1fai:L   (ALA109) to   (ASN212)  THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9, FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY  |   IMMUNOGLOBULIN 
3hc0:L   (THR109) to   (SER208)  BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR  |   IGG1 FAB, BHA10, IMMUNE SYSTEM 
3hc0:B   (THR109) to   (SER208)  BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR  |   IGG1 FAB, BHA10, IMMUNE SYSTEM 
1fbi:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME  |   COMPLEX (ANTIBODY/ANTIGEN) 
3hc3:L   (THR109) to   (SER208)  BHA10 IGG1 FAB DOUBLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR  |   IGG1 FAB, BHA10, IMMUNE SYSTEM 
3hc4:L   (THR109) to   (SER208)  BHA10 IGG1 FAB QUADRUPLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR  |   IGG1 FAB, BHA10, IMMUNE SYSTEM 
2eh7:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMANIZED KR127 FAB  |   HEPATITIS B VIRUS, HUMANIZED ANTIBODY, MONOCLONAL ANTIBODY, NEUTRALIZATION, PRES1, IMMUNE SYSTEM 
2eh8:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE COMPLEX OF HUMANIZED KR127 FAB AND PRES1 PEPTIDE EPITOPE  |   CRYSTAL STRUCTURE, HEPATITIS B VIRUS, HUMANIZED ANTIBODY, MONOCLONAL ANTIBODY, NEUTRALIZATION, PRES1, IMMUNE SYSTEM 
3u7y:L   (THR105) to   (SER204)  STRUCTURE OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV  |   IG FOLD, GP120, ANTI HIV, GLYCOSYLATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2uyl:A   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1  |   FAB FRAGMENT, MONOCLONAL ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, ANTI-LPS VIBRIO CHOLERAE 
2uyl:M   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1  |   FAB FRAGMENT, MONOCLONAL ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, ANTI-LPS VIBRIO CHOLERAE 
2uyl:V   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1  |   FAB FRAGMENT, MONOCLONAL ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, ANTI-LPS VIBRIO CHOLERAE 
2uyl:X   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1  |   FAB FRAGMENT, MONOCLONAL ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, ANTI-LPS VIBRIO CHOLERAE 
1fe8:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING  |   COLLAGEN BINDING, CONFORMATIONAL CHANGES, EPITOPE, VON WILLEBRAND FACTOR A-TYPE DOMAIN, IMMUNE SYSTEM 
1fe8:M   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING  |   COLLAGEN BINDING, CONFORMATIONAL CHANGES, EPITOPE, VON WILLEBRAND FACTOR A-TYPE DOMAIN, IMMUNE SYSTEM 
1fe8:N   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING  |   COLLAGEN BINDING, CONFORMATIONAL CHANGES, EPITOPE, VON WILLEBRAND FACTOR A-TYPE DOMAIN, IMMUNE SYSTEM 
4jzn:D   (THR108) to   (SER207)  THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1  |   FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4jzn:P   (THR108) to   (SER207)  THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1  |   FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4jzo:B   (THR108) to   (ASN209)  THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27  |   FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4jzo:E   (THR108) to   (ASN209)  THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27  |   FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4jzo:F   (THR108) to   (ASN209)  THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27  |   FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4jzo:H   (THR108) to   (ASN209)  THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27  |   FAB FRAGMENT, IMMUNGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
1r3j:A   (ALA109) to   (ASN212)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+  |   MEMBRANE PROTEIN, POTASSIUM CHANNEL, KCSA-FAB COMPLEX, THALLIUM 
1r3k:A   (ALA109) to   (ARG211)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+  |   MEMBRANE PROTEIN, POTASSIUM CHANNEL, KCSA-FAB COMPLEX, THALLIUM 
3hfm:L   (ALA109) to   (ARG211)  STRUCTURE OF AN ANTIBODY-ANTIGEN COMPLEX. CRYSTAL STRUCTURE OF THE HY/HEL-10 FAB-LYSOZYME COMPLEX  |   COMPLEX(ANTIBODY-ANTIGEN) 
3u9u:B   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN ERBB4/HER4 IN COMPLEX WITH THE FAB FRAGMENT OF MAB1479  |   CELL SURFACE RECEPTOR, TRANSFERASE, TYROSINE KINASE RECEPTOR 
3u9u:D   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN ERBB4/HER4 IN COMPLEX WITH THE FAB FRAGMENT OF MAB1479  |   CELL SURFACE RECEPTOR, TRANSFERASE, TYROSINE KINASE RECEPTOR 
3uaj:L   (THR110) to   (ASN211)  CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2  |   DENGUE ANTIBODY MEMBRANE FUSION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3uaj:D   (THR110) to   (ARG212)  CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2  |   DENGUE ANTIBODY MEMBRANE FUSION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1fh5:L   (ALA110) to   (ASN211)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MONOCLONAL ANTIBODY MAK33  |   FAB, BIP, IMMUNE SYSTEM 
4ypg:A   (THR110) to   (ASN211)  STRUCTURAL INSIGHTS INTO THE NEUTRALIZATION PROPERTIES OF A HUMAN ANTI-INTERFERON MONOCLONAL ANTIBODY  |   THERAPEUTIC MAB, IFN-ALPHA2A 
4ypg:L   (THR110) to   (SER209)  STRUCTURAL INSIGHTS INTO THE NEUTRALIZATION PROPERTIES OF A HUMAN ANTI-INTERFERON MONOCLONAL ANTIBODY  |   THERAPEUTIC MAB, IFN-ALPHA2A 
3ubx:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX  |   IMMUNOLOGY, MOUSE CD1D/NKT, MAB, IMMUNE SYSTEM 
3ubx:I   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX  |   IMMUNOLOGY, MOUSE CD1D/NKT, MAB, IMMUNE SYSTEM 
4k23:L   (ALA109) to   (ARG211)  STRUCTURE OF ANTI-UPAR FAB ATN-658  |   IMMUNE SYSTEM 
3uc0:L   (THR110) to   (PHE210)  CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2  |   DENGUE ANTIBODY MEMBRANE FUSION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3uc0:M   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2  |   DENGUE ANTIBODY MEMBRANE FUSION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3hi1:L   (THR109) to   (SER208)  STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105  |   HIV, GP120, CD4 BINDING SITE ANTIBODY, F105, IMMUNE EVASION, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, STRUCTURAL PROTEIN- IMMUNE SYSTEM COMPLEX 
3hi1:A   (THR109) to   (SER208)  STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105  |   HIV, GP120, CD4 BINDING SITE ANTIBODY, F105, IMMUNE EVASION, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, STRUCTURAL PROTEIN- IMMUNE SYSTEM COMPLEX 
3hi5:L   (THR108) to   (GLY211)  CRYSTAL STRUCTURE OF FAB FRAGMENT OF AL-57  |   FAB FRAGMENT, LIGAND MIMETIC, INTEGRIN, I DOMAIN, CELL ADHESION, IMMUNE SYSTEM 
3hi6:L   (THR108) to   (SER207)  CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57  |   INTEGRIN, I DOMAIN, FAB, LIGAND MIMETIC ANTIBODY, CELL ADHESION, ALTERNATIVE SPLICING, CALCIUM, DISULFIDE BOND, GLYCOPROTEIN, MAGNESIUM, MEMBRANE, POLYMORPHISM, RECEPTOR, TRANSMEMBRANE, CELL ADHESION/IMMUNE SYSTEM COMPLEX 
1fj1:A   (ALA109) to   (ASN210)  LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2  |   OSPA, LYME DISEASE, ANTIBODY FAB FRAGMENT, NEUTRALIZING EPITOPE, IMMUNE SYSTEM 
1fj1:C   (ALA109) to   (ASN210)  LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2  |   OSPA, LYME DISEASE, ANTIBODY FAB FRAGMENT, NEUTRALIZING EPITOPE, IMMUNE SYSTEM 
4yr6:B   (ALA109) to   (ASN212)  FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE  |   GPIBA SHEDDING INHIBITOR, 5G6, KL10, IMMUNE SYSTEM 
4yr6:E   (ALA109) to   (ASN210)  FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE  |   GPIBA SHEDDING INHIBITOR, 5G6, KL10, IMMUNE SYSTEM 
1fl3:L   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF THE BLUE FLUORESCENT ANTIBODY (19G2) IN COMPLEX WITH STILBENE HAPTEN AT 277K  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1fl3:B   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF THE BLUE FLUORESCENT ANTIBODY (19G2) IN COMPLEX WITH STILBENE HAPTEN AT 277K  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1fl6:L   (THR109) to   (SER208)  THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4  |   CATALYTIC ANTIBODY, GERMLINE ANTIBODY, SULFIDE OXIDASE, IMMUNE SYSTEM 
1fl6:A   (THR109) to   (GLY212)  THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4  |   CATALYTIC ANTIBODY, GERMLINE ANTIBODY, SULFIDE OXIDASE, IMMUNE SYSTEM 
1fns:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4  |   VON WILLEBRAND FACTOR, GLYCOPROTEIN IBA (A:ALPHA) BINDING, COMPLEX (WILLEBRAND-IMMUNOGLOBULIN), BLOOD COAGULATION TYPE 2B VON WILLEBRAND DISEASE, IMMUNE SYSTEM 
2exw:D   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF A ECCLC-FAB COMPLEX IN THE ABSENCE OF BOUND IONS  |   CLC FAMILY OF CL- CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX 
2exw:F   (ALA108) to   (ALA211)  CRYSTAL STRUCTURE OF A ECCLC-FAB COMPLEX IN THE ABSENCE OF BOUND IONS  |   CLC FAMILY OF CL- CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX 
2exy:D   (ALA108) to   (ALA211)  CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC, FAB COMPLEXED IN ABSENCE OF BOUND IONS  |   CLC FAMILY OF CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX 
2exy:F   (ALA108) to   (ALA211)  CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC, FAB COMPLEXED IN ABSENCE OF BOUND IONS  |   CLC FAMILY OF CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX 
2ez0:D   (ALA108) to   (ALA211)  CRYSTAL STRUCTURE OF THE S107A/E148Q/Y445A MUTANT OF ECCLC, IN COMPLEX WITH A FAB FRAGMENT  |   CLC FAMILY OF CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX 
2ez0:F   (ALA108) to   (ALA211)  CRYSTAL STRUCTURE OF THE S107A/E148Q/Y445A MUTANT OF ECCLC, IN COMPLEX WITH A FAB FRAGMENT  |   CLC FAMILY OF CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX 
2v7h:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT  |   MONOCLONAL ANTIBODY, MANNOPYRANOSIDE SPECIFICITY, MOLECULAR MIMICRY, IMMUNE SYSTEM 
2v7n:A   (THR150) to   (GLY253)  UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4  |   BINDING PROTEIN, RECOMBINANT FAB FRAGMENT, SYNTHETIC ANTIBODY LIBRARY (HUCAL), PHAGE DISPLAY, IMMUNE SYSTEM 
2v7n:C   (THR150) to   (SER249)  UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4  |   BINDING PROTEIN, RECOMBINANT FAB FRAGMENT, SYNTHETIC ANTIBODY LIBRARY (HUCAL), PHAGE DISPLAY, IMMUNE SYSTEM 
2v7n:E   (THR150) to   (GLY253)  UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4  |   BINDING PROTEIN, RECOMBINANT FAB FRAGMENT, SYNTHETIC ANTIBODY LIBRARY (HUCAL), PHAGE DISPLAY, IMMUNE SYSTEM 
2v7n:G   (THR150) to   (ARG252)  UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4  |   BINDING PROTEIN, RECOMBINANT FAB FRAGMENT, SYNTHETIC ANTIBODY LIBRARY (HUCAL), PHAGE DISPLAY, IMMUNE SYSTEM 
1frg:L   (ALA115) to   (ARG217)  CRYSTAL STRUCTURE, SEQUENCE, AND EPITOPE MAPPING OF A PEPTIDE COMPLEX OF AN ANTI-INFLUENZA HA PEPTIDE ANTIBODY FAB 26(SLASH)9: FINE-TUNING ANTIBODY SPECIFICITY  |   IMMUNOGLOBULIN/VIRUS HEMAGGLUTININ, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1rfd:L   (ALA109) to   (ASN210)  ANTI-COCAINE ANTIBODY M82G2  |   ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM 
1fsk:B   (ALA109) to   (ASN210)  COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1  |   BET V 1, BV16 FAB FRAGMENT, ANTIBODY ALLERGEN COMPLEX, IMMUNE SYSTEM 
1fsk:E   (ALA109) to   (ASN210)  COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1  |   BET V 1, BV16 FAB FRAGMENT, ANTIBODY ALLERGEN COMPLEX, IMMUNE SYSTEM 
1fsk:H   (ALA109) to   (ASN210)  COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1  |   BET V 1, BV16 FAB FRAGMENT, ANTIBODY ALLERGEN COMPLEX, IMMUNE SYSTEM 
1fsk:K   (ALA109) to   (ASN210)  COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1  |   BET V 1, BV16 FAB FRAGMENT, ANTIBODY ALLERGEN COMPLEX, IMMUNE SYSTEM 
4k7p:X   (THR109) to   (ASN210)  GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
2f19:L   (ALA109) to   (ASN210)  THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9, FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY  |   IMMUNOGLOBULIN 
3ujt:L   (ALA109) to   (ASN210)  STRUCTURE OF THE FAB FRAGMENT OF AB-52, AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS  |   IMMUNOGLOBULIN, IMMUNE SYSTEM, O-ANTIGEN 
3ujt:M   (ALA109) to   (ASN210)  STRUCTURE OF THE FAB FRAGMENT OF AB-52, AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS  |   IMMUNOGLOBULIN, IMMUNE SYSTEM, O-ANTIGEN 
1rhh:C   (THR108) to   (GLY211)  CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION  |   FAB, ANTIBODY, X5, HIV-1, BROADLY NEUTRALIZING, IMMUNE SYSTEM 
1rih:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF FAB 14F7, A UNIQUE ANTI-TUMOR ANTIBODY SPECIFIC FOR N-GLYCOLYL GM3  |   ANTIBODY, CARBOHYDRATE-BINDING FAB, SPECIFIC FOR NEUGC-GM3, IMMUNOGLOBULIN, BETA-SHEET TOPOLOGY, IMMUNE SYSTEM 
4k94:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF KIT D4D5 FRAGMENT IN COMPLEX WITH ANTI-KIT ANTIBODY FAB19  |   RECEPTOR TYROSINE KINASE (RTK), FAB, IG SF, IMMUNE SYSTEM 
1riv:L   (ALA109) to   (ASN210)  ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE  |   ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM 
4kaq:L   (THR108) to   (GLY211)  STRUCTURE OF RITUXIMAB FAB  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
2f5b:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41, IMMUNOGLOBULIN 
1rmf:L   (ALA114) to   (ASN215)  STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN 
2f5a:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5  |   FAB, HIV-1 NEUTRALIZATION, GP41, IMMUNOGLOBULIN 
3hmw:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF USTEKINUMAB FAB  |   USTEKINUMAB, CNTO1275, IL-12, IL-23, ANTIBODY, FAB, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3hmx:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX  |   USTEKINUMAB, CNTO1275, IL-12, IL-23, ANTIBODY, FAB, MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, SECRETED, GROWTH FACTOR, CYTOKINE-MMUNE SYSTEM COMPLEX, CYTOKINE-IMMUNE SYSTEM COMPLEX 
4z0b:L   (ALA108) to   (ARG211)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-OFLOXACIN ANTIBODY AND EXPLORATION ITS RECEPTOR BINDING SITE  |   OFLOXACIN ELISA FAB, IMMUNE SYSTEM 
3hns:L   (ALA109) to   (ASN212)  CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE  |   ANTIBODY-CARBOHYDRATE COMPLEX, OLIGOFURANOSIDE, TUBERCULOSIS, IMMUNE SYSTEM 
3hnt:L   (ALA109) to   (ASN212)  CS-35 FAB COMPLEX WITH A LINEAR, TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN  |   ANTIBODY-CARBOHYDRATE COMPLEX, OLIGOFURANOSIDE, TUBERCULOSIS, IMMUNE SYSTEM 
3hnv:L   (ALA109) to   (ASN212)  CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE)  |   ANTIBODY-CARBOHYDRATE COMPLEX, OLIGOFURANOSIDE, TUBERCULOSIS, IMMUNE SYSTEM 
2fbj:L   (ALA108) to   (ASN211)  REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN 
1ru9:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE (A) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED IN-HOUSE.  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM 
1rua:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE (B) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM 
1ruk:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE (C) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM 
1rul:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE (D) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 5.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM 
1rum:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE (F) OF H2O2-SOAKED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM 
1ruq:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE (H) OF U.V.-IRRADIATED DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED IN HOUSE.  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM 
1rur:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE (I) OF NATIVE DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9- 1.  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM 
2fec:O   (ALA108) to   (ALA211)  STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI  |   CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN 
2fee:L   (ALA108) to   (ALA211)  STRUCTURE OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI IN NABR  |   CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN 
2fed:D   (ALA108) to   (ALA211)  STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI  |   CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN 
2fed:F   (ALA108) to   (ARG210)  STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI  |   CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN 
2vdq:L   (ALA109) to   (ARG211)  INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQRGDV  |   CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, PLATELET INTEGRIN ALPHAIIBBETA3, GLYCOPROTEIN, CELL ADHESION, MEMBRANE, INTEGRIN, RECEPTOR, ANTAGONIST, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, CELL ADHESION/IMMUNE SYSTEM COMPLEX 
2fgw:L   (THR109) to   (ASN210)  X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
1rz7:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 48D  |   HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM 
1rz8:C   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B  |   HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM 
1rzg:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D  |   HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM 
1rzg:D   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D  |   HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM 
1rzi:K   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB  |   HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM 
1rzi:O   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB  |   HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM 
4z5r:P   (THR109) to   (ARG211)  RONTALIZUMAB FAB BOUND TO INTERFERON-A2  |   ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX 
4kjq:D   (ALA108) to   (ALA211)  STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE  |   MEMBRANE TRANSPORTER, FLUORIDE, TRANPORT PROTEIN, MEMBRANE PROTEIN 
4kjq:F   (ALA108) to   (ALA211)  STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE  |   MEMBRANE TRANSPORTER, FLUORIDE, TRANPORT PROTEIN, MEMBRANE PROTEIN 
4kjw:D   (ALA108) to   (ALA211)  STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN, MEMBRANE PROTEIN 
4kjw:F   (ALA108) to   (ALA211)  STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN, MEMBRANE PROTEIN 
1g9m:L   (THR111) to   (ASN212)  HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B  |   COMPLEX (HIV ENVELOPE PROTEIN-CD4-FAB), HIV-1 EXTERIOR ENVELOPE GP120 FROM LABORATORY-ADAPTED ISOLATE, HXBC2, SURFACE T-CELL GLYCOPROTEIN CD4, ANTIGEN-BINDING FRAGMENT OF HUMAN IMMUNOGLOBULIN 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2fjf:C   (THR109) to   (SER208)  STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB  |   ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM 
2fjf:G   (THR109) to   (SER208)  STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB  |   ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM 
2fjf:O   (THR109) to   (ARG211)  STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB  |   ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM 
2fjf:S   (THR109) to   (SER208)  STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB  |   ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM 
2fjf:U   (THR109) to   (PHE209)  STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB  |   ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM 
2fjg:L   (THR109) to   (ARG211)  STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF  |   PROTEIN FAB COMPLEX, FAB, VEGF, CYSTINE KNOT, HORMONE-GROWTH FACTOR- IMMUNE SYSTEM COMPLEX 
2fjg:A   (THR109) to   (ARG211)  STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF  |   PROTEIN FAB COMPLEX, FAB, VEGF, CYSTINE KNOT, HORMONE-GROWTH FACTOR- IMMUNE SYSTEM COMPLEX 
2fjh:A   (THR109) to   (SER208)  STRUCTURE OF THE B20-4 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF  |   VEGF, FAB, PROTEIN FAB COMPLEX, CYSTINE KNOT, HORMONE-GROWTH FACTOR- IMMUNE SYSTEM COMPLEX 
4kk5:D   (ALA108) to   (ALA211)  STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE  |   MEMBRANE TRANSPORTER, FLUORIDE, BROMIDE, TRANSPORT PROTEIN 
4kk5:F   (ALA108) to   (ALA211)  STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE  |   MEMBRANE TRANSPORTER, FLUORIDE, BROMIDE, TRANSPORT PROTEIN 
1gaf:L   (THR109) to   (PHE209)  48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA- NITROPHENYL PHOSPHONATE)-PENTANOIC ACID  |   ESTER HYDROLYSIS, ESTEROLYTIC, FAB, CATALYTIC ANTIBODY 
4kk6:D   (ALA108) to   (ALA211)  STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
4kk6:F   (ALA108) to   (ALA211)  STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
4kk9:D   (ALA108) to   (ALA211)  STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
4kk9:F   (ALA108) to   (ALA211)  STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
4kkb:D   (ALA108) to   (ALA211)  STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
4kkb:F   (ALA108) to   (ALA211)  STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
4kka:D   (ALA108) to   (ALA211)  STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
4kka:F   (ALA108) to   (ALA211)  STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
3utz:D   (THR114) to   (ARG216)  ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL  |   STRUCTURAL GENOMICS, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, FAB DOMAIN, IMMUNE SYSTEM 
3utz:E   (THR114) to   (ARG216)  ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL  |   STRUCTURAL GENOMICS, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, FAB DOMAIN, IMMUNE SYSTEM 
4kkc:D   (ALA108) to   (ALA211)  STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
4kkc:F   (ALA108) to   (ALA211)  STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
4kkl:D   (ALA108) to   (ALA211)  STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE  |   MEMBRANE TRANSPORTER, TRANPORT PROTEIN, MEMBRANE PROTEIN 
4kkl:F   (ALA108) to   (ALA211)  STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE  |   MEMBRANE TRANSPORTER, TRANPORT PROTEIN, MEMBRANE PROTEIN 
4z7n:L   (ALA109) to   (ASN212)  INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE  |   CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX 
4z7o:L   (ALA109) to   (ASN212)  INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE  |   CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX 
4z8f:L   (ALA109) to   (ASN210)  FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA, 5'-P5(DT)P- 3'  |   ANTIBODY, FAB, CARBOHYDRATE, LIPID A, DNA, IMMUNE SYSTEM-DNA COMPLEX 
3hr5:A   (THR114) to   (SER213)  M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB  |   FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM 
3hr5:P   (THR114) to   (ASN215)  M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB  |   FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM 
3hr5:Q   (THR114) to   (SER213)  M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB  |   FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM 
1s3k:L   (THR114) to   (SER213)  CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE  |   IMMUNOGLOBULIN FOLD, BETA BARREL, HUMANIZED ANTIBODY, ANTIGEN BINDING FRAGMENT, IMMUNE SYSTEM 
1ggb:L   (ALA109) to   (ARG211)  MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY  |   IMMUNOGLOBULIN 
1ggc:L   (ALA109) to   (ARG211)  MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY  |   IMMUNOGLOBULIN 
1s5h:A   (ALA109) to   (ARG211)  POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+  |   K+ CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, SELECTIVITY FILTER, ION OCCUPANCY, MEMBRANE PROTEIN 
1s5i:L   (ALA109) to   (ASN210)  FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2, CRYSTAL STRUCTURE  |   MONOCLONAL ANTIBODY, ANTIGEN-BINDING FRAGMENT, INTERLEUKIN- 2, X-RAY ANALYSIS, CRYSTAL STRUCTURE, IMMUNE SYSTEM 
1ggi:M   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN  |   IMMUNOGLOBULIN 
4zd3:L   (THR129) to   (LYS227)  STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY FAB FRAGMENT  |   TRANSGLUTAMINASE 2, ANTIBODY, FAB FRAGMENT, CELIAC DISEASE, IMMUNE SYSTEM 
3v0v:L   (GLY109) to   (ARG211)  FAB WN1 222-5 UNLIGANDED  |   BETA SHEETS, ANTIBODY, FAB, IMMUNE SYSTEM 
4zff:B   (THR109) to   (SER208)  DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF  |   FAB, DAF, ANGIOGENESIS, TIE RECEPTOR, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
4zff:L   (THR109) to   (SER208)  DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF  |   FAB, DAF, ANGIOGENESIS, TIE RECEPTOR, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
4zfg:L   (THR109) to   (SER208)  DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2  |   FAB, DAF, ANGIOGENESIS, TIE RECEPTOR, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
2vl5:B   (ALA113) to   (ASN214)  STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1  |   RHEUMATOID FACTOR, IMMUNE SYSTEM, ARTHRITIS, AUTOANTIBODIES, COLLAGEN TYPE II 
2vl5:D   (ALA113) to   (ASN214)  STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1  |   RHEUMATOID FACTOR, IMMUNE SYSTEM, ARTHRITIS, AUTOANTIBODIES, COLLAGEN TYPE II 
4zfo:L   (THR109) to   (SER208)  J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269)  |   ANTIBODY FAB-LIGAND COMPLEX ANTI-BCMA ANTI-TUMOR, IMMUNE SYSTEM 
4zfo:B   (THR109) to   (SER208)  J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269)  |   ANTIBODY FAB-LIGAND COMPLEX ANTI-BCMA ANTI-TUMOR, IMMUNE SYSTEM 
1seq:L   (ALA108) to   (SER211)  FAB MNAC13  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4kph:L   (ALA109) to   (ASN212)  STRUCTURE OF THE FAB FRAGMENT OF N62, A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN  |   ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM, CARBOHYDRATE/SUGAR BINDING, PLASMA 
2fx7:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 16-RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
2fx8:M   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
2fx8:N   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
2fx8:O   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
2fx9:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
2fx9:M   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
3hzk:A   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM 
3hzm:A   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM 
3hzv:A   (ALA108) to   (ARG210)  CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM 
3hzy:A   (ALA108) to   (ARG210)  CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM 
4kq4:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3v6f:B   (ALA116) to   (ARG218)  CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND  |   IMMUNOGLOBULIN DOMAIN, ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM 
3v6f:D   (ALA116) to   (ARG218)  CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND  |   IMMUNOGLOBULIN DOMAIN, ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM 
3v6f:F   (ALA116) to   (ARG218)  CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND  |   IMMUNOGLOBULIN DOMAIN, ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM 
3v6f:L   (ALA116) to   (ARG218)  CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND  |   IMMUNOGLOBULIN DOMAIN, ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM 
3v6o:F   (ALA111) to   (ARG213)  LEPTIN RECEPTOR-ANTIBODY COMPLEX  |   RECEPTOR-ANTIBODY COMPLEX, CYTOKINE RECEPTOR, ANTIBODY FAB FRAGMENT, IMMUNOGLOBULIN FOLD, LEPTIN RECEPTOR-ANTIBODY COMPLEX, IMMUNE SYSTEM 
3v6z:B   (ALA116) to   (ARG218)  CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN  |   DIMER INVERSION, FOUR-HELIX BUNDLE, IMMUNE SYSTEM 
3v6z:D   (ALA116) to   (ARG218)  CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN  |   DIMER INVERSION, FOUR-HELIX BUNDLE, IMMUNE SYSTEM 
3v7a:G   (ALA110) to   (ASN211)  STRUCTURAL BASIS FOR BROAD DETECTION OF GENOGROUP II NOROVIRUSES BY A MONOCLONAL ANTIBODY THAT BINDS TO A SITE OCCLUDED IN THE VIRAL PARTICLE  |   VIRUS, PROTEIN-FAB COMPLEX, BROADLY-REACTIVE ANTIBODY, IMMUNE SYSTEM 
3v7a:H   (ALA110) to   (ASN211)  STRUCTURAL BASIS FOR BROAD DETECTION OF GENOGROUP II NOROVIRUSES BY A MONOCLONAL ANTIBODY THAT BINDS TO A SITE OCCLUDED IN THE VIRAL PARTICLE  |   VIRUS, PROTEIN-FAB COMPLEX, BROADLY-REACTIVE ANTIBODY, IMMUNE SYSTEM 
1gpo:L   (ALA114) to   (ARG216)  CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT  |   PROTEIN ENGINEERING, ANTIBODY DESIGN, IMMUNOGLOBULIN STRUCTURE, ANTIGEN-BINDING SITE, CANONICAL CONFORMATION, COMPLEMENTARITY- DETERMINING REGION, IMMUNE SYSTEM 
1gpo:M   (ALA114) to   (ASN217)  CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT  |   PROTEIN ENGINEERING, ANTIBODY DESIGN, IMMUNOGLOBULIN STRUCTURE, ANTIGEN-BINDING SITE, CANONICAL CONFORMATION, COMPLEMENTARITY- DETERMINING REGION, IMMUNE SYSTEM 
3i2c:L   (ALA113) to   (ASN214)  CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO4088  |   IL-23, ANTIBODY, FAB, IMMUNE SYSTEM 
2g2r:L   (ALA109) to   (ASN212)  GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)  |   IMMUNOGLOBULIN,GREEN-FLUORESCENT ANTIBODY, STILBENE-COMPLEX, IMMUNE SYSTEM 
2g2r:A   (ALA109) to   (ASN212)  GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)  |   IMMUNOGLOBULIN,GREEN-FLUORESCENT ANTIBODY, STILBENE-COMPLEX, IMMUNE SYSTEM 
2vq1:A   (ALA109) to   (ARG211)  ANTI TRIMERIC LEWIS X FAB54-5C10-A  |   MONOCLONAL ANTIBODY, RECEPTOR, DIAGNOSIS, SCHISTOSOMIASIS, CARBOHYDRATE RECOGNITION, IMMUNE SYSTEM 
2vq1:E   (ALA109) to   (ASN210)  ANTI TRIMERIC LEWIS X FAB54-5C10-A  |   MONOCLONAL ANTIBODY, RECEPTOR, DIAGNOSIS, SCHISTOSOMIASIS, CARBOHYDRATE RECOGNITION, IMMUNE SYSTEM 
2g5b:A   (ALA108) to   (ASN211)  CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.  |   6A7, BAX, FAB, ANTIBODY, FAB-PEPTIDE COMPLEX, APOPTOSIS 
2g5b:C   (ALA108) to   (ASN211)  CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.  |   6A7, BAX, FAB, ANTIBODY, FAB-PEPTIDE COMPLEX, APOPTOSIS 
2g5b:E   (ALA108) to   (ASN211)  CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.  |   6A7, BAX, FAB, ANTIBODY, FAB-PEPTIDE COMPLEX, APOPTOSIS 
2g5b:G   (ALA108) to   (ASN211)  CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.  |   6A7, BAX, FAB, ANTIBODY, FAB-PEPTIDE COMPLEX, APOPTOSIS 
4kuz:L   (THR114) to   (ASN215)  CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4kvn:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF FAB 39.29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/PERTH/16/2009 (H3N2)  |   IGG, ANTIBODY, IMMUNE SYSTEM 
2g75:B   (PRO110) to   (PRO209)  CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY  |   SARS, S PROTEIN, ANTIBODY, EPITOPES, VACCINES, INHIBITORS, IMMUNE SYSTEM 
2g75:D   (PRO110) to   (PRO209)  CRYSTAL STRUCTURE OF ANTI-SARS M396 ANTIBODY  |   SARS, S PROTEIN, ANTIBODY, EPITOPES, VACCINES, INHIBITORS, IMMUNE SYSTEM 
2vwe:J   (ALA108) to   (ASN211)  CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT  |   IMMUNE SYSTEM, GLYCOPROTEIN, CYSTEINE-KNOT, GROWTH FACTOR, VEGF-B, MITOGEN, SECRETED, ANGIOGENESIS, NEUTRALIZING ANTIBODY, HEPARIN-BINDING, ALTERNATIVE SPLICING 
2vxq:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB  |   RECEPTOR, SECRETED, RPHL P 2, ALLERGEN, ALLERGEN/IGE FAB COMPLEX, RECOMBINANT GRASS POLLEN ALLERGEN 
2vxt:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB  |   FAB, IL-18, SECRETED, CYTOKINE, AUTOIMMUNITY, GLYCOPROTEIN, TH1/TH2 CELLS, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
2vxu:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT  |   FAB, IL-18, AUTOIMMUNITY, TH1/TH2 CELLS, IMMUNE SYSTEM 
2vxu:M   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT  |   FAB, IL-18, AUTOIMMUNITY, TH1/TH2 CELLS, IMMUNE SYSTEM 
2vxv:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT  |   IMMUNE SYSTEM, IL-18, FAB, TH1/TH2 CELLS, AUTOIMMUNITY 
2gfb:A   (GLY109) to   (ASN212)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
2gfb:C   (GLY109) to   (ASN212)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
2gfb:E   (GLY109) to   (ASN212)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
2gfb:G   (GLY109) to   (ASN212)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
2gfb:I   (GLY109) to   (ASN212)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
2gfb:K   (GLY109) to   (ASN212)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
2gfb:M   (GLY109) to   (ASN212)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
2gfb:O   (GLY109) to   (ASN212)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
4kzd:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF AN RNA APTAMER IN COMPLEX WITH FLUOROPHORE AND FAB  |   G-QUADRUPLEX, FLUORESCENCE, FLUOROPHORE BINDING, IN VITRO, IMMUNE SYSTEM-RNA COMPLEX 
1sy6:L   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF CD3GAMMAEPSILON HETERODIMER IN COMPLEX WITH OKT3 FAB FRAGMENT  |   CD3 GAMMA, CD3 EPSILON, OKT3 FAB, SIGNALING PROTEIN/ANTIBIOTIC COMPLEX 
3vfg:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE  |   IMMUNOGLOBULIN, ANTIBODY, GD2 GANGLIOSIDE, IMMUNE SYSTEM 
3vg0:L   (ALA111) to   (ASN212)  ANTIBODY FAB FRAGMENT  |   ANTIBODY FAB FRAGMENT, IMMUNOGLOBULIN FOLD, N-LINKED GLYCOSYLATION SITE, FAB FRAGMENT, LBD DOMAIN OF OBR RECEPTOR, IMMUNE SYSTEM 
3vg9:B   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION  |   7 TRANSMEMBRANE RECEPTOR, SIGNAL TRANSDUCTION, SIGNALING PROTEIN 
3vi4:E   (ALA114) to   (ARG216)  CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE  |   BETA PROPELLER FOLD, ROSSMANN FOLD, BETA SANDWICH, FIBRONECTIN RECEPTOR, CELL ADHESION-IMMUNE SYSTEM COMPLEX 
1t2q:L   (ALA115) to   (ASN218)  THE CRYSTAL STRUCTURE OF AN NNA7 FAB THAT RECOGNIZES AN N-TYPE BLOOD GROUP ANTIGEN  |   FAB, GLYCOPHORIN A, BLOOD GROUP ANTIGEN, IMMUNE SYSTEM 
2gjz:L   (ALA109) to   (ASN212)  STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)  |   IMMUNOGLOBULIN,CATALYTIC ANTIBODY, ELIMINATION, IMMUNE SYSTEM 
2gjz:A   (ALA109) to   (ASN212)  STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)  |   IMMUNOGLOBULIN,CATALYTIC ANTIBODY, ELIMINATION, IMMUNE SYSTEM 
1t3f:A   (THR109) to   (GLY212)  THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP  |   ANTIBODY ENGINEERING, HUMANIZED AND CHIMERIC ANTIBODY, FAB, X-RAY STRUCTURE, GAMMA-INTERFERON, IMMUNE SYSTEM 
1h3p:L   (ALA109) to   (ARG211)  STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS  |   IMMUNOGLOBULIN, ANTIBODY FAB FRAGMENT 
1t4k:A   (SER109) to   (ASN212)  CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB  |   ENANTIOSELECTIVITY, ALDOLASE ANTIBODY, REACTIVE LYSINE, ALDOL REACTION, IMMUNE SYSTEM 
1t4k:C   (SER109) to   (ASN212)  CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB  |   ENANTIOSELECTIVITY, ALDOLASE ANTIBODY, REACTIVE LYSINE, ALDOL REACTION, IMMUNE SYSTEM 
4l5f:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII  |   ANTIBODY, FAB, NEUTRALIZING, VIRUS, ENVELOPE, VIRAL PROTEIN, IMMUNE SYSTEM, ANTIBODY EPITOPE, INFECTIOUS DISEASE, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID), NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES 
3idg:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWD  |   HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM 
3idj:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(ORN)WAS  |   HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM 
3idi:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ALDKWNQ  |   HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM 
3idm:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(NRG)WAS  |   HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM 
3idn:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(PAF)WAS  |   HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM 
3idx:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C222  |   HIV-1, ANTIBODY, GP120, B13, ENVELOPE GLYCAN PROTEIN, CD4-BINDING SITE, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, HOST- VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM 
1t66:L   (ALA114) to   (ASN215)  THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.  |   ANTIBODY, FAB, FLUORESCEIN, IMMUNE SYSTEM 
1t66:C   (ALA114) to   (ASN215)  THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.  |   ANTIBODY, FAB, FLUORESCEIN, IMMUNE SYSTEM 
2w0f:B   (ALA109) to   (ASN212)  POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM  |   IMMUNE SYSTEM METAL TRANSPORT COMPLEX, QUATERNARY AMMONIUM, PROTEIN-ANTIBODY FAB COMPLEX, IONIC CHANNEL, ION TRANSPORT, POTASSIUM CHANNEL 
3iet:A   (ALA109) to   (GLU212)  CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN  |   GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM 
3iet:C   (ALA109) to   (CYS213)  CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN  |   GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM 
3if1:A   (ALA109) to   (GLU212)  CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC  |   GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM 
3if1:C   (ALA109) to   (GLU212)  CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC  |   GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM 
2gsi:A   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE  |   FAB, IGG, STAPHYLOCOCCAL NUCLEASE, IMMUNE SYSTEM 
2gsi:C   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE  |   FAB, IGG, STAPHYLOCOCCAL NUCLEASE, IMMUNE SYSTEM 
2gsi:E   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE  |   FAB, IGG, STAPHYLOCOCCAL NUCLEASE, IMMUNE SYSTEM 
2gsi:G   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE  |   FAB, IGG, STAPHYLOCOCCAL NUCLEASE, IMMUNE SYSTEM 
4lbe:B   (ALA109) to   (ASN212)  STRUCTURE OF KCSA WITH R122A MUTATION  |   METAL TRANSPORT, PH-GATED POTASSIUM CHANNEL, TRANSPORT PROTEIN, MEMBRANE PROTEIN 
3ikc:A   (ALA108) to   (ASN211)  STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO  |   ANTIBODY, KDO, CHLAMYDIA, LPS, FAB, CARBOHYDRATE, IMMUNE SYSTEM 
4zs6:L   (THR108) to   (ASN209)  RECEPTOR BINDING DOMAIN AND FAB COMPLEX  |   COMPLEX, FAB, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM 
4zs6:D   (THR108) to   (ARG210)  RECEPTOR BINDING DOMAIN AND FAB COMPLEX  |   COMPLEX, FAB, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM 
4zso:A   (ALA108) to   (ASN211)  CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6, A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30, AND AN INHIBITORY ANTIBODY  |   TUMOR LIGAND B7-H6, ANTIBODY, IMMUNE SYSTEM 
4zso:C   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6, A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30, AND AN INHIBITORY ANTIBODY  |   TUMOR LIGAND B7-H6, ANTIBODY, IMMUNE SYSTEM 
4lcu:B   (ALA109) to   (ASN212)  STRUCTURE OF KCSA WITH E118A MUTATION  |   VOLTAGE GATED POTASSIUM CHANNEL, POTASSIUM CHANNEL, TRANSPORT PROTEIN, MEMBRANE PROTEIN, PH-GATED POTASSIUM CHANNEL 
2w60:B   (ALA114) to   (ASN215)  ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4  |   ANTIBODY ANTI-CITRULLIN, ARTHRITIS, IMMUNE SYSTEM 
2w65:B   (ALA114) to   (ASN217)  ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE  |   ARTHRITIS, COLLAGEN TYPE II, ANTIBODY ANTI-CITRULLIN, IMMUNE SYSTEM 
2w65:D   (ALA114) to   (ASN217)  ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE  |   ARTHRITIS, COLLAGEN TYPE II, ANTIBODY ANTI-CITRULLIN, IMMUNE SYSTEM 
4leo:B   (THR115) to   (ASN216)  CRYSTAL STRUCTURE OF ANTI-HER3 FAB RG7116 IN COMPLEX WITH THE EXTRACELLULAR DOMAINS OF HUMAN HER3 (ERBB3)  |   FAB FRAGMENT, THERAPEUTIC ANTIBODY, HER3 RECEPTOR, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
4lex:L   (THR114) to   (SER213)  UNLIGANDED CRYSTAL STRUCTURE OF MAB7  |   FAB FRAGMENT, ANTI-GCGR, FAB HEAVY AND LIGHT CHAIN, ANTIBODY, IMMUNE SYSTEM 
4lf3:A   (THR109) to   (ARG211)  INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR  |   FAB FRAGMENT, GCGR, IMMUNE SYSTEM 
4lf3:D   (THR109) to   (SER208)  INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR  |   FAB FRAGMENT, GCGR, IMMUNE SYSTEM 
1hez:A   (THR109) to   (ARG211)  ANTIBODY-ANTIGEN COMPLEX  |   ANTIBODY, SUPERANTIGEN 
1hez:C   (THR109) to   (SER208)  ANTIBODY-ANTIGEN COMPLEX  |   ANTIBODY, SUPERANTIGEN 
2h1p:L   (ALA114) to   (ASN217)  THE THREE-DIMENSIONAL STRUCTURES OF A POLYSACCHARIDE BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY: IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES  |   ANTIBODY STRUCTURE, CRYPTOCOCCUS, PEPTIDE, PHAGE LIBRARY, POLYSACCHARIDE, COMPLEX (ANTIBODY/PEPTIDE) 
1tjh:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE  |   2F5, ANTIBODY, GP41, HIV-1, NEUTRALIZING, MEMBRANE-PROXIMAL, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1hh6:A   (ALA109) to   (ASN210)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE  |   ANTIBODY/PEPTIDE, POLYSPECIFICITY, CROSSREACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1, IMMUNE SYSTEM 
1hh9:A   (ALA109) to   (ASN210)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE  |   IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIBODY/PEPTIDE), POLYSPECIFICITY, CROSSREACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1 
2h2p:F   (ALA108) to   (ALA211)  CRYSTAL STRUCTURE OF CLC-EC1 IN COMPLEX WITH FAB FRAGMENT IN SECN-  |   CLC; TRANSPORTER; CHLORIDE; ANTIPORT, ION TRANSPORT 
2w9d:L   (ALA108) to   (ASN209)  STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY   AT 1.57 A RESOLUTION.  |   IMMUNE SYSTEM, PRION, PRP, FAB 
1hil:A   (ALA109) to   (ARG211)  STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION  |   IMMUNOGLOBULIN 
1hil:C   (ALA109) to   (ARG211)  STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION  |   IMMUNOGLOBULIN 
1him:H   (ALA109) to   (ASN210)  STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY- ANTIGEN RECOGNITION  |   IMMUNOGLOBULIN 
1hin:L   (ALA109) to   (ARG211)  STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY-ANTIGEN RECOGNITION  |   IMMUNOGLOBULIN 
4liq:L   (THR108) to   (GLY211)  STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CSF-1 RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF RG7155  |   CSF-1 RECEPTOR, RECEPTOR TYROSINE KINASE, ANTIBODY, FAB FRAGMENT, IGG LIKE DOMAIN, IMMUNE SYSTEM 
2h8p:B   (ALA109) to   (ARG211)  STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER  |   CHANNEL, SEMI-SYNTHETIC, ESTER, MEMBRANE PROTEIN 
2h9g:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)  |   PHAGE DISPLAY, PROTEIN ENGINEERING, COMBINATORIAL MUTAGENESIS, ANTIBODY LIBRARY, DEATH RECEPTOR-5, AGONISTS, IMMUNE SYSTEM- APOPTOSIS COMPLEX 
2h9g:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)  |   PHAGE DISPLAY, PROTEIN ENGINEERING, COMBINATORIAL MUTAGENESIS, ANTIBODY LIBRARY, DEATH RECEPTOR-5, AGONISTS, IMMUNE SYSTEM- APOPTOSIS COMPLEX 
1tpx:C   (ALA109) to   (ASN212)  OVINE RECOMBINANT PRP(114-234), ARQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY  |   PRION, ANTIBODY, UNKNOWN FUNCTION 
3ivk:L   (THR110) to   (ASN211)  CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT  |   CATALYTIC RNA, PROTEIN RNA COMPLEX, RNA POLYMERASE RIBOZYME, RNA HAIRPIN EPITOPE, IMMUNE SYSTEM - RNA COMPLEX 
3ivk:B   (THR110) to   (ASN211)  CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT  |   CATALYTIC RNA, PROTEIN RNA COMPLEX, RNA POLYMERASE RIBOZYME, RNA HAIRPIN EPITOPE, IMMUNE SYSTEM - RNA COMPLEX 
4zyk:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14  |   IG DOMAIN, FAB, IMMUNE SYSTEM 
4zyk:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14  |   IG DOMAIN, FAB, IMMUNE SYSTEM 
4lkc:A   (THR110) to   (SER209)  AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO  |   IMMUNOGLOBULIN, ANTIBODY, PCSK9, IMMUNE SYSTEM 
2hfg:L   (THR108) to   (ASN209)  CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB  |   FAB FRAGMENT, TNFRSF, ANTIBODY-RECEPTOR COMPLEX, CRD, IMMUNE SYSTEM 
4lkx:B   (THR109) to   (SER208)  HUMANIZED ANTIBODY 4B12 FAB COMPLEXED WITH A CEMX SEGMENT  |   IMMUNOGLOBULIN, ANTIBODY, FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM 
3ixt:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE  |   FAB, RSV, SYNAGIS, MOTAVIZUMAB, MONOCLONAL, COMPLEX, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM 
3ixt:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE  |   FAB, RSV, SYNAGIS, MOTAVIZUMAB, MONOCLONAL, COMPLEX, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM 
2hh0:L   (THR153) to   (SER268)  STRUCTURE OF AN ANTI-PRP FAB, P-CLONE, IN COMPLEX WITH ITS COGNATE BOVINE PEPTIDE EPITOPE.  |   PRION, PRP, FAB, IMMUNE SYSTEM 
3vrl:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF BMJ4 P24 CAPSID PROTEIN IN COMPLEX WITH A10F9 FAB  |   HIV-1 CAPSIDE P24, CAPSID PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3vrl:F   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF BMJ4 P24 CAPSID PROTEIN IN COMPLEX WITH A10F9 FAB  |   HIV-1 CAPSIDE P24, CAPSID PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
2hkf:L   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF THE COMPLEX FAB M75- PEPTIDE  |   IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM 
2hkh:L   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF THE FAB M75  |   IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM 
5a16:B   (ALA113) to   (ASN214)  CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1  |   IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER 
5a16:D   (ALA113) to   (ASN214)  CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1  |   IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER 
5a16:F   (ALA113) to   (ASN214)  CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1  |   IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER 
2hlf:F   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNELS AND TRANSPOTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX, PROTON TRANSPORT,MEMBRANE PROTEIN 
4lou:D   (ALA108) to   (ALA211)  STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE  |   CL-/H+ ANTIPORTER, MEMBRANE PROTEIN, TRANPORT PROTEIN 
4lou:F   (ALA108) to   (ALA211)  STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE  |   CL-/H+ ANTIPORTER, MEMBRANE PROTEIN, TRANPORT PROTEIN 
1tzg:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41  |   ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
1tzg:M   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41  |   ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
1tzi:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF  |   PHAGE DISPLAY, ANTIBODY LIBRARY, PROTEIN ENGINEERING, IMMUNE SYSTEM 
1hzh:M   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN  |   IMMUNOGLOBULIN, ANTIBODY, B12, IMMUNE SYSTEM 
4lqf:L   (ALA115) to   (ASN216)  STRUCTURE OF MURINE IGG2B A2C7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.3 ANGSTROMS  |   IGG DOMAIN, ANTIBODY-ANTIGEN COMPLEX, FV, CH1, IGG2B, ANTIGEN-BINDING FRAGMENT (FAB), A33R ANTIGEN, PAPAIN DIGEST OF THE MAB, EEV MEMBRANE (OUTER MEMBRANE OF VACCINIA EV FORM), IMMUNE SYSTEM 
3vw3:L   (ALA109) to   (ARG211)  ANTIBODY 64M-5 FAB IN COMPLEX WITH A DOUBLE-STRANDED DNA (6-4) PHOTOPRODUCT  |   PROTEIN-DNA COMPLEX, DNA (6-4) PHOTOPRODUCT, IMMUNOGLOBULIN, IMMUNE SYSTEM-DNA COMPLEX 
4lri:B   (THR114) to   (SER213)  ANTI CMV FAB FRAGMENT  |   FAB FRAGMENT, CMV NEUTRALIZING ANTIBODY, GLYCOPROTEIN H OR GH FROM CMV, IMMUNE SYSTEM 
2hrp:L   (ALA109) to   (ARG211)  ANTIGEN-ANTIBODY COMPLEX  |   FAB FRAGMENT, CROSS-REACTIVITY, HIV1 PROTEASE, ENZYME INHIBITION, COMPLEX (IMMUNOGLOBULIN/PEPTIDE) 
4lss:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE A STRAIN KER_2018_11 GP120  |   ANTIBODY ANTIGEN COMPLEX, NEUTRALIZING ANTIBODY VRC01, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX 
4lst:L   (THR111) to   (ASN212)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE C STRAIN ZM176.66 GP120  |   NEUTRALIZING ANTIBODY VRC01, HIV ENVELOPE GLYCOPROTEIN GP120, ANTIBODY ANTIGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3w14:D   (ALA109) to   (GLY212)  INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1,CR,L2, FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14  |   CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN, HORMONE-HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX 
3w14:Q   (ALA109) to   (GLY212)  INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1,CR,L2, FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14  |   CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN, HORMONE-HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX 
2ht2:D   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
2ht2:F   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
2ht3:D   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445L MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
2ht4:D   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445W MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
2ht4:F   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445W MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
2htk:D   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
2htk:F   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
2htl:D   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445F MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
2htl:F   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445F MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
4lu5:L   (ALA114) to   (ASN215)  STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS  |   IGG DOMAIN, ANTIBODY-ANTIGEN COMPLEX, FV, CH1, IGG2A, ANTIGEN-BINDING FRAGMENT (FAB), A33R ANTIGEN, PAPAIN DIGEST OF THE MAB, EEV MEMBRANE (OUTER MEMBRANE OF VACCINIA EV FORM), IMMUNE SYSTEM 
4lu5:M   (ALA114) to   (ASN217)  STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS  |   IGG DOMAIN, ANTIBODY-ANTIGEN COMPLEX, FV, CH1, IGG2A, ANTIGEN-BINDING FRAGMENT (FAB), A33R ANTIGEN, PAPAIN DIGEST OF THE MAB, EEV MEMBRANE (OUTER MEMBRANE OF VACCINIA EV FORM), IMMUNE SYSTEM 
1u6a:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105  |   IMMUNOGLOBULIN, FAB, F105, GP120, HIV, IMMUNE SYSTEM 
5a3i:D   (THR114) to   (ASN215)  CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ  |   VIRAL PROTEIN, HAEMAGGLUTININ, NEUTRALIZING ANTIBODY, BIRD FLU, H5N1, INFLUENZA VIRUS, GLYCOPROTEIN 
2hvj:B   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+  |   POTASSIUM CHANNEL, MEMBRANE PROTEIN, TETRABUTYLAMMONIUM, K+, KCSA 
1u8k:A   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8h:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8i:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8j:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8m:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8n:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKFAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8o:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKHAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8p:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ECDKWCS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8q:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u91:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW- [DAP]-S (CYCLIC)  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u93:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW- [DAP]-S (CYCLIC)  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u95:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1i7z:A   (THR109) to   (SER208)  ANTIBODY GNC92H2 BOUND TO LIGAND  |   IGG FOLD, ANTIBODY, CHIMERA, IMMUNE SYSTEM 
1i7z:C   (THR109) to   (ASN210)  ANTIBODY GNC92H2 BOUND TO LIGAND  |   IGG FOLD, ANTIBODY, CHIMERA, IMMUNE SYSTEM 
1i9i:L   (ALA114) to   (ARG216)  NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT  |   FAB FRAGMENT, ANTI-TESTOSTERONE, RECOMBINANT, MONOCLONAL, IMMUNE SYSTEM 
1ibg:L   (ALA109) to   (ARG211)  STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50  |   IMMUNOGLOBULIN, FAB, COMPLEX, IMMUNE SYSTEM 
4m1g:L   (ALA110) to   (ASN213)  STRUCTURE OF MURINE IGG2A A27D7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 1.6 ANGSTROMS  |   IGG DOMAIN, ANTIBODY-ANTIGEN COMPLEX, FV, CH1, IGG2A, ANTIGEN-BINDING FRAGMENT (FAB), A33R ANTIGEN, PAPAIN DIGEST OF THE MAB, EEV MEMBRANE (OUTER MEMBRANE OF VACCINIA EV FORM), IMMUNE SYSTEM 
1ifh:L   (ALA109) to   (ARG211)  A DETAILED ANALYSIS OF THE FREE AND BOUND CONFORMATION OF AN ANTIBODY: X-RAY STRUCTURES OF ANTI-PEPTIDE FAB 17(SLASH)9 AND THREE DIFFERENT FAB-PEPTIDE COMPLEXES  |   IMMUNOGLOBULIN 
1igc:L   (ALA109) to   (ASN209)  IGG1 FAB FRAGMENT (MOPC21) COMPLEX WITH DOMAIN III OF PROTEIN G FROM STREPTOCOCCUS  |   PROTEIN G, STREPTOCOCCUS, COMPLEX (ANTIBODY/BINDING PROTEIN) COMPLEX 
1igf:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS  |   IMMUNOGLOBULIN 
1igf:M   (ALA109) to   (ASN210)  CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS  |   IMMUNOGLOBULIN 
1igj:A   (ALA109) to   (ARG211)  26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY  |   IMMUNOGLOBULIN 
1igt:A   (GLY101) to   (ASN210)  STRUCTURE OF IMMUNOGLOBULIN  |   INTACT IMMUNOGLOBULIN V REGION C REGION, IMMUNOGLOBULIN 
1uj3:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI- TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR  |   TISSUE FACTOR, ANTIGEN, ANTIBODY, FAB, IMMUNE SYSTEM/BLOOD CLOTTING COMPLEX 
2i5y:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B  |   HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2i5y:Q   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B  |   HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2i60:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF [PHE23]M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B  |   HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, [PHE23]M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2i60:Q   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF [PHE23]M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B  |   HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, [PHE23]M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3w9d:B   (THR109) to   (SER208)  STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB  |   IGG FOLD, HSV GD, IMMUNE SYSTEM 
3w9d:D   (THR109) to   (SER208)  STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB  |   IGG FOLD, HSV GD, IMMUNE SYSTEM 
3w9e:B   (THR109) to   (SER208)  STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB COMPLEX WITH HSV-2 GD  |   IGG FOLD, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2i9l:A   (ALA114) to   (ASN215)  STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN  |   NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX 
2i9l:C   (ALA114) to   (ASN215)  STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN  |   NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX 
2i9l:E   (ALA114) to   (ASN215)  STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN  |   NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX 
2i9l:G   (ALA114) to   (ASN215)  STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN  |   NEUTRALIZING ANTIBODY, POXVIRUS, ANTIBODY COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX 
4m48:L   (ALA110) to   (ARG212)  X-RAY STRUCTURE OF DOPAMINE TRANSPORTER ELUCIDATES ANTIDEPRESSANT MECHANISM  |   SLC6, NEUROTRANSMITTER TRANSPORTER, TRANSPORT PROTEIN 
1um4:L   (THR111) to   (ASN212)  CATALYTIC ANTIBODY 21H3 WITH HAPTEN  |   CATALYTIC ANTIBODY LIGAND TRANSESTERIFICATION, IMMUNE SYSTEM 
1um5:L   (THR111) to   (ASN212)  CATALYTIC ANTIBODY 21H3 WITH ALCOHOL SUBSTRATE  |   CATALYTIC ANTIBODY LIGAND TRANSESTERIFICATION, IMMUNE SYSTEM 
1iqw:L   (ALA113) to   (ARG215)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A  |   IMMUNOGLOBULIN, FAB, ANTI_FAS, AGONISTIC ANTIBODY, APOPTOSIS, IMMUNE SYSTEM 
4m61:C   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4m6o:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309  |   IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM 
4m7k:L   (THR115) to   (SER214)  CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10  |   ANTIBODY, IMMUNE SYSTEM 
4m7z:C   (ALA109) to   (ASN210)  UNLIGANDED 1 CRYSTAL STRUCTURE OF S25-26 FAB  |   BETA-SANDWICH, CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM 
4m7z:L   (ALA109) to   (ASN210)  UNLIGANDED 1 CRYSTAL STRUCTURE OF S25-26 FAB  |   BETA-SANDWICH, CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM 
4m93:L   (ALA109) to   (ASN210)  UNLIGANDED 2 CRYSTAL STRUCTURE OF S25-26 FAB  |   CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM 
2iff:L   (ALA107) to   (ARG209)  STRUCTURE OF AN ANTIBODY-LYSOZYME COMPLEX: EFFECT OF A CONSERVATIVE MUTATION  |   IMMUNOGLOBULIN/HYDROLASE(O-GLYCOSYL), IMMUNOGLOBULIN-HYDROLASE(O- GLYCOSYL) COMPLEX 
4ma1:C   (ALA109) to   (ASN210)  UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB  |   CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM 
4ma1:F   (ALA109) to   (ASN212)  UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB  |   CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM 
4ma1:L   (ALA109) to   (ASN210)  UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB  |   CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM 
4ma3:L   (ARG114) to   (SER214)  CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095  |   IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM 
4ma7:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE  |   IMMUNOGLOBULIN FOLD, FAB, ANTIBODY, MOUSE PRION PROTEIN, IMMUNE SYSTEM 
4ma8:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE  |   IMMUNOGLOBULIN FOLD, FAB, ANTIBODY, MOUSE PRION PROTEIN, IMMUNE SYSTEM 
4mau:L   (THR113) to   (GLY216)  CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244  |   IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM 
3wd5:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT  |   ANTIBODY BINDING EPITOPE, IMMUNE SYSTEM 
2ih1:B   (ALA109) to   (ASN212)  ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION  |   ION CHANNEL D-AMINO ACID SEMI-SYNTHETIC, MEMBRANE PROTEIN 
2ih3:B   (ALA109) to   (ASN212)  ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION  |   ION CHANNEL D-AMINO ACID SEMI-SYNTHETIC, MEMBRANE PROTEIN 
3we6:B   (ALA114) to   (ASN217)  CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT  |   IMMUNOGLOBLIN, ANTI-PROSTAGLANDIN E2 ANTIBODY, PROSTAGLANDIN E2, IMMUNE SYSTEM 
5ado:L   (THR111) to   (ASN212)  CRYSTAL STRUCTURE OF THE PARAOXON-MODIFIED A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT  |   IMMUNE SYSTEM, ENZYME REPROGRAMMING, ANTIBODIES, IG SUPERFAMILY, IN SILICO ANTIBODY MATURATION 
5adp:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF THE A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT  |   IMMUNE SYSTEM, ENZYME REPROGRAMMING, ANTIBODIES, IG SUPERFAMILY, IN SILICO ANTIBODY MATURATION 
3j2y:A   (ALA108) to   (ASN211)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY 9.8B, IMMUNE SYSTEM 
3j2y:C  (ALA1108) to  (ASN1211)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY 9.8B, IMMUNE SYSTEM 
3j2y:E  (ALA2108) to  (ASN2211)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY 9.8B, IMMUNE SYSTEM 
3j2y:G  (ALA3108) to  (ASN3211)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY 9.8B, IMMUNE SYSTEM 
3j2z:A   (ALA108) to   (ASN211)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M10, IMMUNE SYSTEM 
3j2z:C  (ALA1108) to  (ASN1211)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M10, IMMUNE SYSTEM 
3j2z:E  (ALA2108) to  (ASN2211)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M10, IMMUNE SYSTEM 
3j2z:G  (ALA3108) to  (ASN3211)  ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10  |   ALPHA VIRUS, CHIKUNGUNYA VLP, NEUTRALIZING ANTIBODY M10, IMMUNE SYSTEM 
1uwg:L   (THR109) to   (ARG211)  MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9  |   ANTIBODY, CATALYTIC ANTIBODY 
1uwg:X   (THR109) to   (ARG211)  MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9  |   ANTIBODY, CATALYTIC ANTIBODY 
3wfc:L   (ALA109) to   (ASN210)  REDUCED AND CARBONMONOXIDE-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT  |   METAL-BINDING, MEMBRANE PROTEIN, IMMUNE SYSTEM-OXIDOREDUCTASE COMPLEX 
3wfd:L   (ALA109) to   (ASN212)  REDUCED AND ACETALDOXIME-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT  |   METAL-BINDING, MEMBRANE PROTEIN, IMMUNE SYSTEM-OXIDOREDUCTASE COMPLEX 
1uwx:K   (ALA110) to   (ARG212)  P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT  |   IMMUNE SYSTEM, ANTIBODY/COMPLEX, FAB, IMMUNOGLOBULIN, PROTEIN G, PORA, ANTIBODY, IGB 
1uwx:L   (ALA110) to   (ARG212)  P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT  |   IMMUNE SYSTEM, ANTIBODY/COMPLEX, FAB, IMMUNOGLOBULIN, PROTEIN G, PORA, ANTIBODY, IGB 
3wfe:L   (ALA109) to   (ASN212)  REDUCED AND CYANIDE-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT  |   METAL-BINDING, MEMBRANE PROTEIN, IMMUNE SYSTEM-OXIDOREDUCTASE COMPLEX 
1uyw:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2  |   IMMUNE SYSTEM 
1uyw:N   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2  |   IMMUNE SYSTEM 
1uz6:M   (ALA108) to   (ASN209)  ANTI-LEWIS X FAB FRAGMENT UNCOMPLEXED  |   IMMUNE SYSTEM, ANTIBODY/COMPLEX, ANTIBODY, ANTI-CARBOHYDRATE 
1uz6:V   (ALA108) to   (ASN209)  ANTI-LEWIS X FAB FRAGMENT UNCOMPLEXED  |   IMMUNE SYSTEM, ANTIBODY/COMPLEX, ANTIBODY, ANTI-CARBOHYDRATE 
1uz8:A   (ALA108) to   (ASN209)  ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X  |   IMMUNE SYSTEM, ANTIBODY, ANTI-CARBOHYDRATE 
1uz8:L   (ALA108) to   (ASN211)  ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X  |   IMMUNE SYSTEM, ANTIBODY, ANTI-CARBOHYDRATE 
3whx:B   (ALA114) to   (ARG216)  CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE1 COMPLEX  |   IMMUNOGLOBLIN, ANTI-PROSTAGLANDIN E2 ANTIBODY, PROSTAGLANDIN E2, IMMUNE SYSTEM 
3wih:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.  |   FIBRONECTIN TYPE-III DOMAIN, HEPATOCELLULAR CARCINOMA ANTIGEN, ANGIOGENESIS, IMMUNE SYSTEM 
3wih:M   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.  |   FIBRONECTIN TYPE-III DOMAIN, HEPATOCELLULAR CARCINOMA ANTIGEN, ANGIOGENESIS, IMMUNE SYSTEM 
4mhh:I   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)  |   H5N1 INFLUENZA VIRUS, BROADLY NEUTRALIZING MURINE ANTIBODY, ESCAPE MUTANT, PASSIVE IMMUNOTHERAPY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2ipt:L   (ALA108) to   (ASN209)  PFA1 FAB FRAGMENT  |   WWDDD, CDR, ABETA, IMMUNE SYSTEM 
2ipu:L   (ALA108) to   (ASN209)  PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE  |   WWDDD, CDR, ABETA, IMMUNE SYSTEM 
2iqa:L   (ALA108) to   (ASN209)  PFA2 FAB FRAGMENT, MONOCLINIC APO FORM  |   PFA2, WWDDD, CDR, IMMUNE SYSTEM 
2iqa:A   (ALA108) to   (ASN209)  PFA2 FAB FRAGMENT, MONOCLINIC APO FORM  |   PFA2, WWDDD, CDR, IMMUNE SYSTEM 
1v7m:L   (ALA108) to   (ASN211)  HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB  |   THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX 
1v7m:M   (ALA108) to   (ARG210)  HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB  |   THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX 
1v7n:L   (ALA108) to   (ASN211)  HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB  |   THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX 
1v7n:M   (ALA108) to   (ASN209)  HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB  |   THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX 
1v7n:O   (LEU103) to   (ASN209)  HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB  |   THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX 
3j42:H  (ALA1109) to  (ASN1210)  OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY  |   DENGUE, MATURATION, IMMATURE, ANTIBODY, VIRUS-IMMUNE SYSTEM COMPLEX 
3j42:J  (ALA1109) to  (ASN1210)  OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY  |   DENGUE, MATURATION, IMMATURE, ANTIBODY, VIRUS-IMMUNE SYSTEM COMPLEX 
3j42:L  (ALA1109) to  (ASN1210)  OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY  |   DENGUE, MATURATION, IMMATURE, ANTIBODY, VIRUS-IMMUNE SYSTEM COMPLEX 
1jgu:L   (ALA109) to   (ASN210)  STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4  |   IGG FOLD, IMMUNE SYSTEM 
1jgv:L   (ALA109) to   (ASN210)  STRUCTURAL BASIS FOR DISFAVORED ELIMINATION REACTION IN CATALYTIC ANTIBODY 1D4  |   IGG FOLD, IMMUNE SYSTEM 
1jhk:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF THE ANTI-ESTRADIOL ANTIBODY 57-2  |   ANTIBODY, STEROID, IMMUNE SYSTEM 
1vge:L   (THR109) to   (ASN210)  TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY  |   TR1.9, ANTI-THYROID PEROXIDASE, AUTOANTIBODY, IMMUNOGLOBULIN 
4mqx:D   (ALA108) to   (ALA211)  CLC-EC1 FAB COMPLEX CYSLESS A399C-A432C MUTANT  |   ALPHA HELICAL TRANSMEMBRANE PROTEIN, CL/H ANTIPORTER, METAL TRANSPORT, MEMBRANE PROTEIN 
4mqx:F   (ALA108) to   (ALA211)  CLC-EC1 FAB COMPLEX CYSLESS A399C-A432C MUTANT  |   ALPHA HELICAL TRANSMEMBRANE PROTEIN, CL/H ANTIPORTER, METAL TRANSPORT, MEMBRANE PROTEIN 
5aum:B   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE  |   ANTIBODY, PEPTIDE LIGAND, PROTEASE, ELISA, WESTERN BLOTTING, IMMUNE SYSTEM-PEPTIDE COMPLEX 
5aum:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE  |   ANTIBODY, PEPTIDE LIGAND, PROTEASE, ELISA, WESTERN BLOTTING, IMMUNE SYSTEM-PEPTIDE COMPLEX 
2j4w:L   (ALA109) to   (ASN212)  STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1- FAB F8.12.19 COMPLEX  |   IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, MEMBRANE, TRANSMEMBRANE, HYPOTHETICAL PROTEIN, ANTIBODY CROSS- REACTIVITY, SURFACE ACTIVE PROTEIN, MALARIA VACCINE CANDIDATE, APICAL MEMBRANE ANTIGEN 1, IMMUNE SYSTEM 
1jnl:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES  |   IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM 
1jnn:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES  |   IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM 
4msw:B   (ALA109) to   (ASN212)  Y78 ESTER MUTANT OF KCSA IN HIGH K+  |   MEMBRANE PROTEIN, CHANNEL, ESTER, UNNATURAL AMINO ACID, TRANSPORT PROTEIN 
1jps:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44  |   ANTIGEN-ANTIBODY RECOGNITION, HUMANIZED ANTIBODY, BLOOD COAGULATION, INTERFACE WATER MOLECULES, CRYSTAL STRUCTURE, IMMUNE SYSTEM 
4mwf:B   (THR109) to   (ASN210)  STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C  |   IMMUNOGLOBULIN FOLD, HCV E2, IMMUNE SYSTEM 
4mwf:L   (THR109) to   (ASN210)  STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C  |   IMMUNOGLOBULIN FOLD, HCV E2, IMMUNE SYSTEM 
2xkn:A   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7  |   IMMUNE SYSTEM, IMMUNOGLOBULIN 
2xkn:C   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7  |   IMMUNE SYSTEM, IMMUNOGLOBULIN 
4mxv:E   (THR109) to   (SER208)  STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB  |   TNF, TUMOR NECROSIS FACTOR, TNFR RECEPTOR, LYMPHOTOXIN BETA RECEPTOR, LYMPHOTOXIN ALPHA, LYMPHOID DEVELOPMENT, TUMOR IMMUNITY, AUTO- IMMUNITY, CYTOKINE-IMMUNE SYSTEM COMPLEX 
4mxw:V   (THR109) to   (ARG211)  STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB  |   TNF, TUMOR NECROSIS FACTOR, TNFR RECEPTOR, LYMPHOTOXIN BETA RECEPTOR, LYMPHOTOXIN ALPHA, LYMPHOID DEVELOPMENT, TUMOR IMMUNITY, AUTO- IMMUNITY, CYTOKINE-IMMUNE SYSTEM COMPLEX 
4mxw:L   (THR109) to   (ARG211)  STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB  |   TNF, TUMOR NECROSIS FACTOR, TNFR RECEPTOR, LYMPHOTOXIN BETA RECEPTOR, LYMPHOTOXIN ALPHA, LYMPHOID DEVELOPMENT, TUMOR IMMUNITY, AUTO- IMMUNITY, CYTOKINE-IMMUNE SYSTEM COMPLEX 
5az2:L   (ALA108) to   (ASN211)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 9E5, A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN EPIREGULIN  |   ANTIBODY, IMMUNOGLOBULIN, MONOCLONAL ANTIBODY, EPIDERMAL GROWTH FACTOR, IMMUNE SYSTEM 
3j93:L   (ALA109) to   (ASN210)  FITTING OF FAB INTO THE CRYOEM DENSITY MAP OF EV71 PROCAPSID IN COMPLEX WITH FAB22A12  |   FAB, EV71, FAB22A12, IMMUNE SYSTEM 
3x3g:L   (THR109) to   (ASN210)  FAB FRAGMENT FROM ANTI TRAIL-R2 HUMAN AGONIST ANTIBODY KMTR2  |   AGONIST ANTIBODY, ANTI TRAIL-R2, IMMUNE SYSTEM 
2xqy:K   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, ENVELOPE PROTEIN 
2xqy:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, ENVELOPE PROTEIN 
5b3j:F   (ALA108) to   (ARG210)  ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL  |   NMDA RECEPTOR, TRANSPORT PROTEIN 
5b3j:L   (ALA108) to   (ARG210)  ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL  |   NMDA RECEPTOR, TRANSPORT PROTEIN 
2jel:L   (ALA109) to   (ASN212)  JEL42 FAB/HPR COMPLEX  |   ANTIBODY-PROTEIN COMPLEX, HISTIDINE-CONTAINING PROTEIN, MOLECULAR RECOGNITION, COMPLEX (ANTIBODY/ANTIGEN) 
3jab:L   (ALA109) to   (ASN210)  DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR, PDE6  |   PHOSPHODIESTERASE, PHOTORECEPTOR, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3jab:R   (ALA109) to   (ASN210)  DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR, PDE6  |   PHOSPHODIESTERASE, PHOTORECEPTOR, HYDROLASE-IMMUNE SYSTEM COMPLEX 
5bmf:L  (THR2001) to  (SER2100)  CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT  |   ANTIBODY, HAPTEN BINDING, THEOPHYLLINE, IMMUNE SYSTEM 
2xtj:C   (THR108) to   (SER207)  THE CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH 1D05 FAB  |   HYDROLASE-ANTIBODY COMPLEX, SERINE PROTEASE, LDL-C, LDLR, EGF-A, HYPERCHOLESTEROLEMIA 
5bo1:M   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB  |   JAG, NOTCH, ANTAGONIST, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
4n8c:M   (ALA115) to   (ASN216)  THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS  |   ANTIBODY-PEPTIDE COMPLEX, INFLUENZA A VIRUS PROTEIN, IMMUNE SYSTEM 
5bq7:B   (PRO115) to   (ALA213)  CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS-HUMAN FAB 5F-10 FRAGMENT  |   HUMAN ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM 
4n9g:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9  |   ANTIBODY, HAIRPIN, EPITOPE SCAFFOLD, IMMUNE SYSTEM 
4n9g:N   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9  |   ANTIBODY, HAIRPIN, EPITOPE SCAFFOLD, IMMUNE SYSTEM 
2jk5:B   (ALA109) to   (ASN212)  POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K  |   IMMUNE SYSTEM-METAL TRANSPORT COMPLEX, QUATERNARY AMMONIUM, PROTEIN-ANTIBODY FAB COMPLEX, IONIC CHANNEL, ION TRANSPORT 
1wc7:A   (ALA109) to   (GLU213)  FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE  |   ANTIBODY, CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, PHOSPHOPYRIDOXYL-L-ALANINE 
1wcb:A   (ALA109) to   (GLU213)  PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN  |   CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, HAPTEN, PHOSPHOPYRIDOXYL-L-LYSINE, IMMUNE SYSTEM 
1wcb:L   (ALA109) to   (GLU213)  PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN  |   CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, HAPTEN, PHOSPHOPYRIDOXYL-L-LYSINE, IMMUNE SYSTEM 
1k4c:B   (ALA109) to   (ASN212)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+  |   K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN 
1k4d:B   (ALA109) to   (ASN212)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+  |   K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN 
2xza:L   (THR111) to   (ASN212)  CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT  |   IMMUNE SYSTEM 
2xzc:L   (THR111) to   (ASN212)  CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT  |   IMMUNE SYSTEM 
5bvj:A   (THR109) to   (SER208)  THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA  |   IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM 
5bvj:C   (THR109) to   (ASN210)  THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA  |   IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM 
5bvj:E   (THR109) to   (SER208)  THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA  |   IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM 
5bvj:G   (THR109) to   (SER208)  THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA  |   IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM 
5bvp:L   (THR109) to   (SER208)  THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA  |   IMMUNOGLOBULIN, FAB, CYTOKINE, BETA TREFOIL, IMMUNE SYSTEM 
1wej:L   (ALA109) to   (ASN212)  IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION  |   IMMUNOGLOBULIN, IGG1 KAPPA, FAB FRAGMENT, HORSE CYTOCHROME C, COMPLEX (ANTIBODY/ELECTRON TRANSPORT) 
4ngh:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY 4E10 FAB FRAGMENT IN COMPLEX WITH A HYDROCARBON-STAPLED PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41 AND A TETHERED PHOSPHATE MOIETY.  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, 4E10 FAB, ANTIBODY-EPITOPE COMPLEX, GP41 HIV-1, HYDROCARBON STAPLE, IMMUNE SYSTEM 
4nhc:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY 4E10 FAB FRAGMENT IN COMPLEX WITH A HYDROCARBON-STAPLED PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41.  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, 4E10 FAB, ANTIBODY-EPITOPE COMPLEX, GP41 HIV-1, HYDROCARBON STAPLE, IMMUNE SYSTEM 
1kb5:L   (ALA109) to   (ASN210)  MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX  |   T-CELL RECEPTOR, STRAND SWITCH, FAB, ANTICLONOTYPIC, (IMMUNOGLOBULIN/RECEPTOR), COMPLEX (IMMUNOGLOBULIN/RECEPTOR) COMPLEX 
4nhg:C   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4nhh:L   (THR109) to   (SER208)  STRUCTURE OF 2G12 IGG DIMER  |   IG, ANTIBODY, IMMUNE SYSTEM 
4nhh:K   (THR109) to   (SER208)  STRUCTURE OF 2G12 IGG DIMER  |   IG, ANTIBODY, IMMUNE SYSTEM 
4nhh:G   (THR109) to   (SER208)  STRUCTURE OF 2G12 IGG DIMER  |   IG, ANTIBODY, IMMUNE SYSTEM 
4nhh:F   (THR109) to   (SER208)  STRUCTURE OF 2G12 IGG DIMER  |   IG, ANTIBODY, IMMUNE SYSTEM 
4nhh:Q   (THR109) to   (SER208)  STRUCTURE OF 2G12 IGG DIMER  |   IG, ANTIBODY, IMMUNE SYSTEM 
4nhh:P   (THR109) to   (SER208)  STRUCTURE OF 2G12 IGG DIMER  |   IG, ANTIBODY, IMMUNE SYSTEM 
3zkm:D   (ALA113) to   (ASN214)  BACE2 FAB COMPLEX  |   HYDROLASE-IMMUNE SYSTEM COMPLEX, HYDROLASE, ASPARTYL PROTEASE/FAB COMPLEX 
3zkm:L   (ALA113) to   (ASN214)  BACE2 FAB COMPLEX  |   HYDROLASE-IMMUNE SYSTEM COMPLEX, HYDROLASE, ASPARTYL PROTEASE/FAB COMPLEX 
3zkn:D   (ALA113) to   (ASN214)  BACE2 FAB INHIBITOR COMPLEX  |   IMMUNE SYSTEM-HYDROLASE COMPLEX, FAB COMPLEX 
3zkn:L   (ALA113) to   (ASN214)  BACE2 FAB INHIBITOR COMPLEX  |   IMMUNE SYSTEM-HYDROLASE COMPLEX, FAB COMPLEX 
1kc5:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF ANTIBODY PC287 IN COMPLEX WITH PS1 PEPTIDE  |   ANTIBODY, PEPTIDE ANTIGEN, COMPLEX (ANTIBODY/PEPTIDE), IMMUNE SYSTEM 
1kcr:L   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE  |   ANTIBODY, PEPTIDE ANTIGEN COMPLEX (ANTIBODY/PEPTIDE), IMMUNE SYSTEM 
1kcs:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE  |   ANTIBODY, PEPTIDE ANTIGEN COMPLEX (ANTIBODY/PEPTIDE), IMMUNE SYSTEM 
4nja:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF FAB 6C8 IN COMPLEX WITH MPTS  |   IMMUNOGLOBULIN FOLD, MPTS BINDING, IMMUNE SYSTEM 
1kcv:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF ANTIBODY PC282  |   ANTI-PEPTIDE ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM 
5bzd:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF PCDN-27A, AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES  |   HIV, ANTIBODY, FAB, IMMUNE SYSTEM 
5bzd:C   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF PCDN-27A, AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES  |   HIV, ANTIBODY, FAB, IMMUNE SYSTEM 
5bzw:A   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF PCDN-27B, AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES  |   HIV, ANTIBODY, FAB, IMMUNE SYSTEM 
4nm4:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043  |   IMMUNE SYSTEM, IMMUNE RECOGNITION, ANTIBODY, FAB, IMMUNOGLOBULIN, INFLUENZA HEMAGGLUTININ 
4nm4:M   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043  |   IMMUNE SYSTEM, IMMUNE RECOGNITION, ANTIBODY, FAB, IMMUNOGLOBULIN, INFLUENZA HEMAGGLUTININ 
4nm8:N   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, IMMUNOGLOBULIN' 
5c0n:L   (THR114) to   (ARG216)  DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE  |   AP2, FABP4, FAB, TYPE II DIABETES, LIPID TRANSPORT 
1kel:L   (ALA114) to   (ASN217)  CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID)  |   SULFIDE OXIDATION, MONOOXYGENASE, OXYGENATION, FAB, IMMUNOGLOBULIN, CATALYTIC ANTIBODY 
1kem:L   (ALA114) to   (ASN217)  CATALYTIC ANTIBODY 28B4 FAB FRAGMENT  |   SULFIDE OXIDATION, MONOOXYGENASE, OXYGENATION, FAB, IMMUNOGLOBULIN, CATALYTIC ANTIBODY 
2y5t:B   (ALA113) to   (ASN214)  CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE  |   IMMUNE SYSTEM, ANTIBODY, RHEUMATOID ARTHRITIS, ARTHRITOGENIC 
1kfa:L   (ALA114) to   (ALA217)  CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4  |   IMMUNOGLOBUILN FOLD, IMMUNE SYSTEM 
4nnp:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT  |   ABC SUPERFAMILY ATP BINDING CASSETTE TRANSPORTER, MNTC, FAB, APO, MRSA, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4nnp:Y   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT  |   ABC SUPERFAMILY ATP BINDING CASSETTE TRANSPORTER, MNTC, FAB, APO, MRSA, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4np4:L   (THR110) to   (ARG212)  CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB  |   BEZLOTOXUMAB, HUMAN ANTIBODY, FAB, CROP DOMAIN, CYTOTOXIN, SHORT REPEAT, LONG REPEAT, TCDB, RECEPTOR BINDING, IMMUNE SYSTEM 
4np4:M   (THR110) to   (ARG212)  CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB  |   BEZLOTOXUMAB, HUMAN ANTIBODY, FAB, CROP DOMAIN, CYTOTOXIN, SHORT REPEAT, LONG REPEAT, TCDB, RECEPTOR BINDING, IMMUNE SYSTEM 
1kn2:L   (ALA109) to   (ASN212)  CATALYTIC ANTIBODY D2.3 COMPLEX  |   ABZYME, TRANSITION STATE ANALOG, IMMUNE SYSTEM 
1kn4:L   (ALA109) to   (ASN212)  CATALYTIC ANTIBODY D2.3 COMPLEX  |   ABZYME, TRANSITION STATE ANALOG, IMMUNE SYSTEM 
1kno:A   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES  |   CATALYTIC ANTIBODY 
1kno:C   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES  |   CATALYTIC ANTIBODY 
1kno:E   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES  |   CATALYTIC ANTIBODY 
4nrx:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE  |   IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM 
4nrx:B   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE  |   IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM 
4nrx:E   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE  |   IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM 
4nry:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66  |   IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM 
4nrz:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6  |   IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM 
2mcg:2    (ASP97) to   (PRO212)  THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS  |   IMMUNOGLOBULIN 
4nug:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT151  |   IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM, HIV ENVELOPE 
4nuj:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY PGT152  |   IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM, HIV ENVELOPE 
4nwu:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF APE1551, AN ANTI-HUMAN NGF FAB WITH A NINE AMINO ACID INSERTION IN CDR H1  |   BETA-SANDWICH, HUMAN BETA NERVE GROWTH FACTOR, IMMUNE SYSTEM 
5c7k:F   (THR109) to   (ARG211)  CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195  |   HIV-1, SOSIP, PGT128, 8ANC195, IMMUNE SYSTEM 
1xct:C   (ALA115) to   (ASN218)  COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A, L57H, Y64W) IN SPACE GROUP P21212  |   CRYSTAL PACKING, FAB, PROTEIN L, PEPTIDE COMPLEX, IMMUNE SYSTEM 
5c8j:B   (THR110) to   (SER209)  A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE  |   MEMBRANE PROTEIN INSERTASE, MEMBRANE PROTEIN 
5c8j:D   (THR110) to   (SER209)  A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE  |   MEMBRANE PROTEIN INSERTASE, MEMBRANE PROTEIN 
5c8j:H   (THR110) to   (SER209)  A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE  |   MEMBRANE PROTEIN INSERTASE, MEMBRANE PROTEIN 
1xf4:L   (ALA109) to   (ASN210)  STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING  |   ANTIBODY, FAB, IMMUNOGLOBULIN, ANTI-DNA, ANTI-SSDNA, AUTOANTIBODY, TWINNING, IMMUNE SYSTEM 
1xf3:L   (ALA109) to   (ASN212)  STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65  |   ANTIBODY, FAB, IMMUNOGLOBULIN, ANTI-DNA, ANTI-SSDNA, AUTOANTIBODY, IMMUNE SYSTEM 
1xf3:A   (ALA109) to   (ASN212)  STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65  |   ANTIBODY, FAB, IMMUNOGLOBULIN, ANTI-DNA, ANTI-SSDNA, AUTOANTIBODY, IMMUNE SYSTEM 
1xf5:C   (ALA115) to   (ASN218)  COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C, Y64W)IN SPACE GROUP P21212  |   CRYSTAL PACKING, FAB, PROTEIN L, PEPTIDE COMPLEX, IMMUNE SYSTEM 
2nr6:E   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2  |   BLA G 2, FAB, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4o4y:L   (ARG114) to   (SER214)  CRYSTAL STRUCTURE OF THE ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE  |   IMMUNOGLOBULIN FOLD, ANTIBODY, HINGE, IMMUNE SYSTEM 
2ymx:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF INHIBITORY ANTI-ACHE FAB408  |   IMMUNE SYSTEM, ACETYLCHOLINESTERASE, INHIBITION, BACK DOOR REGION 
5cd3:H   (THR111) to   (ARG213)  STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7  |   VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM 
5cd3:B   (THR111) to   (ARG213)  STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7  |   VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM 
5cd3:D   (THR111) to   (ARG213)  STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7  |   VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM 
5cd3:F   (THR111) to   (ARG213)  STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7  |   VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM 
1xgp:A   (ALA109) to   (ASN212)  STRUCTURE FOR ANTIBODY HYHEL-63 Y33A MUTANT COMPLEXED WITH HEN EGG LYSOZYME  |   HYHEL-63, 2.1A RESOLUTION, Y33A MUTANT, IMMUNE SYSTEM 
1xgq:A   (ALA109) to   (ASN210)  STRUCTURE FOR ANTIBODY HYHEL-63 Y33V MUTANT COMPLEXED WITH HEN EGG LYSOZYME  |   HYHEL-63, 2.1A RESOLUTION, Y33V MUTANT, IMMUNE SYSTEM 
1xgr:A   (ALA109) to   (ASN212)  STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME  |   HYHEL-63, 2.1A CRYSTAL STRUCTURE, Y33I MUTANT, IMMUNE SYSTEM 
1xgu:A   (ALA109) to   (ASN212)  STRUCTURE FOR ANTIBODY HYHEL-63 Y33F MUTANT COMPLEXED WITH HEN EGG LYSOZYME  |   HYHEL-63, 2.1A CRYSTAL STRUCTURE, Y33F MUTANT, IMMUNE SYSTEM 
1xgy:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L  |   META-I, RHODOPSIN, FAB, IGG, K42-41L, PHAGE DISPLAY, ANTIBODY, IMMUNOGLOBULIN, ANTIBODY IMPRINTING, PEPTIDE MIMETICS, IMMUNE SYSTEM 
1xgy:M   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L  |   META-I, RHODOPSIN, FAB, IGG, K42-41L, PHAGE DISPLAY, ANTIBODY, IMMUNOGLOBULIN, ANTIBODY IMPRINTING, PEPTIDE MIMETICS, IMMUNE SYSTEM 
1l7t:L   (ALA114) to   (ARG216)  CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB FRAGMENT  |   ANTI-TESTOSTERONE, FAB FRAGMENT, AFFINITY AND SPECIFICITY MATURED, IMMUNE SYSTEM 
5cey:A   (PRO110) to   (ALA208)  CRYSTAL STRUCTURE OF FAB 9H+3L, A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES  |   HIV-1, ANTIBODY, IMMUNE SYSTEM 
2ypv:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY  |   IMMUNE SYSTEM, VACCINE, MONOCLONAL ANTIBODY, MAB, EPITOPE MAPPING 
4oaw:A   (THR109) to   (ASN210)  FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158  |   IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM 
5cil:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF NON-NEUTRALIZING VERSION OF 4E10 (WDWD) WITH EPITOPE BOUND  |   BROADLY NEUTRALIZING ANTIBODY, RECOMBINANT FAB, ENV-PEPTIDE, HIV-1, EPITOPE, IMMUNE SYSTEM 
5cip:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF UNBOUND 4E10  |   BROADLY NEUTRALIZING ANTIBODY, RECOMBINANT FAB, ENV-PEPTIDE, HIV-1, EPITOPE, IMMUNE SYSTEM 
5cip:B   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF UNBOUND 4E10  |   BROADLY NEUTRALIZING ANTIBODY, RECOMBINANT FAB, ENV-PEPTIDE, HIV-1, EPITOPE, IMMUNE SYSTEM 
2nxz:C  (THR2111) to  (SER2210)  HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B  |   HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2ny1:C  (THR2111) to  (SER2210)  HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C, T257S, S334A, S375W, Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B  |   HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2ny3:C  (THR2111) to  (SER2210)  HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E267C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B  |   HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2ny4:C  (THR2111) to  (SER2210)  HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E268C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B  |   HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4ods:L   (ALA109) to   (ASN212)  UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S55-3  |   CARBOHYDRATE BINDING, IMMUNE SYSTEM 
4odu:B   (ALA109) to   (ASN210)  UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15  |   CARBOHYDRATE BINDING, IMMUNE SYSTEM 
2ny6:C  (THR2111) to  (SER2210)  HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B  |   HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2ny7:L   (THR109) to   (SER208)  HIV-1 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH THE BROADLY NEUTRALIZING CD4-BINDING-SITE ANTIBODY B12  |   HIV, GP120, BROADLY NEUTRALIZING ANTIBODY, B12, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4odw:L   (ALA109) to   (ASN212)  UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6  |   CARBOHYDRATE BINDING, IMMUNE SYSTEM 
4odw:B   (ALA109) to   (ASN210)  UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6  |   CARBOHYDRATE BINDING, IMMUNE SYSTEM 
1lk3:L   (ALA108) to   (ASN209)  ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT  |   ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM 
5cjx:E   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER  |   HIV-1 ENV TRIMER, IG FOLD, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5cjx:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER  |   HIV-1 ENV TRIMER, IG FOLD, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4ogx:L   (THR108) to   (SER207)  CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.4 ANGSTROM RESOLUTION  |   FAB, ANTIBODY, KALLIKREIN, BLOOD, PLASMA, PLASMA KALLIKREIN- MEDIATED EDEMA, ACUTE HEREDITARY ANGIOEDEMA, HAE, HMWK, SERPIN C1-INHIBITOR, C1-INH, HEREDITARY ANGIOEDEMA, HAW, BRADYKININ, FLETCHER FACTOR, KININOGENIN, SERINE PROTEASE, EDEMA, HYDROLASE-ANTIBODY COMPLEX 
4ogy:L   (THR108) to   (SER207)  CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.1 ANGSTROM RESOLUTION  |   FAB, ANTIBODY, KALLIKREIN, BLOOD, PLASMA, PLASMA KALLIKREIN- MEDIATED EDEMA, ACUTE HEREDITARY ANGIOEDEMA, HAE, HMWK, SERPIN C1-INHIBITOR, C1-INH, HEREDITARY ANGIOEDEMA, HAW, BRADYKININ, FLETCHER FACTOR, KININOGENIN, SERINE PROTEASE, EDEMA, HYDROLASE-ANTIBODY COMPLEX 
4ogy:N   (THR108) to   (SER207)  CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.1 ANGSTROM RESOLUTION  |   FAB, ANTIBODY, KALLIKREIN, BLOOD, PLASMA, PLASMA KALLIKREIN- MEDIATED EDEMA, ACUTE HEREDITARY ANGIOEDEMA, HAE, HMWK, SERPIN C1-INHIBITOR, C1-INH, HEREDITARY ANGIOEDEMA, HAW, BRADYKININ, FLETCHER FACTOR, KININOGENIN, SERINE PROTEASE, EDEMA, HYDROLASE-ANTIBODY COMPLEX 
5cma:A   (THR109) to   (SER208)  ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT  |   B7-H3 8H9 MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
1lo0:L   (ALA114) to   (ASN215)  CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX  |   CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM 
1lo2:L   (ALA114) to   (ASN215)  RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY  |   CATALYTIC ANTIBODY, FAB, RETRO-DIELS-ALDERASE, IMMUNE SYSTEM 
5cp7:A   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES  |   ANTIGEN-BINDING FRAGMENT, ANTI-SULFONAMIDES ANTIBODY, IMMUNE SYSTEM 
5cp7:C   (ALA114) to   (ASN217)  CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES  |   ANTIGEN-BINDING FRAGMENT, ANTI-SULFONAMIDES ANTIBODY, IMMUNE SYSTEM 
5cp7:E   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES  |   ANTIGEN-BINDING FRAGMENT, ANTI-SULFONAMIDES ANTIBODY, IMMUNE SYSTEM 
2z91:B   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9  |   IMMUNOGLOBRIN FOLD, IMMUNE SYSTEM 
2z92:B   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE  |   IMMUNOGLOBRIN FOLD, IMMUNE SYSTEM 
4ojf:L   (THR109) to   (ARG211)  HUMANISED 3D6 FAB COMPLEXED TO AMYLOID BETA 1-8  |   AMYLOID, BAPINEUZUMAB, 3D6, ALZHEIMER'S DISEASE, IMMUNOGLOBULIN, IMMUNOTHERAPY, AMYLOID BETA, IMMUNE SYSTEM 
2o5x:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP, AN ENGINEERED DIELS- ALDERASE FAB WITH NM STEROID-BINDING AFFINITY  |   IMMUNOGLOBULIN, CHIMERIC FAB, ANTIBODY ENGINEERING, EVOLUTION OF LIGAND RECOGNITION, IMMUNE SYSTEM 
4olu:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF ANTIBODY VRC07 IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE  |   VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4olv:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54F IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE  |   VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54F, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4olw:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54H IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE  |   VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54H, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4olx:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54L IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE  |   VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54L, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4olz:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54W IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE  |   VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54W, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4om0:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54Y IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE  |   VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54Y, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4om1:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF ANTIBODY VRC07-I30Q, G54W, S58N IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE  |   VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-I30Q, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4onf:L   (ALA114) to   (ASN215)  FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-7  |   ANTIBODY, AMYLOID BETA PEPTIDE, IMMUNE SYSTEM 
5csz:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11  |   ANTIBODY, ALZHEIMER, ABETA, GANTENERUMAB, GANT_ABETA_1_11 09-A, IMMUNE SYSTEM 
5csz:B   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11  |   ANTIBODY, ALZHEIMER, ABETA, GANTENERUMAB, GANT_ABETA_1_11 09-A, IMMUNE SYSTEM 
3kdm:L   (THR113) to   (ASN214)  CRYSTAL STRUCTURE OF HUMAN ANTI-STEROID FAB 5F2 IN COMPLEX WITH TESTOSTERONE  |   IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN FAB FRAGMENT, ANTI-STEROID 
3kdm:A   (THR113) to   (SER212)  CRYSTAL STRUCTURE OF HUMAN ANTI-STEROID FAB 5F2 IN COMPLEX WITH TESTOSTERONE  |   IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN FAB FRAGMENT, ANTI-STEROID 
2zkh:L   (ALA108) to   (ARG210)  HUMAN THROMBOPOIETIN NEUTRALIZING ANTIBODY TN1 FAB  |   THROMBOPOIETIN, FAB FRAGMENT(ANTIBODY), IMMUNE SYSTEM 
5cws:A   (THR132) to   (ARG234)  CRYSTAL STRUCTURE OF THE INTACT CHAETOMIUM THERMOPHILUM NSP1-NUP49- NUP57 CHANNEL NUCLEOPORIN HETEROTRIMER BOUND TO ITS NIC96 NUCLEAR PORE COMPLEX ATTACHMENT SITE  |   NUCLEOCYTOPLASMIC TRANSPORT, PROTEIN TRANSPORT 
4oqt:L   (THR110) to   (SER209)  LINGO-1/LI81 FAB COMPLEX  |   LEUCINE RICH REPEAT, IG DOMAIN, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX 
1m7i:A   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE  |   FAB-CARBOHYDRATE INTERACTIONS; SHIGELLA O-ANTIGEN; AND ANTI- CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
4ot1:L   (PRO112) to   (PRO211)  STRUCTURAL BASIS FOR THE RECOGNITION OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B BY THE NEUTRALIZING HUMAN ANTIBODY SM5-1  |   IMMUNOGLOBULIN, PH DOMAIN, ANTIBODY-ANTIGEN RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4ouu:L   (ALA114) to   (ASN217)  ANTI-MT1-MMP MONOCLONAL ANTIBODY  |   STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, IMMUNOGLOBULIN FOLD, HYDROLASE 
4ouu:A   (ALA114) to   (ASN215)  ANTI-MT1-MMP MONOCLONAL ANTIBODY  |   STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, IMMUNOGLOBULIN FOLD, HYDROLASE 
5czv:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20350 FAB  |   ANTIBODY, NOTCH3, ONCOLOGY, IMMUNE SYSTEM 
5czx:D   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20358 FAB  |   ANTIBODY, NOTCH3, ONCOLOGY, IMMUNE SYSTEM 
5czx:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20358 FAB  |   ANTIBODY, NOTCH3, ONCOLOGY, IMMUNE SYSTEM 
1y0l:L   (THR109) to   (SER208)  CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1y0l:A   (THR109) to   (SER208)  CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1y0l:C   (THR109) to   (SER208)  CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1y0l:E   (THR109) to   (SER208)  CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1mcp:L   (ALA115) to   (ARG217)  PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS  |   IMMUNOGLOBULIN 
1mcq:B   (PRO113) to   (ALA211)  PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS  |   IMMUNOGLOBULIN 
1mcr:B   (PRO113) to   (ALA211)  PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS  |   IMMUNOGLOBULIN 
1mcs:A   (PRO113) to   (PRO212)  PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS  |   IMMUNOGLOBULIN 
1mex:L   (ALA109) to   (ASN212)  ANTIBODY CATALYSIS OF A BIMOLECULAR CYCLOADDITION REACTION  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1mf2:L   (ALA109) to   (ARG211)  ANTI HIV1 PROTEASE FAB COMPLEX  |   FAB FRAGMENT, CROSS-REACTIVITY, HIV1 PROTEASE, ENZYME INHIBITION, IMMUNOGLOBULIN 
1mf2:M   (ALA109) to   (ARG211)  ANTI HIV1 PROTEASE FAB COMPLEX  |   FAB FRAGMENT, CROSS-REACTIVITY, HIV1 PROTEASE, ENZYME INHIBITION, IMMUNOGLOBULIN 
4oz4:B   (ALA114) to   (ASN215)  X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.  |   FAB, APO-FORM, IMMUNE SYSTEM 
1mhh:A   (ALA109) to   (ASN212)  ANTIBODY-ANTIGEN COMPLEX  |   ANTIBODY-ANTIGEN COMPLEX, B CELL SUPERANTIGEN, IMMUNOGLOBULIN BINDING PROTEIN, IMMUNE SYSTEM 
1mhh:C   (ALA109) to   (ASN212)  ANTIBODY-ANTIGEN COMPLEX  |   ANTIBODY-ANTIGEN COMPLEX, B CELL SUPERANTIGEN, IMMUNOGLOBULIN BINDING PROTEIN, IMMUNE SYSTEM 
3klh:C   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)  |   HIV-1, REVERSE TRANSCRIPTASE, RT, AZT, AZT EXCISION, AZT RESISTANCE, RESISTANCE MECHANISM, AZT RESISTANCE MUTATIONS, P51/P66, NUCLEOSIDE INHIBITOR, AIDS, HIV, DNA POLYMERASE, NRTI, NUCLEOTIDE EXCISION, DNA-DIRECTED DNA POLYMERASE, MAGNESIUM, METAL-BINDING, MULTIFUNCTIONAL ENZYME, NUCLEASE, RNA-DIRECTED DNA POLYMERASE, TRANSFERASE, TRANSFERASE-DNA COMPLEX 
1mim:L   (THR106) to   (ASN207)  IGG FAB FRAGMENT (CD25-BINDING)  |   IMMUNOGLOBULIN, C REGION 
1mj7:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393 AND A TRANSITION-STATE ANALOG  |   CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, TSA, IMMUNE SYSTEM 
1mj8:L   (ALA109) to   (ASN212)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126  |   CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM 
4aei:L   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX  |   IMMUNE SYSTEM-TOXIN COMPLEX, ALPHA-TOXIN, CONFORMATIONAL REARRANGEMENT, COMBINING SITE, EPITOPE, PHARMACOLOGICAL SITE, VENOM, VOLTAGE-ACTIVATED SODIUM CHANNEL 
4aei:M   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX  |   IMMUNE SYSTEM-TOXIN COMPLEX, ALPHA-TOXIN, CONFORMATIONAL REARRANGEMENT, COMBINING SITE, EPITOPE, PHARMACOLOGICAL SITE, VENOM, VOLTAGE-ACTIVATED SODIUM CHANNEL 
4aei:N   (ALA114) to   (ASN217)  CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX  |   IMMUNE SYSTEM-TOXIN COMPLEX, ALPHA-TOXIN, CONFORMATIONAL REARRANGEMENT, COMBINING SITE, EPITOPE, PHARMACOLOGICAL SITE, VENOM, VOLTAGE-ACTIVATED SODIUM CHANNEL 
5d1q:A   (THR109) to   (SER208)  ISDB NEAT2 BOUND BY CLONE D2-06  |   ISDB NEAT2, IGVH1-69, GERMLINE ENCODED, IMMUNE SYSTEM 
5d1z:A   (THR111) to   (SER210)  ISDB NEAT1 BOUND BY CLONE D4-10  |   ISDB, NEAT1, GERMLINE ENCODED, IMMUNE SYSTEM 
5d1z:H   (THR111) to   (ASN212)  ISDB NEAT1 BOUND BY CLONE D4-10  |   ISDB, NEAT1, GERMLINE ENCODED, IMMUNE SYSTEM 
1mjj:A   (ALA109) to   (ASN212)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG  |   CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1mjj:L   (ALA109) to   (ASN210)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG  |   CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1mju:L   (ALA109) to   (ASN212)  1.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12  |   CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM 
4ag4:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX  |   IMMUNE SYSTEM-TRANSFERASE COMPLEX 
1mlc:A   (ALA109) to   (ARG211)  MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME  |   COMPLEX (ANTIBODY/ANTIGEN) 
4p3c:L   (ALA115) to   (ASN216)  MT1-MMP:FAB COMPLEX (FORM I)  |   IMMUNE SYSTEM 
4p3d:B   (ALA115) to   (ASN218)  MT1-MMP:FAB COMPLEX (FORM II)  |   IMMUNE SYSTEM 
4p3d:L   (ALA115) to   (ASN218)  MT1-MMP:FAB COMPLEX (FORM II)  |   IMMUNE SYSTEM 
1mnu:L   (ALA114) to   (ASN215)  UNLIGANDED BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS  |   MURINE IMMUNOGLOBULIN IGG2A KAPPA, BACTERICIDAL ANTIBODY, EPITOPE P1.16 OF PORA FROM NEISSERIA MENINGITIDIS, UNLIGANDED, IMMUNE SYSTEM 
1mpa:L   (ALA114) to   (ASN215)  BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS  |   MURINE IMMUNOGLOBULIN IGG2A KAPPA, BACTERICIDAL ANTIBODY, EPITOPE P1.16 OF PORA FROM NEISSERIA MENINGITIDIS, COMPLEX (IMMUNOGLOBULIN/PEPTIDE) 
35c8:L   (ALA109) to   (ASN210)  CATALYTIC ANTIBODY 5C8, FAB-INHIBITOR COMPLEX  |   CATALYTIC ANTIBODY, FAB, RING CLOSURE REACTION 
1mre:L   (ALA109) to   (ARG211)  PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES  |   IMMUNOGLOBULIN 
1mrf:L   (ALA109) to   (ARG211)  PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES  |   IMMUNOGLOBULIN 
4p9h:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2  |   IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX 
1yec:L   (GLY109) to   (ASN212)  STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.3)  |   CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 
1yee:L   (ALA109) to   (ASN212)  STRUCTURE OF A CATALYTIC ANTIBODY, IGG2A FAB FRAGMENT (D2.5)  |   CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 
1yeg:L   (GLY109) to   (ASN212)  STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH REACTION PRODUCT  |   CATALYTIC ANTIBODY 
1yei:L   (ALA109) to   (ASN212)  CATALYTIC ANTIBODY D2.3 COMPLEX  |   CATALYTIC ANTIBODY D2.3 COMPLEX, IMMUNE SYSTEM 
1yej:L   (ALA109) to   (ASN212)  CATALYTIC ANTIBODY COMPLEX  |   ABZYME, TRANSITION STATE ANALOG, IMMUNE SYSTEM 
5d8j:L   (THR110) to   (ASN211)  DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES.  |   AP2, FABP4, DIABETES, METABOLIC SYNDROME, IMMUNE SYSTEM 
5d93:B   (THR108) to   (SER207)  OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY  |   ENZYME, INHIBITOR, THIOREDOXIN FOLD, ANTIBODY, OXIDOREDUCTASE 
5d93:E   (THR108) to   (SER207)  OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY  |   ENZYME, INHIBITOR, THIOREDOXIN FOLD, ANTIBODY, OXIDOREDUCTASE 
5d96:I   (ALA109) to   (ASN210)  OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1  |   ENZYME, INHIBITOR, ANTIBODY, DUAL-SPECIFICITY, IMMUNE SYSTEM 
1yjd:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)  |   IGSF, CD28 HOMODIMER, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX 
5dd5:L   (ALA109) to   (SER208)  CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES  |   HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM 
3kym:C   (THR109) to   (GLU213)  CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB  |   IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM 
1ynk:L   (ALA109) to   (ASN210)  IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETENERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647  |   SWEETENER COMPOUND, SC45657 AND NC174, IMMUNE SYSTEM 
1ynt:A   (ALA109) to   (ASN210)  STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY  |   TOXOPLASMA GONDII, RECOMBINANT SAG1, CONFORMATIONAL EPITOPE, IMMUNE SYSTEM 
1ynt:C  (ALA1109) to  (ASN1210)  STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY  |   TOXOPLASMA GONDII, RECOMBINANT SAG1, CONFORMATIONAL EPITOPE, IMMUNE SYSTEM 
3l1o:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE, CRYSTALLIZED IN THE PRESENCE OF ZINC  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
1yqv:L   (ALA109) to   (ASN212)  THE CRYSTAL STRUCTURE OF THE ANTIBODY FAB HYHEL5 COMPLEX WITH LYSOZYME AT 1.7A RESOLUTION  |   HYHEL-5 ANTIBODY, LYSOZYME, IMMUNE SYSTEM 
1n64:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6  |   ANTIBODY PEPTIDE COMPLEX, IMMUNE SYSTEM 
5dk3:A   (THR113) to   (ASN214)  CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY  |   CANCER, ANTIBODY, SUBCLASSES, IGG4, MELANOMA, IMMUNE SYSTEM 
5dk3:F   (THR113) to   (ASN214)  CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY  |   CANCER, ANTIBODY, SUBCLASSES, IGG4, MELANOMA, IMMUNE SYSTEM 
3l5w:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB  |   IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, POLYMORPHISM, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3l5w:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB  |   IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, POLYMORPHISM, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3l5x:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND H2L6 FAB  |   IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, POLYMORPHISM, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
1yy8:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225  |   FAB FRAGMENT; ANTIBODY DRUG; CANCER, IMMUNE SYSTEM 
1yy8:C   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225  |   FAB FRAGMENT; ANTIBODY DRUG; CANCER, IMMUNE SYSTEM 
1yyl:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B  |   HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M33, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1yyl:Q  (THR1109) to  (SER1208)  CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B  |   HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M33, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1yym:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF F23, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B  |   HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, F23, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4plj:L   (ALA109) to   (ASN212)  HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12  |   COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUME SYSTEM COMPLEX 
4plj:C   (ALA109) to   (ARG211)  HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12  |   COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUME SYSTEM COMPLEX 
5dlm:L   (ALA114) to   (ASN217)  COMPLEX OF INFLUENZA M2E AND ANTIBODY  |   COMPLEX, ANTIBODY, EXTRACELLULAR DOMAIN, IMMUNE SYSTEM 
3l7f:L   (THR109) to   (SER208)  STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836  |   IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3l7f:D   (THR109) to   (ASN210)  STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836  |   IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3l7e:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836  |   IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3l7e:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836  |   IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5dmi:L   (THR109) to   (SER208)  STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH CHI220 FAB  |   CELL SURFACE RECEPTOR, ANTIBODY-ANTIGEN COMPLEX, ANTITUMOR, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX 
1z3g:M   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8  |   2A8 FAB, PVS25, IMMUNE SYSTEM-CELL ADHESION COMPLEX 
4poz:C   (ALA109) to   (ASN210)  FAB FRAGMENT OF DER P 1 SPECIFIC ANTIBODY 10B9  |   ANTIBODY, ALLERGY, IMMUNE SYSTEM 
4pp1:C   (ALA108) to   (ARG210)  THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8  |   ALLERGEN, ANTIBODY, IMMUNE SYSTEM 
4pp1:E   (ALA108) to   (ARG210)  THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8  |   ALLERGEN, ANTIBODY, IMMUNE SYSTEM 
5do2:L   (ALA109) to   (ASN210)  COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY  |   RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE, 4C2 ANTIBODY, NEURALIZATION, RECEPTOR-BINDING BLOCKING., VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5do2:D   (ALA109) to   (ASN210)  COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY  |   RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE, 4C2 ANTIBODY, NEURALIZATION, RECEPTOR-BINDING BLOCKING., VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4pp2:A   (ALA109) to   (ARG211)  THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9  |   ALLERGEN, ANTIBODY, IMMUNE SYSTEM 
4pp2:C   (ALA109) to   (ARG211)  THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9  |   ALLERGEN, ANTIBODY, IMMUNE SYSTEM 
4al8:L   (ALA109) to   (ASN212)  STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12  |   IMMUNE SYSTEM, ANTIBODY, NEUTRALISATION 
4ala:L   (ALA109) to   (ASN212)  STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12  |   IMMUNE SYSTEM, ANTIBODY, NEUTRALISATION 
4am0:D   (ALA109) to   (ASN212)  STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12  |   VIRAL PROTEIN, ANTIBODY, NEUTRALISATION 
4am0:F   (ALA109) to   (ASN212)  STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12  |   VIRAL PROTEIN, ANTIBODY, NEUTRALISATION 
4ps4:L   (THR108) to   (SER207)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB  |   IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3ldb:B   (ALA115) to   (LEU215)  STRUCTURE OF JMJD6 COMPLEXD WITH ALPHA-KETOGLUTARATE AND FAB FRAGMENT.  |   JMJ6D, ALPHA-KETOGLUTARATE, FAB FRAGMENTS, IMMUNE SYSTEM 
4ptt:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF ANTI-23F STREP FAB C05  |   ANTIBODY, FAB FRAGMENT, 23F, RHAMNOSE, IMMUNE SYSTEM 
4ptu:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF ANTI-23F STREP FAB C05 WITH RHAMNOSE  |   ANTIBODY, FAB FRAGMENT, 23F, RHAMNOSE, IMMUNE SYSTEM 
4pub:L   (THR108) to   (ASN209)  CRYSTAL STRUCTURE OF FAB DX-2930  |   FAB, ANTIBODY, KALLIKREIN, BLOOD, PLASMA, PLASMA KALLIKREIN-MEDIATED EDEMA, ACUTE HEREDITARY ANGIOEDEMA, HAE, IMMUNE SYSTEM 
5dqj:L   (ALA109) to   (ARG211)  STRUCTURE OF UNLIGANDED S55-5 FAB  |   ANTIBODY, FAB, CARBOHYDRATE BINDING, PHOSPHOLIPID, IMMUNE SYSTEM 
5dqj:B   (ALA109) to   (ASN212)  STRUCTURE OF UNLIGANDED S55-5 FAB  |   ANTIBODY, FAB, CARBOHYDRATE BINDING, PHOSPHOLIPID, IMMUNE SYSTEM 
1za6:C   (THR115) to   (SER214)  THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY  |   IMMUNOGLOBULIN FOLD, CH2-DOMAIN-DELETION, IMMUNE SYSTEM 
5dr5:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF THE SCLEROSTIN-NEUTRALIZING FAB ABD09097  |   SCLEROSTIN-NEUTRALIZING, FAB, WNT INHIBITOR, IMMUNE SYSTEM 
1zan:L   (ALA110) to   (ASN211)  CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB  |   IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM 
5drw:B   (THR115) to   (ARG217)  CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET #4 CASE CLL183  |   IMMUNOGLOBULIN FOLD, B-CELL RECEPTOR, CHRONIC LYMPHOCYTIC LEUKEMIA, IMMUNE SYSTEM, RECEPTOR-LIGAND COMPLEX 
5drx:L   (THR115) to   (ASN216)  CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET #4 CASE CLL240  |   IMMUNOGLOBULIN FOLD, B CELL RECEPTOR, CHRONIC LYMPHOCYTIC LEUKEMIA, IMMUNE SYSTEM, RECEPTOR-LIGAND COMPLEX 
5drx:B   (THR115) to   (ASN216)  CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET #4 CASE CLL240  |   IMMUNOGLOBULIN FOLD, B CELL RECEPTOR, CHRONIC LYMPHOCYTIC LEUKEMIA, IMMUNE SYSTEM, RECEPTOR-LIGAND COMPLEX 
5drz:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE  |   IGG, VIRAL PROTEIN, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM 
5drz:A   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE  |   IGG, VIRAL PROTEIN, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM 
5dsc:F   (ASP109) to   (ASN207)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE  |   HYPUSINE, ANTIBODY, FABHPU24.B, EIF5A, IMMUNE SYSTEM 
3liz:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3  |   HYDROLASE-IMMUNE SYSTEM COMPLEX 
4py7:J   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF FAB 3.1  |   IMMUNOGLOBULIN FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEMAGGLUTININ GLYCOPROTEINS, IMMUNE SYSTEM 
4py7:B   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF FAB 3.1  |   IMMUNOGLOBULIN FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEMAGGLUTININ GLYCOPROTEINS, IMMUNE SYSTEM 
4q0x:L   (ALA114) to   (ARG216)  CRYSTAL STRUCTURE OF NON-NEUTRALIZING ANTIBODY IN COMPLEX WITH EPITOPE II OF HCV E2  |   ANTIBODY, ANTI-HCV E2, HCV E2, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
1zlu:L   (THR109) to   (ASN210)  FAB 2G12 + MAN5  |   HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM 
1zlv:L   (THR109) to   (SER208)  FAB 2G12 + MAN7  |   HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM 
1zlv:K   (THR109) to   (SER208)  FAB 2G12 + MAN7  |   HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM 
1zlw:L   (THR109) to   (ASN210)  FAB 2G12 + MAN8  |   HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM 
5dyo:B   (ALA114) to   (ASN215)  FAB43.1 COMPLEX WITH FLOURESCEIN  |   ANTIBODY FAB FLOURESCEIN, IMMUNE SYSTEM 
5e08:L   (THR110) to   (SER209)  SPECIFIC RECOGNITION OF A SINGLE-STRANDED RNA SEQUENCE BY AN ENGINEERED SYNTHETIC ANTIBODY FRAGMENT  |   ANTIBODY, FAB, SSRNA, IMMUNE SYSTEM-RNA COMPLEX 
3ls4:L   (ALA110) to   (ASN211)  CRYSTAL STRUCTURE OF ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT IN COMPLEX WITH THC  |   IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN, FAB FRAGMENT, CANNABINOID COMPLEX 
3ls5:L   (ALA110) to   (ASN211)  ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT, FREE FORM  |   IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN, FAB FRAGMENT, CANNABINOID COMPLEX 
5e1a:B   (ALA109) to   (ASN212)  STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS  |   KCSA, MUTATION, PROTONS, POTASSIUM CHANNELS, METAL TRANSPORT 
5e2t:L   (THR114) to   (ASN215)  CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY AT8 FAB  |   IMMUNE SYSTEM 
5e2v:L   (THR114) to   (SER213)  ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE  |   IMMUNE SYSTEM 
5e2w:L   (THR114) to   (SER213)  ANTI-TAU AT8 FAB WITH TRIPLY PHOSPHORYLATED TAU PEPTIDE  |   IMMUNE SYSTEM 
1zwi:B   (ALA109) to   (ASN212)  STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL  |   X-RAY CRYSTALLOGRAPHY; POTASSIUM ION CHANNEL; TRANSMEMBRANE PROTEIN, IMMUNE SYSTEM-ION TRANSPORT COMPLEX 
4q6i:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF MURINE 2D5 FAB, A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4  |   IG FOLD, ANTIBODY, ANTI-CD4, HIV-1 NEUTRALIZATION, CD4, IMMUNE SYSTEM 
4q6i:F   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF MURINE 2D5 FAB, A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4  |   IG FOLD, ANTIBODY, ANTI-CD4, HIV-1 NEUTRALIZATION, CD4, IMMUNE SYSTEM 
4q6i:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF MURINE 2D5 FAB, A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4  |   IG FOLD, ANTIBODY, ANTI-CD4, HIV-1 NEUTRALIZATION, CD4, IMMUNE SYSTEM 
25c8:L   (ALA109) to   (ARG211)  CATALYTIC ANTIBODY 5C8, FAB-HAPTEN COMPLEX  |   CATALYTIC ANTIBODY, FAB, RING CLOSURE REACTION 
5e8d:L   (ALA108) to   (ASN211)  CRYSTAL STRUCTURE OF HUMAN EPIREGULIN IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY 9E5  |   ANTIBODY, IMMUNOGLOBULIN, MONOCLONAL ANTIBODY, EPIDERMAL GROWTH FACTOR, CANCER, IMMUNE SYSTEM 
5e8e:A   (THR110) to   (LEU211)  CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB  |   IMMUNE SYSTEM-HYDROLASE COMPLEX, IMMUNE SYSTEM, INHIBITOR 
2a1w:L   (ALA114) to   (ARG216)  ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM I  |   IMMUNE SYSTEM 
2a1w:M   (ALA114) to   (ARG216)  ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM I  |   IMMUNE SYSTEM 
5e94:C   (THR109) to   (ASN210)  ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN  |   ANTIBODY ANTAGONIST GLP-1 RECEPTOR, IMMUNE SYSTEM, MEMBRANE PROTEIN 
4q9q:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF AN RNA APTAMER BOUND TO BROMO-LIGAND ANALOG IN COMPLEX WITH FAB  |   G-QUADRUPLEX, FLUORESCENCE, FLUOROPHORE, RNA 
5ea0:L   (THR109) to   (SER208)  STRUCTURE OF THE ANTIBODY 7968 WITH HUMAN COMPLEMENT FACTOR H-DERIVED PEPTIDE  |   COMPLEMENT FACTOR H CFH SCR19 SCR19-20, IMMUNE SYSTEM 
5ebl:B   (ALA109) to   (ASN212)  KCSA T75G IN THE CONDUCTIVE STATE  |   ALPHA-HELICAL, MEMBRANE PROTEIN, FAB, CHANNEL 
5ebm:B   (ALA109) to   (ASN212)  KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE  |   ALPHA-HELICAL, MEMBRANE PROTEIN, FAB, CHANNEL 
4qf1:B   (PRO109) to   (PRO208)  CRYSTAL STRUCTURE OF UNLIGANDED CH59UA, THE INFERRED UNMUTATED ANCESTOR OF THE RV144 ANTI-HIV ANTIBODY LINEAGE PRODUCING CH59  |   ANTI-HIV ANTIBODY, GP120, IMMUNE SYSTEM 
5ec1:B   (ALA109) to   (PHE209)  KCSA WITH V76ESTER MUTATION  |   ALPHA HELICAL, CHANNEL, FAB, MEMBRANE PROTEIN 
5ec2:B   (ALA109) to   (ASN210)  KCSA WITH V76ESTER+G77DA MUTATIONS  |   ALPHA-HELICAL, CHANNEL, FAB, MEMBRANE PROTEIN 
2a6d:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE  |   GERMLINE, FAB, ANTIBODY, IMMUNE SYSTEM 
2a6d:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE  |   GERMLINE, FAB, ANTIBODY, IMMUNE SYSTEM 
2a6i:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE KLASIPTHTSPL  |   IMMUNOGLOBULIN FOLD, FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM 
2a6j:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36- 65  |   GERMLINE, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
2a77:L   (ALA114) to   (ARG216)  ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM II  |   IMMUNE SYSTEM 
3b2u:D   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8  |   CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
3b2u:K   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8  |   CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
3b2u:X   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8  |   CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
4qhl:B   (PRO109) to   (PRO208)  I3.2 (UNBOUND) FROM CH103 LINEAGE  |   FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM 
3m8o:L   (THR114) to   (ASN215)  HUMAN IGA1 FAB FRAGMENT  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
2aab:L   (ALA109) to   (GLY212)  STRUCTURAL BASIS OF ANTIGEN MIMICRY IN A CLINICALLY RELEVANT MELANOMA ANTIGEN SYSTEM  |   ANTI-IDIOTYPIC ANTIBODY, MOLECULAR MIMICRY, MELANOMA, IMMUNOTHERAPY, IMMUNE SYSTEM 
5eii:B   (THR109) to   (SER208)  STRUCTURAL DETERMINATION OF AN PROTEIN COMPLEX OF A FAB WITH INCREASED SOLUBILITY  |   ANTIBODY, FAB, ASF1, STRUCTURAL GENOMICS, PSI-BIOLOGY, CHAPERONE- ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM 
5eii:L   (THR109) to   (SER208)  STRUCTURAL DETERMINATION OF AN PROTEIN COMPLEX OF A FAB WITH INCREASED SOLUBILITY  |   ANTIBODY, FAB, ASF1, STRUCTURAL GENOMICS, PSI-BIOLOGY, CHAPERONE- ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM 
2adg:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425  |   ANTI-CD4, INTERFACIAL METAL, ANTIBODY RECOGNITION, IMMUNE SYSTEM 
3mck:L   (ALA114) to   (ASN217)  CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705  |   IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3mck:A   (ALA114) to   (ASN217)  CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705  |   IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
2adj:A   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM  |   ANTI-CD4, INTERFACIAL METAL, ANTIBODY RECOGNITION, IMMUNE SYSTEM 
3mcl:L   (THR107) to   (SER206)  ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21  |   IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
4qnp:F   (ALA108) to   (ARG210)  CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY  |   INFLUENZA, NEURAMINIDASE, ANTIBODY, NEUTRALIZING ANTIBODY, HYDROLASE- IMMUNE SYSTEM COMPLEX 
3bae:L   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-28)  |   ABETA, AMYLOID BETA PEPTIDE, FAB, WO2, ALZHEIMER'S DISEASE, IMMUNOTHERAPIES, APP, IMMUNE SYSTEM 
5eoq:L   (ALA114) to   (ASN215)  STRUCTURE OF THE MURINE FAB 1G6 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 31-40  |   ANTIBODY, FAB, VACCINIA VIRUS, NEUTRALIZING, LINEAR EPITOPE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5epm:B   (ALA114) to   (ASN215)  CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT  |   CERATOTOXIN, RANDOM MUTAGENESIS, NAV1.7 ION CHANEL, TOXIN-IMMUNE SYSTEM COMPLEX 
5epm:F   (ALA114) to   (ASN217)  CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT  |   CERATOTOXIN, RANDOM MUTAGENESIS, NAV1.7 ION CHANEL, TOXIN-IMMUNE SYSTEM COMPLEX 
5erw:B   (ALA108) to   (ASN209)  STRUCTURE OF HCV E2 GLYCOPROTEIN ANTIGENIC EPITOPE II BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC84-26  |   IMMUNE SYSTEM, COMPLEX, HEPATITIS C VIRUS, E2 GLYCOPROTEIN, EPITOPE II, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3mnv:A   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT  |   HIV-1, HIV, GP41, MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM 
3mnw:A   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT WITH A GP41 MPER-DERIVED PEPTIDE IN A HELICAL CONFORMATION  |   HIV-1, HIV GP41, MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM 
3mnz:A   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT WITH A GP41 MPER-DERIVED PEPTIDE BEARING ALA SUBSTITUTIONS IN A HELICAL CONFORMATION  |   HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM 
3mo1:A   (LEU104) to   (SER208)  CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT  |   HIV-1, HIV, GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM 
3moa:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 17 AA GP41 MPER-DERIVED PEPTIDE  |   HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM 
3mod:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED IGG) WITH 11 AA GP41 MPER-DERIVED PEPTIDE  |   HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM 
5esa:B   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF ANTI-HCV E2 ANTIBODY HC84-26  |   HEPATITIS C VIRUS, E2 GLYCOPROTEIN, ANTIBODY, IMMUNE SYSTEM 
4bh7:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE PPYPAWHAPGNI  |   IMMUNE SYSTEM, CONVERGENCE OF ANTIBODY SPECIFICITIES 
4bh8:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE GDPRPSYISHLL  |   IMMUNE SYSTEM, GERMLINE ANTIBODY, ANTIBODY POLYSPECIFICTY 
5esv:B   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.  |   HIV-1, ENV, V1V2, CH0219, CHAVI, SCAFFOLD, CAP256, IMMUNE SYSTEM 
5esv:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.  |   HIV-1, ENV, V1V2, CH0219, CHAVI, SCAFFOLD, CAP256, IMMUNE SYSTEM 
5esz:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244  |   HIV-1, ENV, V1V2, CH0219, CHAVI, IMMUNE SYSTEM 
4qt5:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR  |   GRAVES DISEASE, ANTIBODY, TSH RECEPTOR, THYROID, IMMUNE SYSTEM 
4qt5:A   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR  |   GRAVES DISEASE, ANTIBODY, TSH RECEPTOR, THYROID, IMMUNE SYSTEM 
5etu:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5etu:C   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
4qth:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12  |   ANTIBODY, IMMUNE SYSTEM 
4qth:B   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12  |   ANTIBODY, IMMUNE SYSTEM 
5eu7:D   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE IN COMPLEX WITH FAB  |   INTEGRASE, FAB, HIV, VIRAL PROTEIN 
5eu7:C   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE IN COMPLEX WITH FAB  |   INTEGRASE, FAB, HIV, VIRAL PROTEIN 
3bjl:A   (PRO113) to   (PRO212)  LOC, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN AMMONIUM SULFATE  |   BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES, IMMUNOGLOBULIN 
3bkc:L   (ALA108) to   (ASN211)  CRYSTAL STRUCTURE OF ANTI-AMYLOID BETA FAB WO2 (P21, FORMB)  |   ABETA, AMYLOID BETA PEPTIDE, FAB, WO2, ALZHEIMER'S DISEASE, IMMUNOTHERAPIES, APP, IMMUNE SYSTEM 
3bkj:L   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-16)  |   ABETA, AMYLOID BETA PEPTIDE, FAB, WO2, ALZHEIMER'S DISEASE, IMMUNOTHERAPIES, APP, IMMUNE SYSTEM 
3bkm:L   (ALA108) to   (ASN209)  STRUCTURE OF ANTI-AMYLOID-BETA FAB WO2 (FORM A, P212121)  |   ABETA, AMYLOID BETA PEPTIDE, FAB, WO2, ALZHEIMER'S DISEASE, IMMUNOTHERAPIES, APP, IMMUNE SYSTEM 
3bky:L   (THR108) to   (SER207)  CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE  |   2H7, C2H7, CHIMERIC ANTIBODY, FAB, CD20, FAB-PEPTIDE COMPLEX, B-CELL ACTIVATION, MEMBRANE, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM 
3mug:C   (PRO109) to   (ALA210)  CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY  |   PG16, FAB, SULFOTYROSINE, HIV, IMMUNE SYSTEM 
3bn9:C   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2  |   ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME- INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, POLYMORPHISM, SERINE PROTEASE, SIGNAL- ANCHOR, TRANSMEMBRANE 
3bpc:A   (ALA108) to   (ASN209)  CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4- EPI-2,3-DEHYDRO KDO (4.8) KDO  |   FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
3bqu:A   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX  |   BETA SHEET, IMMUNE SYSTEM 
3bqu:C   (ALA109) to   (PHE209)  CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX  |   BETA SHEET, IMMUNE SYSTEM 
4qww:C   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX  |   A/B HYDROLASE FOLD, ACETYLCHOLINESTERASE, MONOCLONAL ANTIBODY, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4qww:E   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX  |   A/B HYDROLASE FOLD, ACETYLCHOLINESTERASE, MONOCLONAL ANTIBODY, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4qxg:L   (THR110) to   (ARG212)  ANTIGEN BINDING FRAGMENT OF AN ANTI IFNAR1 ANTIBODY  |   IGV AND IGC TYPE FOLDS, ANTIGEN BINDING, IFNAR1, INTERFERON ALPHA RECEPTOR 1, IMMUNE SYSTEM 
5f3h:B   (THR109) to   (SER208)  STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY  |   MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
5f3h:D   (THR109) to   (SER208)  STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY  |   MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
5f3h:F   (THR109) to   (ARG211)  STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY  |   MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
5f3h:H   (THR109) to   (ARG211)  STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY  |   MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
3bsz:L   (ALA113) to   (ARG215)  CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX  |   RETINOL, VITAMIN A, PROTEIN-PROTEIN COMPLEX, RBP, TTR, AMYLOID, DISEASE MUTATION, GLYCOPROTEIN, HORMONE, POLYNEUROPATHY, RETINOL- BINDING, SECRETED, THYROID HORMONE, TRANSPORT, SENSORY TRANSDUCTION, VISION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
3bsz:M   (ALA113) to   (ARG215)  CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX  |   RETINOL, VITAMIN A, PROTEIN-PROTEIN COMPLEX, RBP, TTR, AMYLOID, DISEASE MUTATION, GLYCOPROTEIN, HORMONE, POLYNEUROPATHY, RETINOL- BINDING, SECRETED, THYROID HORMONE, TRANSPORT, SENSORY TRANSDUCTION, VISION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4qxu:L   (ALA114) to   (ASN215)  NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE- SWIVELING CONFORMATIONAL ANTIBODY  |   STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, IGG FOLD, IMMUNE SYSTEM 
3mxv:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA  |   CHIMERA, FAB FRAGMENT, ANTIBODY, SONIC HEDGEHOG, IMMUNE SYSTEM 
3mxw:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT  |   ANTIBODY COMPLEX, FAB FRAGMENT, METALLOPROTEASE, CALCIUM BINDING, ZINC HYDROLASE, DEVELOPMENT, MORPHOGEN, SIGNALING PROTEIN 
5f88:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5f88:C   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5f96:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.12 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120  |   HIV-1, ANTIBODY, CH235 LINEAGE, VH1-46 GERMLINE, IMMUNE SYSTEM 
5f9o:L   (THR108) to   (SER207)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.09 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120  |   ANTIBODY EVOLUTION HIV-1 BROADLY NEUTRALIZING CD4 BINDING SITE, IMMUNE SYSTEM 
3bz4:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE  |   O-ANTIGEN, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM 
3bz4:C   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE  |   O-ANTIGEN, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM 
3bz4:E   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE  |   O-ANTIGEN, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM 
5f9w:C   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120  |   HIV-1, VH1-46 GERMLINE, NEUTRALIZING ANTIBODY, CH235, IMMUNE SYSTEM 
5f9w:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120  |   HIV-1, VH1-46 GERMLINE, NEUTRALIZING ANTIBODY, CH235, IMMUNE SYSTEM 
3c08:L   (THR108) to   (SER207)  CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB/EMD72000 (FAB72000)  |   FAB FRAGMENT, ANTITUMOR, DRUG, IMMUNE SYSTEM 
5fcu:L   (PRO109) to   (PRO208)  CRYSTAL STRUCTURE OF THE INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4  |   HIV-1 GP120, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5ff6:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
4r4b:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C  |   IGG, FAB, HIV, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4r4b:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C  |   IGG, FAB, HIV, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4r4n:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120  |   HIV-1 ATTACHMENT GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX 
4r4n:K   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120  |   HIV-1 ATTACHMENT GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX 
4r4n:R   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120  |   HIV-1 ATTACHMENT GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX 
5fgb:A   (THR109) to   (SER208)  THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.4  |   FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEPATITIS C VIRUS E2, IMMUNE SYSTEM 
5fgb:B   (THR109) to   (SER208)  THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.4  |   FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEPATITIS C VIRUS E2, IMMUNE SYSTEM 
5fgc:B   (THR109) to   (SER208)  THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.8  |   FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEPATITIS C VIRUS E2, VIRAL PROTEIN 
3c5s:A   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG  |   ANTIBODY, O-ANTIGEN, LPS, SHIGELLA FLEXNERI, IMMUNE SYSTEM 
3c5s:C   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG  |   ANTIBODY, O-ANTIGEN, LPS, SHIGELLA FLEXNERI, IMMUNE SYSTEM 
5fha:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 114  |   IG DOMAIN, FAB, IMMUNE SYSTEM 
3c6s:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE  |   O-ANTIGEN, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM 
3c6s:C   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE  |   O-ANTIGEN, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM 
3c6s:E   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE  |   O-ANTIGEN, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM 
5fhx:L   (THR232) to   (ARG334)  CRYSTAL STRUCTURE OF CODV IN COMPLEX WITH IL4 AT 2.55 ANG. RESOLUTION.  |   CROSS-OVER DUAL VARIABLE IMMUNOGLOBULIN MULTIFUNCTIONAL BIOTHERAPEUTIC DRUG, CODV, IMMUNE SYSTEM 
3n85:L   (THR109) to   (ASN210)  CRYSTALLOGRAPHIC TRIMER OF HER2 EXTRACELLULAR REGIONS IN COMPLEX WITH TRYPTOPHAN-RICH ANTIBODY FRAGMENT  |   HER2, ERBB2, TRP/SER LIBRARY, PHAGE DISPLAY, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
4r7d:B   (THR109) to   (ARG211)  FAB HU 15C1  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4r7d:H   (THR109) to   (SER208)  FAB HU 15C1  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4r7d:J   (THR109) to   (SER208)  FAB HU 15C1  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4r7d:N   (THR109) to   (ASN210)  FAB HU 15C1  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4r7n:H   (THR109) to   (ARG211)  FAB C2E3  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
3na9:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF FAB15  |   ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM 
3nab:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF FAB15 MUT6  |   ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM 
3nac:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF FAB15 MUT7  |   ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM 
4r96:A   (THR115) to   (ASN216)  STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET  |   IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET 
4r96:C   (THR115) to   (ASN216)  STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET  |   IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET 
4r96:E   (THR115) to   (ASN216)  STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET  |   IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET 
4r96:L   (THR115) to   (ASN216)  STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET  |   IMMUNOGLOBULIN DOMAINS, IMMUNE SYSTEM, CMET 
4rau:A   (ALA111) to   (ASN214)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:D   (ALA111) to   (ASN214)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:G   (ALA111) to   (ASN214)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:J   (ALA111) to   (ASN214)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:M   (ALA111) to   (ASN214)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:P   (ALA111) to   (ASN214)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:S   (ALA111) to   (ASN214)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:V   (ALA111) to   (ASN214)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rbp:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE  |   IMMUNOGLOBULIN FOLD, HIV NEUTRALIZING, HIV-1 GP120, IMMUNE SYSTEM 
4rbp:K   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE  |   IMMUNOGLOBULIN FOLD, HIV NEUTRALIZING, HIV-1 GP120, IMMUNE SYSTEM 
4rdq:F   (ALA109) to   (ASN210)  CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM  |   TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN 
4rdq:H   (ALA109) to   (ASN210)  CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM  |   TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN 
4rdq:J   (ALA109) to   (ASN210)  CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM  |   TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN 
4rdq:L   (ALA109) to   (ASN212)  CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM  |   TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN 
4rdq:N   (ALA109) to   (ASN210)  CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM  |   TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN 
3ncj:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF FAB15 MUT8  |   ANTIBODY, IMMUNE SYSTEM 
3cfb:L   (ALA109) to   (ASN212)  HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K  |   IMMUNOGLOBULIN, BLUE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM, ELECTRON TRANSFER 
3cfb:A   (ALA109) to   (ASN212)  HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K  |   IMMUNOGLOBULIN, BLUE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM, ELECTRON TRANSFER 
3cfc:L   (ALA109) to   (ASN212)  HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2  |   IMMUNOGLOBULIN, BLUE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM, ELECTRON TRANSFER 
3cfk:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:C   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:E   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:G   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:J   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:M   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfk:O   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, CHIMERA, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfj:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfj:A   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfj:C   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3cfj:E   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, APO FORM, PROTON TRANSFER, CONFORMATIONAL CHANGE, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN V REGION 
3nfp:B   (THR108) to   (GLY211)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN  |   IL-2RA, CD25, DACLIZUMAB, ZENAPAX, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM, IMMUNE SYSTEM-CYTOKINE COMPLEX 
4rfn:C   (PRO109) to   (PRO208)  CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48  |   HIV-1 GP120, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4rgm:L   (ALA109) to   (ASN212)  STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1  |   NEUTRALIZING ANTIBODY, STAPHYLOCOCCAL ENTEROTOXIN B, TOXIN-IMMUNE SYSTEM COMPLEX 
4rgm:B   (ALA109) to   (ASN212)  STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1  |   NEUTRALIZING ANTIBODY, STAPHYLOCOCCAL ENTEROTOXIN B, TOXIN-IMMUNE SYSTEM COMPLEX 
4rgo:L   (ALA109) to   (ASN212)  STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 14G8  |   NEUTRALIZING ANTIBODY, STAPHYLOCOCCAL ENTEROTOXIN B, TOXIN-IMMUNE SYSTEM COMPLEX 
3nid:F   (ALA109) to   (ASN210)  THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING  |   INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-BLOOD CLOTTING COMPLEX 
3nid:L   (ALA109) to   (ASN210)  THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING  |   INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-BLOOD CLOTTING COMPLEX 
3nif:L   (ALA109) to   (ASN210)  THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING  |   INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-BLOOD CLOTTING COMPLEX 
3nig:L   (ALA109) to   (ASN212)  THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING  |   INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-IMMUNE SYSTEM COMPLEX, CELL ADHESION-BLOOD CLOTTING COMPLEX 
3cle:L   (ALA109) to   (ASN210)  HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23  |   HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3clf:L   (ALA109) to   (ASN210)  HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23  |   HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3cmo:L   (ALA109) to   (ARG211)  HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18  |   HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3cmo:X   (ALA109) to   (ARG211)  HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18  |   HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
4c83:D   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF THE IGG2A LPT3 IN COMPLEX WITH AN 8- SUGAR INNER CORE ANALOGUE OF NEISSERIA MENINGITIDIS  |   IMMUNE SYSTEM, LIPOOLIGOSACCHARIDES, ANTIBODIES, ANTIGEN-ANTIBODY COMPLEX 
4ris:L   (PRO109) to   (PRO208)  STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK  |   ANTIBODY, IGG FOLD, IMMUNE SYSTEM, HIV-1 GP120 V2 REGION 
4cad:A   (ALA109) to   (ASN210)  MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1  |   PROTEIN BINDING, INTEGRAL MEMBRANE PROTEASE, MONOCLONAL ANTIBODY FAB FRAGMENT 
3nps:C   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4  |   HYDROLASE, ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME-INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, MEMBRANE, SERINE PROTEASE, SIGNAL-ANCHOR, TRANSMEMBRANE, HYDROLASE - IMMUNE SYSTEM COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3ntc:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF KD-247 FAB, AN ANTI-V3 ANTIBODY THAT INHIBITS HIV-1 ENTRY  |   KD-247, HUMANIZED ANTIBODY, ANTI-V3, FAB, IMMUNE SYSTEM 
4rnr:B   (PRO109) to   (PRO208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV ANTIBODY PGT130  |   PGT130, PGT 130, IMMUNOGLOBULIN FOLD, BROADLY NEUTRALIZING ANTIBODY, HIV-1 GP120 BINDING, N-LINKED GLYCAN, IMMUNE SYSTEM 
5fuo:L   (THR112) to   (ASN213)  EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE  |   IMMUNE SYSTEM, ANTI-ALBUMIN, FAB FRAGMENT, SERUM HALF-LIFE, FCRN, HUMAN SERUM ALBUMIN 
4rqq:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY  |   IGG, ANTI-HIV-1 ANTIBODY, HIV-1 ENV TRIMER, IMMUNE SYSTEM 
4rqs:C   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HIV-1 GP120 CORE BOUND TO CD4 AND 17B FAB  |   IMMUNOGLOBULIN FOLD, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM 
4rrp:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16  |   STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, CHAPERONE-ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM 
4rrp:B   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16  |   STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, CHAPERONE-ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM 
3csy:B   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR  |   GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3csy:H   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR  |   GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3nz8:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8  |   ANTIGEN BINDING, ANTIBODY, FAB, IMMUNOLOGICAL, HIV-2, V3, GP125, IMMUNE SYSTEM 
3cvh:L   (ALA108) to   (ASN209)  HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE  |   MHC, TCR, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, ALLERGEN, PHOSPHOPROTEIN, SECRETED, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3cvi:L   (ALA108) to   (ASN209)  HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE  |   FAB, IMMUNE SYSTEM 
3o2v:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF 1E9 PHEL89SER/LEUH47TRP/METH100BPHE, AN ENGINEERED DIELS-ALDERASE FAB WITH MODIFIED SPECIFICITY AND CATALYTIC ACTIVITY  |   IGG ANTIBODY FAB, IMMUNE SYSTEM 
4cmh:C   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984  |   HYDROLASE-IMMUNE SYSTEM COMPLEX, MULTIPLE MYELOMA 
3cxd:L   (SER109) to   (ASN210)  CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH ITS EPITOPE PEPTIDE  |   FAB, OSTEOPONTIN, OPN, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM 
3o41:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE  |   IMMUNOGLOBULIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3o41:B   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE  |   IMMUNOGLOBULIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3o45:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE  |   IMMUNOGLOBULIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3o45:B   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE  |   IMMUNOGLOBULIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4cni:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6  |   IMMUNE SYSTEM,  CDP6038, INTERLEUKIN 6 
3o6l:L   (ALA114) to   (ARG216)  ANTI-TAT HIV 11H6H1 FAB' COMPLEXED WITH A 15-MER TAT PEPTIDE  |   ANTIGEN-BINDING SITE, U-SHAPED GROOVE, IMMUNE SYSTEM, TAT HIV 
3d0l:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671  |   HIV, ANTIBODY, NEUTRALIZATION, EPITOPE, 2F5, GP41, IMMUNE SYSTEM 
3d0v:A   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LLELDKWASLW  |   2F5, HIV, GP41, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM 
4s1d:L   (ALA109) to   (ASN210)  STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE  |   ANTIBODY, FAB FRAGMENT, HAPTEN, MAB_M33_FAB_FRAGMENT, IMMUNE SYSTEM 
4s1d:D   (ALA109) to   (ARG211)  STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE  |   ANTIBODY, FAB FRAGMENT, HAPTEN, MAB_M33_FAB_FRAGMENT, IMMUNE SYSTEM 
4s1s:L   (THR111) to   (ASN212)  CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY, 45-VRC01.H5.F-185917, IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE  |   HIV-1, NEUTRALIZING ANTIBODIES, VRC01-LINEAGE, ANTIBODY MATURATION, EVOLUTIONARY RATE, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX 
4s2s:L   (ALA115) to   (ARG217)  CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4s2s:B   (ALA115) to   (ASN216)  CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
3oau:L   (THR109) to   (ASN210)  ANTIBODY 2G12 RECOGNIZES DI-MANNOSE EQUIVALENTLY IN DOMAIN- AND NON- DOMAIN-EXCHANGED FORMS, BUT ONLY BINDS THE HIV-1 GLYCAN SHIELD IF DOMAIN-EXCHANGED  |   FAB, IMMUNE SYSTEM 
3oay:K   (THR109) to   (SER208)  A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY  |   FAB, IMMUNE SYSTEM 
3oay:L   (THR109) to   (SER208)  A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY  |   FAB, IMMUNE SYSTEM 
3oaz:K   (THR109) to   (SER208)  A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY  |   FAB, IMMUNE SYSTEM 
3oaz:L   (THR109) to   (SER208)  A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY  |   FAB, IMMUNE SYSTEM 
3ob0:L   (THR109) to   (ASN210)  A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY  |   FAB, IMMUNE SYSTEM 
3ob0:K   (THR109) to   (ASN210)  A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY  |   FAB, IMMUNE SYSTEM 
3d85:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB  |   INTERLEUKIN-23, FAB, IMMUNE SYSTEM/CYTOKINE COMPLEX 
3d9a:L   (ALA109) to   (ASN212)  HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME  |   LYSOZYME, HYHEL10, FAB, ANTIBODY, ANTIGEN, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, GLYCOSIDASE, HYDROLASE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4tnv:K   (PRO112) to   (ARG211)  C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION  |   MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4tnv:L   (PRO112) to   (ARG211)  C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION  |   MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4tnv:Z   (PRO112) to   (ARG211)  C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION  |   MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4tqe:L   (ALA114) to   (ASN217)  STRUCTURE OF TAU PEPTIDE IN COMPLEX WITH TAU5 ANTIBODY FAB FRAGMENT  |   INTRINSICALLY DISORDERED PROTEIN, IMMUNE SYSTEM 
3det:D   (ALA108) to   (ALA211)  STRUCTURE OF THE E148A, Y445A DOUBLY UNGATED MUTANT OF E.COLI CLC_EC1, CL-/H+ ANTIPORTER  |   CLC_EC1, ANTIPORTER, EXCHANGE-TRANSPORTER, DOUBLY UNGATED MUTANT, CHLORIDE, INNER MEMBRANE, ION TRANSPORT, MEMBRANE, STRESS RESPONSE, TRANSMEMBRANE, MEMBRANE PROTEIN 
5ggs:B   (THR113) to   (SER212)  PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB  |   ANTIBODY, IMMUNE SYSTEM 
5ggs:D   (THR113) to   (SER212)  PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB  |   ANTIBODY, IMMUNE SYSTEM 
5ggu:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF TREMELIMUMAB FAB  |   ANTIBODY, IMMUNE SYSTEM 
5ggu:B   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF TREMELIMUMAB FAB  |   ANTIBODY, IMMUNE SYSTEM 
5ggv:L   (THR109) to   (SER208)  CTLA-4 IN COMPLEX WITH TREMELIMUMAB FAB  |   ANTIBODY, IMMUNE SYSTEM 
4trp:L   (ALA115) to   (ASN218)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.  |   ANTIBODY, IMMUNE SYSTEM 
5gir:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE  |   FAB, PEPTIDE LIGAND, MUTATION, IMMUNE SYSTEM 
5gir:B   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE  |   FAB, PEPTIDE LIGAND, MUTATION, IMMUNE SYSTEM 
5gis:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE  |   FAB, PEPTIDE LIGAND, MUTATION, IMMUNE SYSTEM 
3dif:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF FABOX117  |   ANTIBODY FRAGMENTS, FABS, TRANSIENT EXPRESSION, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3ojd:A   (ALA109) to   (ARG211)  ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)  |   BETA-SANDWICH IMMUNOGLOBULIN FOLD, ANTIGEN BINDING, SECRETED PROTEIN, ANTI-INDOLICIDIN FAB, SURROGATE RECEPTOR, IMMUNE SYSTEM 
4tuj:B   (ALA115) to   (ARG217)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.  |   ANTIBODY, NEUROBLASTOMA, IMMUNE SYSTEM 
4tuj:D   (ALA115) to   (ARG217)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.  |   ANTIBODY, NEUROBLASTOMA, IMMUNE SYSTEM 
4tuk:L   (ALA115) to   (ASN218)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.  |   IMMUNE SYSTEM, NEUROBLASTOMA 
4tul:L   (ALA115) to   (ASN218)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.  |   IMMUNE SYSTEM, NEUROBLASTOMA 
4tuo:B   (ALA115) to   (ASN216)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.  |   NEUROBLASTOMA, IMMUNE SYSTEM 
4tuo:D   (ALA115) to   (ASN218)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.  |   NEUROBLASTOMA, IMMUNE SYSTEM 
3oke:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM 
3okl:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM 
3okn:A   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM 
3oko:A   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM 
3dro:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN GROWN IN AMMONIUM SULFATE  |   HIV-1, GP41, 2F5, NMAB, IMMUNE SYSTEM 
3drq:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671 SOAKED IN PEG/2- PROPANOL SOLUTION  |   HIV-1, 2F5, GP41, NMAB, IMMUNE SYSTEM 
3drt:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 SCRAMBLEDFP-MPER SCRHYB3K CONSTRUCT GIGAFGLLGFLAAGSKK-AHX-K656NEQELLELDKWASLWN671  |   HIV-1, GP41, 2F5, NMAB, IMMUNE SYSTEM 
4u1g:C   (ALA113) to   (ARG215)  PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY QA1  |   MALARIA ERYTHROCYTE INVASION ANTIBODY-MEDIATED INHIBITION, IMMUNE SYSTEM 
4u1g:F   (ALA113) to   (ARG215)  PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY QA1  |   MALARIA ERYTHROCYTE INVASION ANTIBODY-MEDIATED INHIBITION, IMMUNE SYSTEM 
3dsf:L   (SER109) to   (ALA212)  CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH W43A MUTATED EPITOPE PEPTIDE  |   FAB, OSTEOPONTIN, OPN, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM 
3opz:L   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY  |   SIX-BLADED BETA-PROPELLER NEURAMINIDASE IMMUNOGLOBULIN DOMAIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3opz:M   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY  |   SIX-BLADED BETA-PROPELLER NEURAMINIDASE IMMUNOGLOBULIN DOMAIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3opz:N   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY  |   SIX-BLADED BETA-PROPELLER NEURAMINIDASE IMMUNOGLOBULIN DOMAIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3or6:B   (ALA109) to   (ASN210)  ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q  |   INACTIVATION, ALPHA-HELICAL, POTASSIUM CHANNEL, IMMUNE SYSTEM- TRANSPORT PROTEIN COMPLEX 
3dvg:A   (THR111) to   (ASN212)  CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU.3A8 BOUND TO K63-LINKED DI- UBIQUITIN  |   DI-UBIQUITIN, FAB FRAGMENT, ANTIBODY, NUCLEUS, PHOSPHOPROTEIN, RIBOSOMAL PROTEIN, IMMUNE SYSTEM 
5hcg:L   (THR232) to   (ARG334)  CRYSTAL STRUCTURE OF FREE-CODV.  |   CROSS-OVER DUAL VARIABLE IMMUNOGLOBIN, MULTIFUNCTIONAL BIOTHERAPEUTIC FORMAT, BISPECIFIC PROPERTY, CODV, IMMUNE SYSTEM 
5hdb:L   (ALA109) to   (ASN210)  INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054  |   CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX, INTEGRIN INHIBITOR, RGD MIMETICS 
3oz9:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1  |   IMMUNOGLOBULIN FOLD, NON-NEUTRALIZING ANTIBODY, HIV-1 GP41 6-HELIX BUNDLE CORE, IMMUNE SYSTEM 
4dgi:L   (ALA109) to   (ASN212)  STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120- 230  |   PRION, ANTIBODY, PROTEIN BINDING 
4dgv:L   (THR109) to   (ASN210)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1, P2(1) FORM  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4dgy:L   (THR109) to   (SER208)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1, C2 FORM  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4u6h:B   (ALA114) to   (ASN217)  VACCINIA L1/M12B9-FAB COMPLEX  |   IGG2A, FAB, HEAVY CHAIN LIGHT CHAIN 
4u6h:D   (ALA114) to   (ASN215)  VACCINIA L1/M12B9-FAB COMPLEX  |   IGG2A, FAB, HEAVY CHAIN LIGHT CHAIN 
4dke:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1  |   DIMERIC FOUR-HELIX BUNDLE CYTOKINE, IGG, GLYCOSYLATION, CYTOKINE- IMMUNE SYSTEM COMPLEX 
4dke:M   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1  |   DIMERIC FOUR-HELIX BUNDLE CYTOKINE, IGG, GLYCOSYLATION, CYTOKINE- IMMUNE SYSTEM COMPLEX 
4u6v:L   (THR108) to   (ASN209)  MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY  |   ALPHA TOXIN, FAB, STAPHYLOCOCCUS AUREUS, MUTAGENESIS, IMMUNE SYSTEM 
4u6v:M   (THR108) to   (ASN209)  MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY  |   ALPHA TOXIN, FAB, STAPHYLOCOCCUS AUREUS, MUTAGENESIS, IMMUNE SYSTEM 
4dkf:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2  |   DIMERIC FOUR-HELIX BUNDLE CYTOKINE, IGG, GLYCOSYLATION, CYTOKINE- IMMUNE SYSTEM COMPLEX 
4dn3:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888  |   ANTIBODY, IMMUNE SYSTEM 
5hpm:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5hpm:C   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
4uao:B   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI IN COMPLEX WITH AN INVASION INHIBITORY ANTIBODY  |   MALARIA, CELL INVASION, INVASION INHIBITORY ANTIBODY 
4ubd:T   (THR110) to   (ARG212)  CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA  |   HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4dtg:L   (THR114) to   (GLY217)  HEMOSTATIC EFFECT OF A MONOCLONAL ANTIBODY MAB 2021 BLOCKING THE INTERACTION BETWEEN FXA AND TFPI IN A RABBIT HEMOPHILIA MODEL  |   ANTIBODY, INHIBITOR, BLOOD COAGULATION, BLOOD CLOTTING INHIBITOR- IMMUNE SYSTEM COMPLEX 
5hyq:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5hyq:C   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5i16:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-11  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i16:A   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-11  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i17:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-20  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i17:A   (THR110) to   (GLY213)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-20  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i19:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV1-39  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i1c:L   (THR110) to   (ASN211)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-20  |   IMMUNE SYSTEM 
5i1d:L   (THR115) to   (ARG217)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i1d:A   (THR115) to   (SER214)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i1e:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV1-39  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i1h:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-20  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i1j:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-11  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i1l:L   (THR115) to   (ASN216)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i1l:A   (THR115) to   (ASN216)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
4dvb:B   (ALA110) to   (ASN213)  THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112  |   IMMUNE SYSTEM, HYDROLASE 
4dvb:L   (ALA110) to   (ASN213)  THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112  |   IMMUNE SYSTEM, HYDROLASE 
5i2i:A   (THR109) to   (ASN210)  STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE  |   IMMUNE SYSTEM, ANTIBODY 
5i2i:C   (THR109) to   (SER208)  STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE  |   IMMUNE SYSTEM, ANTIBODY 
5i30:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 NEUTRALIZING MONOCLONAL ANTIBODY PL-2 FAB FRAGMENT AT 1.9 A RESOLUTION  |   ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM 
4dvr:L   (THR108) to   (ASN209)  CRYSTAL STRUCTURE OF YU2 GP120 CORE IN COMPLEX WITH FAB 48D AND NBD- 557  |   HIV-1 GP120, CD4 BINDING SITE, NBD-557, IMMUNE SYSTEM-TRANSCRIPTION INHIBITOR COMPLEX 
3phq:A   (ALA112) to   (ASN213)  CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, CARBOHYDRATE-BINDING PROTEIN 
4uil:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.1 WITH QUININE  |   IMMUNE SYSTEM, FAB, QUININE-DEPENDENT, MOUSE MAB 
3pjs:A   (THR111) to   (ASN212)  MECHANISM OF ACTIVATION GATING IN THE FULL-LENGTH KCSA K+ CHANNEL  |   ION CHANNEL, CONDUCTS K+ IONS, CELL MEMBRANE, TRANSPORT PROTEIN 
5i66:B   (ALA129) to   (ASN230)  X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6, A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3pnw:A   (THR112) to   (ARG214)  CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB  |   FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX 
3pnw:D   (THR112) to   (ARG214)  CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB  |   FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX 
3pnw:G   (THR112) to   (ARG214)  CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB  |   FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX 
3pnw:J   (THR112) to   (SER211)  CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB  |   FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX 
3pnw:M   (THR112) to   (GLY215)  CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB  |   FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX 
3pnw:P   (THR112) to   (ARG214)  CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB  |   FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX 
3pnw:S   (THR112) to   (GLY215)  CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB  |   FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX 
3pnw:V   (THR112) to   (SER211)  CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB  |   FAB, STRUCTURAL GENOMICS CONSORTIUM, ANTIBODY, SGC, PROTEIN BINDING- IMMUNE SYSTEM COMPLEX 
5i8c:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 CLADE A BG505 FUSION PEPTIDE (RESIDUE 512- 520) IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC34.01 FAB  |   HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM 
5i8h:F   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB  |   HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM 
5i8h:H   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB  |   HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM 
5i8k:L   (THR112) to   (SER211)  HHH1 FAB FRAGMENT  |   ANTIBODY, GLYCAN BINDING, FAB, ALLERGY, IMMUNE SYSTEM 
5i8o:L   (THR112) to   (ASN213)  HMM5 FAB IN COMPLEX WITH DISACCHARIDE  |   ANTIBODY FAB GLYCAN ALLERGY, IMMUNE SYSTEM 
5i9q:L   (THR102) to   (SER201)  CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120  |   ANTIBODY, IMMUNE SYSTEM, HIV-1 
3pp3:L   (THR114) to   (ASN215)  EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES  |   ANTIBODY FAB-FRAGMENT IG-DOMAIN, ANTIBODY, CD20, IMMUNE SYSTEM 
3pp3:K   (THR114) to   (ASN215)  EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES  |   ANTIBODY FAB-FRAGMENT IG-DOMAIN, ANTIBODY, CD20, IMMUNE SYSTEM 
3pp4:L   (THR114) to   (SER213)  EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES  |   ANTIBODY FAB FRAGMENT IG-DOMAIN, CD20, CYCLIC PEPTIDE, ANTIBODY ANTIGEN, IMMUNE SYSTEM 
5ibt:L   (THR110) to   (ASN211)  UCA FAB (UNBOUND) FROM 6515 LINEAGE  |   ANTIBODY, INFLUENZA, UNBOUND, IMMUNE SYSTEM 
5ibu:B   (THR110) to   (SER209)  6652 FAB (UNBOUND)  |   ANTIBODY, INFLUENZA, UNBOUND, IMMUNE SYSTEM 
5ibu:L   (THR110) to   (SER209)  6652 FAB (UNBOUND)  |   ANTIBODY, INFLUENZA, UNBOUND, IMMUNE SYSTEM 
5icy:C   (THR109) to   (GLY212)  CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5icx:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5icx:C   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5icz:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5icz:C   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5id1:C   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5ies:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.16 A  |   HIV-1 GP120, ENGINEERED OUTER DOMAIN (EOD), GERMLINE TARGETING, CD4 BINDING SITE, VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, IMMUNE SYSTEM, VIRAL-PROTEIN COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, IMMUNE SYSTEM- VIRAL PROTEIN COMPLEX 
5if0:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.44 A  |   HIV-1 GP120, ENGINEERED OUTER DOMAIN (EOD), GERMLINE TARGETING, CD4 BINDING SITE, VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, IMMUNE SYSTEM, VIRAL-PROTEIN COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
5if0:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.44 A  |   HIV-1 GP120, ENGINEERED OUTER DOMAIN (EOD), GERMLINE TARGETING, CD4 BINDING SITE, VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, IMMUNE SYSTEM, VIRAL-PROTEIN COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
5ifa:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF UNBOUND VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR AT 1.82 A  |   VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, CD4 BINDING SITE, IMMUNE SYSTEM, ANTI-HIV-1 
4uta:L   (THR110) to   (ASN211)  CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY 
4uta:M   (THR110) to   (GLY213)  CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY 
4utb:L   (PRO110) to   (ALA208)  CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY , IMMUNE SYSTEM, FAB FRAGMENT 
4utb:M   (PRO110) to   (VAL207)  CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY , IMMUNE SYSTEM, FAB FRAGMENT 
4uuj:B   (ALA109) to   (ASN212)  POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM  |   IMMUNE SYSTEM-METAL TRANSPORT COMPLEX, QUATERNARY AMMONIUM, PROTEIN-ANTIBODY FAB COMPLEX, IONIC CHANNEL, ION TRANSPORT, POTASSIUM CHANNEL 
4uv4:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT  |   IMMUNE SYSTEM, ANTIBODY ENGINEERING, PHAGE DISPLAY, LONG CDR, FORMYL PEPTIDE RECEPTOR-1 
4uv7:L   (THR114) to   (SER213)  THE COMPLEX STRUCTURE OF EXTRACELLULAR DOMAIN OF EGFR AND GC1118A  |   TRANSFERASE, RECEPTOR TYROSINE KINASE, ANTIBODY 
4edw:L   (THR109) to   (SER208)  NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)  |   CYSTINE KNOT, IMMUNOGLOBULIN, GROWTH/SURVIVAL FACTOR, IMMUNE SYSTEM 
4edx:A   (ALA109) to   (ASN212)  NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911  |   CYSTINE KNOT, IMMUNOGLOBULIN, GROWTH/SURVIVAL FACTOR, IMMUNE SYSTEM 
4edx:L   (ALA109) to   (ASN212)  NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911  |   CYSTINE KNOT, IMMUNOGLOBULIN, GROWTH/SURVIVAL FACTOR, IMMUNE SYSTEM 
5ikc:A   (ALA109) to   (ASN212)  X-RAY STRUCURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB  |   DCX DOMAIN, UBIQUITIN-LIKE FOLD, MICROTUBULE ASSOCIATED, SIGNALING PROTEIN, TRANSFERASE 
5ilt:L   (PRO109) to   (LYS207)  CRYSTAL STRUCTURE OF BOVINE FAB A01  |   ANTIBODY FAB ULTRALONG CDR H3, IMMUNE SYSTEM 
5iop:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5iop:C   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
4ene:D   (ALA108) to   (ALA211)  STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX  |   MEMBRANE PROTEIN, COUPLED ION TRANSPORTER, CELL MEMBRANE, TRANSPORT PROTEIN 
4ene:F   (ALA108) to   (ALA211)  STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX  |   MEMBRANE PROTEIN, COUPLED ION TRANSPORTER, CELL MEMBRANE, TRANSPORT PROTEIN 
3q1s:L   (THR109) to   (ARG211)  HIV-1 NEUTRALIZING ANTIBODY Z13E1 IN COMPLEX WITH EPITOPE DISPLAY PROTEIN  |   IMMUNOGLOBULIN FOLD, ANTIBODY, GP41, IMMUNE SYSTEM-CYTOKINE COMPLEX 
5ir1:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5ir1:C   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
3q3g:C   (ALA115) to   (ASN218)  CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY  |   IMMUNE SYSTEM-CELL ADHESION COMPLEX 
3q3g:A   (ALA115) to   (ASN216)  CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY  |   IMMUNE SYSTEM-CELL ADHESION COMPLEX 
3q3g:F   (ALA115) to   (ASN218)  CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY  |   IMMUNE SYSTEM-CELL ADHESION COMPLEX 
3q3g:J   (ALA115) to   (ASN218)  CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY  |   IMMUNE SYSTEM-CELL ADHESION COMPLEX 
5itb:L   (THR129) to   (SER228)  CRYSTAL STRUCTURE OF THE ANTI-RSV F FAB 14N4  |   ANTIBODY, IMMUNE SYSTEM 
3q6f:A   (PRO109) to   (PRO208)  CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120  |   IGG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM 
3q6f:C   (PRO109) to   (ALA207)  CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120  |   IGG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM 
5iv2:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT  |   IMMUNE SYSTEM 
5iv2:C   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT  |   IMMUNE SYSTEM 
4ers:L   (THR109) to   (PHE209)  A MOLECULAR BASIS FOR NEGATIVE REGULATION OF THE GLUCAGON RECEPTOR  |   GLUCAGON RECEPTOR, CLASS-B GPCR, FAB, GLYCOSYLATION, EXTRA-CELLULAR, IMMUNE SYSTEM 
4etq:L   (ALA109) to   (ASN210)  VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5  |   VARIABLE DOMAIN, CONSTANT DOMAIN, IGG2A, IGG DOMAIN, CDR, HYPERVARIABLE REGION, NEUTRALIZING ANTIBODY, BETA SHEET, CARBONIC ANHYDRASE FOLD, LOOSE KNOT, CHONDROITIN-SULFATE BINDING SITE, DELTA 262, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4etq:B   (ALA109) to   (ASN212)  VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5  |   VARIABLE DOMAIN, CONSTANT DOMAIN, IGG2A, IGG DOMAIN, CDR, HYPERVARIABLE REGION, NEUTRALIZING ANTIBODY, BETA SHEET, CARBONIC ANHYDRASE FOLD, LOOSE KNOT, CHONDROITIN-SULFATE BINDING SITE, DELTA 262, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3qa3:C   (ALA115) to   (ASN216)  CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY  |   IMMUNE SYSTEM- CELL ADHESION COMPLEX 
3qa3:A   (ALA115) to   (ASN216)  CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY  |   IMMUNE SYSTEM- CELL ADHESION COMPLEX 
3qa3:F   (ALA115) to   (ASN218)  CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY  |   IMMUNE SYSTEM- CELL ADHESION COMPLEX 
3qa3:J   (ALA115) to   (ASN216)  CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY  |   IMMUNE SYSTEM- CELL ADHESION COMPLEX 
3qcv:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)  |   ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM 
3qcv:M   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)  |   ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM 
3qeg:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN N12-I2 FAB, AN ADCC AND NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY  |   ADCC AND NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I2, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM 
3qeh:B   (THR108) to   (ARG210)  CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY  |   ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I15, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM 
3qeh:D   (THR108) to   (ARG210)  CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY  |   ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I15, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM 
4f2m:B   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10  |   BETA-BARREL, IMMUNOGLOBULIN, VIRUS ENTRY, VIRUS NEUTRALIZATION, CELLULAR RECEPTOR, AMINOPEPTIDASE N, GLYCOSYLATION, VIRUS MEMBRANE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4f2m:D   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10  |   BETA-BARREL, IMMUNOGLOBULIN, VIRUS ENTRY, VIRUS NEUTRALIZATION, CELLULAR RECEPTOR, AMINOPEPTIDASE N, GLYCOSYLATION, VIRUS MEMBRANE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4f33:A   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009  |   IGG, ANTIGEN BINDING, MESOTHELIN, IMMUNE SYSTEM 
4f33:C   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009  |   IGG, ANTIGEN BINDING, MESOTHELIN, IMMUNE SYSTEM 
4f33:E   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009  |   IGG, ANTIGEN BINDING, MESOTHELIN, IMMUNE SYSTEM 
4f33:G   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009  |   IGG, ANTIGEN BINDING, MESOTHELIN, IMMUNE SYSTEM 
4f3f:A   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX  |   ANTIBODY FAB, RECOGNIZE MESOTHELIN, MESOTHELIN, IMMUNE SYSTEM 
4f58:M   (PRO109) to   (PRO208)  FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT  |   IG, ANTIBODY, GP120, IMMUNE SYSTEM 
4f58:N   (PRO109) to   (PRO208)  FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT  |   IG, ANTIBODY, GP120, IMMUNE SYSTEM 
5j3d:B   (THR129) to   (GLY232)  CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F  |   ANTIBODY, VIRUS, COMPLEX, IMMUNE SYSTEM 
5j3d:L   (THR129) to   (ASN230)  CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F  |   ANTIBODY, VIRUS, COMPLEX, IMMUNE SYSTEM 
3qnx:A   (THR114) to   (ARG216)  ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3qnz:A   (THR114) to   (ASN215)  ORTHORHOMBIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC TUBULIN PEPTIDE) SHARING SAME FV AS IGA  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3qpq:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3 
3qpq:E   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3 
3qpq:C   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3 
3qpq:I   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, TLR-3 
3qpx:L   (THR108) to   (ASN209)  CRYSTAL STRUCTURE OF FAB C2507  |   IMMUNOGLOBULIN, IMMUNE SYSTEM, MOUSE IL-17A 
3qrg:L   (THR113) to   (SER212)  CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M  |   FAB STRUCTURE, RSV, IMMUNE SYSTEM 
3qum:M   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY  |   KALLIKREIN FOLD, PROSTATE-SPECIFIC ANTIGEN, SERINE PROTEASE, NEGATIVE REGULATION OF ANGIOGENESIS, NATURAL POST-TRANSDUCTIONAL MODIFICATION, N-LINKED AND O-LINKED GLYCOSYLATION, IMMUNE SYSTEM 
3qwo:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB  |   IMMUNE COMPLEX, IMMUNE SYSTEM 
3r1g:L   (THR109) to   (GLY212)  STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE- BINDING ANTIBODY  |   ASPARTAL PROTEASE, PROTEIN BINDING 
5j9p:B   (ALA109) to   (ASN210)  KCSA IN VITRO  |   MEMBRANE PROTEIN, ION CHANNEL, IN VITRO, METAL TRANSPORT 
3ra7:L   (ALA109) to   (ARG211)  BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY  |   FAB FRAGMENT, ANTIBODY ENGINEERING, CANCER, TARGETED PAYLOAD DELIVERY, IMMUNE SYSTEM 
3ra7:M   (ALA109) to   (ARG211)  BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY  |   FAB FRAGMENT, ANTIBODY ENGINEERING, CANCER, TARGETED PAYLOAD DELIVERY, IMMUNE SYSTEM 
4fp8:M   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:l   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqv:L   (PRO109) to   (ALA207)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5jny:D   (PRO110) to   (ALA208)  CRYSTAL STRUCTURE OF 10E8 FAB  |   MPER, HIV, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM 
5jof:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF VRC03 GHVGLV ANTIGEN-BINDING FRAGMENT.  |   HIV-1, CD4 BINDING SITE, NEUTRALIZING, ANTIBODY DEVELOPMENT, IMMUNE SYSTEM 
5jof:F   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF VRC03 GHVGLV ANTIGEN-BINDING FRAGMENT.  |   HIV-1, CD4 BINDING SITE, NEUTRALIZING, ANTIBODY DEVELOPMENT, IMMUNE SYSTEM 
5jw3:L   (THR105) to   (SER204)  STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H7 HA  |   ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM 
5jw4:N   (THR105) to   (ASN206)  STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA  |   ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM 
5jw4:P   (THR105) to   (ASN206)  STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA  |   ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM 
5jw4:T   (THR105) to   (ASN206)  STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA  |   ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM 
5jw4:V   (THR105) to   (ASN206)  STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA  |   ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM 
5jw4:X   (THR105) to   (ASN206)  STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA  |   ANTIBODY INFLUENZA BROADLY NEUTRALIZING, IMMUNE SYSTEM 
5jw5:L   (THR105) to   (SER204)  STRUCTURE OF MEDI8852 FAB FRAGMENT  |   ANTIBODY INFLUENZA, IMMUNE SYSTEM 
5jw5:B   (THR105) to   (SER204)  STRUCTURE OF MEDI8852 FAB FRAGMENT  |   ANTIBODY INFLUENZA, IMMUNE SYSTEM 
4g3y:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT  |   TNF, INFLIXIMAB, IMMUNE SYSTEM 
4g5z:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE THERAPEUTICAL ANTIBODY FRAGMENT OF CANAKINUMAB IN ITS UNBOUND STATE  |   IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNOGLOBULIN, INTERLEUKINE-1BETA BINDING, CYTOKINE, BLOOD SYSTEM, IMMUNE SYSTEM 
4g6a:D   (ALA109) to   (GLY212)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4g6j:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF CANAKINUMAB  |   IMMUNGLOBULIN FOLD, INTERLEUKIN-1BETA BINDING, IMMUNE SYSTEM 
5k59:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY  |   TOXIN NEUTRALIZING MONOCLONAL ANTIBODY, CONFORMATIONAL EPITOPE, X-RAY CRYSTAL STRUCTURE, IMMUNE SYSTEM 
5k59:F   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY  |   TOXIN NEUTRALIZING MONOCLONAL ANTIBODY, CONFORMATIONAL EPITOPE, X-RAY CRYSTAL STRUCTURE, IMMUNE SYSTEM 
4g7v:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.5 A)  |   MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE 
5k9j:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 ISOLATED FOLLOWING H5 IMMUNIZATION.  |   INFLUENZA, MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM 
5k9q:I   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ  |   HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM 
5k9q:K   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ  |   HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM 
5k9q:L   (THR109) to   (PHE209)  CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ  |   HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM 
5k9q:T   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ  |   HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM 
5k9q:V   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ  |   HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM 
5k9q:Y   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ  |   HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM 
5kan:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ  |   INFLUENZA, MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM 
4gag:L   (ALA109) to   (ARG211)  STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 412-423)  |   ANTIBODY FAB, NEUTRALIZING ANTIBODY, HCV E2 BINDING, IMMUNE SYSTEM 
4gaj:L   (ALA109) to   (ASN210)  STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 411-424)  |   ANTIBODY FAB, NEUTRALIZING ANTIBODY, HCV E2 BINDING, IMMUNE SYSTEM 
4gay:L   (ALA109) to   (ASN210)  STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33  |   ANTIBODY FAB, NEUTRALIZING ANTIBODY, HCV E2, IMMUNE SYSTEM 
4gms:N   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ  |   IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5kn5:B   (THR114) to   (ARG216)  TGFALPHA/EPIREGULIN COMPLEX WITH NEUTRALIZING ANTIBODY LY3016859  |   TGFALPHA EPIREGULIN ANTIBODY FAB, IMMUNE SYSTEM 
5kn5:E   (THR114) to   (ARG216)  TGFALPHA/EPIREGULIN COMPLEX WITH NEUTRALIZING ANTIBODY LY3016859  |   TGFALPHA EPIREGULIN ANTIBODY FAB, IMMUNE SYSTEM 
4gq9:L   (ALA108) to   (ASN211)  CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT  |   IGG FOLD, ANTIBODY, VIRAL PROTEIN 
5kvd:L   (ALA109) to   (ARG211)  ZIKA SPECIFIC ANTIBODY, ZV-2, BOUND TO ZIKA ENVELOPE DIII  |   ZIKA VIRUS, ENVELOPE DIII, VIRAL PROTEIN, ANTIBODY, IGG2C, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID., VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5kw9:L   (THR115) to   (ASN216)  STRUCTURAL BASIS FOR NOROVIRUS NEUTRALIZATION BY A HBGA BLOCKING HUMAN IGA ANTIBODY  |   IGA, NOROVIRUS, NEUTRALISATION, FAB, ANTIBODY, ANTIVIRAL PROTEIN 
5l0q:B   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.  |   ADAM PROTEASE, MAB, 8C7, NOTCH SIGNALING, THERAPEUTIC ANTIBODY, CANCER STEM CELL, DRUG RESISTANCE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
5l0q:E   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.  |   ADAM PROTEASE, MAB, 8C7, NOTCH SIGNALING, THERAPEUTIC ANTIBODY, CANCER STEM CELL, DRUG RESISTANCE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
5l7x:L   (ALA109) to   (ARG211)  AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1- GLYCOSYLATED, CRYSTAL FORM II  |   FAB, ANTIBODY FRAGMENT, GLYCOSILATED, AFAMIN, IMMUNE SYSTEM 
5l88:L   (ALA109) to   (ASN210)  AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1- GLYCOSILATED, CRYSTAL FORM I, NON-PARSIMONIOUS MODEL  |   AFAMIN ANTIBODY, FAB FRAGMENT, IGG1-KAPPA, LIGHT CHAIN GLYCOSILATION, IMMUNE SYSTEM 
5l9d:L   (ALA109) to   (ASN210)  AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1- GLYCOSYLATED, CRYSTAL FORM I, PARSIMONIOUS MODEL  |   AFAMIN ANTIBODY, FAB FRAGMENT, IGG1-KAPPA, LIGHT CHAIN GLYCOSILATION, IMMUNE SYSTEM 
5lgh:L   (ALA109) to   (ARG211)  AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1- GLYCOSILATED, CRYSTAL FORM II, SAME AS 5L7X, BUT ISOMORPHOUS SETTING INDEXED SAME AS 5L88, 5L9D  |   FAB, ANTIBODY FRAGMENT, GLYCOSILATED, AFAMIN, IMMUNE SYSTEM 
5sx4:I   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.  |   CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
5sx5:K   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.  |   CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
5sx5:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.  |   CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
5t1k:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5t1k:C   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5t1l:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5t1l:C   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5t1m:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5t1m:C   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5t5f:L   (ALA114) to   (ARG216)  NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5  |   FHBP, JAR5, EPITOPE MAPPING, MONOCLONAL ANTIBODY, COOPERATIVITY, NEISSERIA MENINGITIDIS, PROTEIN BINDING 
5t5n:F   (ALA109) to   (ASN210)  CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM  |   ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN 
5t5n:H   (ALA109) to   (ASN210)  CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM  |   ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN 
5t5n:L   (ALA109) to   (ASN212)  CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM  |   ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN 
5t5n:N   (ALA109) to   (ASN210)  CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1), TRIPLE MUTANT: I76A, F80A, F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT, CHLORIDE, AND CALCIUM  |   ION CHANNEL, ANION, CHLORIDE, CALCIUM-ACTIVATED, EUKARYOTIC MEMBRANE PROTEIN, CACC, MEMBRANE PROTEIN 
5te4:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE G STRAIN X2088 GP120 CORE  |   HIV-1, VRC01-CLASS ANTIBODY, N6, CD4-BINDING SITE, GP120, IMMUNE SYSTEM 
5tfs:L   (THR111) to   (ASN212)  STRUCTURE OF CHIMERIC 02-K FAB, A VRC01-LIKE GERMLINE ANTIBODY  |   FAB, HIV-1, VRC01, CDRH3, CD4-BS, VH1-2, IMMUNE SYSTEM 
5tgb:L   (THR111) to   (SER210)  STRUCTURE OF CHIMERIC 02-CB FAB, A VRC01-LIKE GERMLINE ANTIBODY  |   FAB, GERMLINE, VRC01-LIKE, CD4-BS, HIV-1, CDRH3, IMMUNE SYSTEM 
5tgb:B   (THR111) to   (ARG213)  STRUCTURE OF CHIMERIC 02-CB FAB, A VRC01-LIKE GERMLINE ANTIBODY  |   FAB, GERMLINE, VRC01-LIKE, CD4-BS, HIV-1, CDRH3, IMMUNE SYSTEM 
6fab:L   (ALA109) to   (ASN212)  THREE-DIMENSIONAL STRUCTURE OF MURINE ANTI-P- AZOPHENYLARSONATE FAB 36-71. 1. X-RAY CRYSTALLOGRAPHY, SITE-DIRECTED MUTAGENESIS, AND MODELING OF THE COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN 
15c8:L   (ALA109) to   (ARG211)  CATALYTIC ANTIBODY 5C8, FREE FAB  |   CATALYTIC ANTIBODY, FAB, RING CLOSURE REACTION 
1n7m:H   (THR109) to   (SER208)  GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN  |   IMMUNE SYSTEM 
2ai0:L   (ALA114) to   (ASN217)  ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III  |   IMMUNE SYSTEM 
2ai0:M   (ALA114) to   (ASN215)  ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III  |   IMMUNE SYSTEM 
2ai0:N   (ALA114) to   (ARG216)  ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III  |   IMMUNE SYSTEM 
2ai0:O   (ALA114) to   (ARG216)  ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III  |   IMMUNE SYSTEM 
2aj3:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18  |   HIV, ANTIBODY, FAB, CD4-BINDING, IMMUNOGLOBULIN, IMMUNE SYSTEM 
2aj3:C   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18  |   HIV, ANTIBODY, FAB, CD4-BINDING, IMMUNOGLOBULIN, IMMUNE SYSTEM 
2aj3:E   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18  |   HIV, ANTIBODY, FAB, CD4-BINDING, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1a4j:L   (THR114) to   (SER213)  DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR  |   IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE 
1a4j:A   (THR114) to   (SER213)  DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR  |   IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE 
2ajx:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH TRANSITION STATE ANALOG  |   CATALYTIC ANTIBODY, FAB, TRANSITION STATE ANALOG, HYDROLYTIC, IMMUNE SYSTEM 
1nc2:A   (PRO112) to   (PRO211)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA  |   ANTIBODY-DOTA COMPLEX, RARE EARTH, DOTA, METAL CHELATE, YTTRIUM, GAMMA TURN, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM 
1nca:L   (ALA109) to   (ASN210)  REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX  |   HYDROLASE(O-GLYCOSYL) 
4gw1:A   (THR109) to   (ASN210)  CQFD MEDITOPE  |   IGG, IMMUNE SYSTEM, EGFR 
4gw1:C   (THR109) to   (SER208)  CQFD MEDITOPE  |   IGG, IMMUNE SYSTEM, EGFR 
1nfd:E   (PRO109) to   (GLU213)  AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY  |   COMPLEX (IMMUNORECEPTOR-IMMUNOGLOBULIN), COMPLEX (IMMUNORECEPTOR- IMMUNOGLOBULIN) COMPLEX 
1ngz:A   (THR109) to   (GLY212)  CHIMERIC GERMLINE FAB 7G12-APO  |   ANTIBODY, IMMUNOGLOBULIN, ANTIGEN BINDING FRAGMENT (FAB), IMMUNE SYSTEM 
1ad0:A   (THR108) to   (SER207)  FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7  |   IMMUNOGLOBULIN, FAB FRAGMENT 
1ad0:C   (THR108) to   (SER207)  FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7  |   IMMUNOGLOBULIN, FAB FRAGMENT 
2atk:B   (ALA109) to   (ASN212)  STRUCTURE OF A MUTANT KCSA K+ CHANNEL  |   K+ CHANNEL, MUTANT KCSA, PROTEIN-ANTIBODY FAB COMPLEX, IMMUNE SYSTEM- ION TRANSPORT COMPLEX 
3egs:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 SCRAMBLEDFP-MPER SCRHYB3K CONSTRUCT GIGAFGLLGFLAAGSKK-AHX-K656NEQELLELDKWASLWN671 SOAKED IN AMMONIUM SULFATE  |   2F5, GP41, HIV, IMMUNE SYSTEM 
3ru8:L   (THR110) to   (GLY213)  STRUCTURE OF AN HIV EPITOPE SCAFFOLD IN COMPLEX WITH NEUTRALIZING ANTIBODY B12 FAB  |   BINDING EPITOPE FROM HIV ON A HETEROLOGOUS PROTEIN, IMMUNE SYSTEM, DE NOVO PROTEIN 
1aj7:L   (THR109) to   (GLU213)  IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY  |   GERMLINE ANTIBODY, FAB, CATALYTIC ANTIBODY, AFFINITY MATURATION, IMMUNOGLOBULIN 
3rvv:C   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1  |   COMPLEX BETWEEN AN ALLERGEN AND FAB FRAGMENT OF 4C1 ANTIBODY, HYDROLASE-IMMUNE SYSTEM COMPLEX 
1ay1:L   (ALA109) to   (ARG211)  ANTI TAQ FAB TP7  |   IMMUNOGLOBULIN, ANTIBODY, FAB, ENZYME INHIBITOR, PCR, HOT START 
2bdn:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY, 11K2  |   ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM 
4hfu:L   (GLY101) to   (ASN210)  CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4hfw:L   (THR108) to   (GLY211)  ANTI ROTAVIRUS ANTIBODY  |   IG FOLD, IMMUNE RESPONSE, ROTAVIRUS VP6 PROTEIN, IMMUNE SYSTEM 
4hfw:A   (THR108) to   (ARG210)  ANTI ROTAVIRUS ANTIBODY  |   IG FOLD, IMMUNE RESPONSE, ROTAVIRUS VP6 PROTEIN, IMMUNE SYSTEM 
4hg4:O   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4hix:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF A HUMANISED 3D6 FAB BOUND TO AMYLOID BETA PEPTIDE  |   IMMUNOGLOBULIN, IMMUNOTHERAPY CANDIDATE, AMYLOID BETA PEPTIDE, PROTEIN FIBRIL-IMMUNE SYSTEM COMPLEX 
3eyo:A   (THR110) to   (GLY213)  CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9  |   HUMAN CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3eyo:C   (THR110) to   (ASN211)  CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9  |   HUMAN CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3eyv:L   (THR114) to   (ARG216)  ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS  |   IMMUNOGLOBULIN FOLD, BETA BARREL, HUMANIZED ANTIBODY, ANTIGEN BINDING FRAGMENT, IMMUNE SYSTEM 
1bj1:L   (THR109) to   (SER208)  VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   COMPLEX (ANTIBODY/ANTIGEN), ANGIOGENIC FACTOR 
1bj1:J   (THR109) to   (SER208)  VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   COMPLEX (ANTIBODY/ANTIGEN), ANGIOGENIC FACTOR 
1bm3:L   (ALA109) to   (ARG211)  IMMUNOGLOBULIN OPG2 FAB-PEPTIDE COMPLEX  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
3f7v:B   (ALA109) to   (ASN212)  KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112  |   KCSA, POTASSIUM CHANNEL, INACTIVATION, OPEN, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX 
3fb5:B   (ALA109) to   (ASN212)  KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112  |   KCSA, OPEN, INACTIVATION, POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX 
3fb7:B   (ALA109) to   (ASN212)  OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION  |   KCSA, OPEN, INACTIVATION, POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX 
4xc3:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH RAC-GLYCEROL 1- PHOSPHATE  |   HIV-1 GP41 MPER, 4E10 FAB, MEMBRANE LIPID, IMMUNE SYSTEM 
4xcy:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)  |   4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL 
4xcy:D   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)  |   4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL 
4xcy:F   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)  |   4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL 
4xcy:I   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)  |   4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL 
1c5d:L   (ALA108) to   (ASN209)  THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4xh2:B   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xh2:D   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xh2:F   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xh2:I   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xh2:K   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xh2:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
2c1o:A   (ALA109) to   (ARG211)  ENAIIHIS FAB FRAGMENT IN THE FREE FORM  |   FAB FRAGMENT, ENANTIOSELECTIVE, FINROZOLE, IMMUNE SYSTEM, ANTIBODY, ENA11HIS ANTIBODY, IMMUNOGLOBULIN DOMAIN 
3sge:L   (ALA114) to   (ARG216)  CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE  |   IMMUNOGLOBULIN, ANTIGEN BINDING, IMMUNE SYSTEM 
3sge:I   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE  |   IMMUNOGLOBULIN, ANTIGEN BINDING, IMMUNE SYSTEM 
1ce1:L   (THR109) to   (SER208)  1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN  |   THERAPEUTIC, ANTIBODY, CD52, IMMUNE SYSTEM 
1cic:C   (ALA109) to   (ASN210)  IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225  |   IMMUNOGLOBULIN, FAB COMPLEX, IDIOTOPE, ANTI-IDIOTOPE 
3sob:L   (THR109) to   (SER208)  THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB  |   BETA PROPELLER, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX 
1clo:L   (ALA109) to   (ASN210)  ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7  |   IMMUNOGLOBULIN, FAB-FRAGMENT 
1ott:D   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148A MUTANT AND FAB COMPLEX  |   CHLORIDE CHANNEL, FAB COMPLEX, ION CHANNEL, MEMBRANE PROTEIN 
1ott:F   (ALA108) to   (ALA211)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148A MUTANT AND FAB COMPLEX  |   CHLORIDE CHANNEL, FAB COMPLEX, ION CHANNEL, MEMBRANE PROTEIN 
4idj:L   (ALA109) to   (ASN212)  S.AUREUS A-HEMOLYSIN MONOMER IN COMPLEX WITH FAB  |   HEMOLYSIN COMPLEX WITH FAB, CYTOLYTIC PROTEIN, FAB, SECRETED, IMMUNE SYSTEM 
1cz8:L   (THR109) to   (SER208)  VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY  |   COMPLEX (ANTIBODY/ANTIGEN), CYSTINE KNOT, FAB FRAGMENT, IMMUNE SYSTEM 
1cz8:X   (THR109) to   (PHE209)  VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY  |   COMPLEX (ANTIBODY/ANTIGEN), CYSTINE KNOT, FAB FRAGMENT, IMMUNE SYSTEM 
1d5b:L   (THR109) to   (ARG211)  UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY  |   IMMUNE SYSTEM 
4xpa:L   (ALA110) to   (ASN211)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO 3, 4DICHLOROPHENETHYLAMINE  |   INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX 
2cgr:L   (ALA114) to   (ASN215)  LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB  |   IMMUNOGLOBULIN 
1pg7:L   (THR109) to   (ASN210)  MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB  |   IMMUNE SYSTEM 
1pg7:M   (THR109) to   (SER208)  MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB  |   IMMUNE SYSTEM 
4xvs:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF HIV-1 DONOR 45 D45-01DG5 COREE GP120 WITH ANTIBODY 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)  |   HIV-1 ANTIBODYOMICS NEUTRALIZING ANTIBODY GERMLINE BINDING, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4xvt:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF HIV-1 93TH057 COREE GP120 WITH ANTIBODY 45- VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)  |   HIV-1 ANTIBODYOMICS NEUTRALIZING ANTIBODY GERMLINE BINDING, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1pkq:A   (THR109) to   (SER208)  MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX  |   AUTOANTIBODY, MULTIPLE SCLEROSIS, EAE, IMMUNE SYSTEM 
1pkq:F   (THR109) to   (SER208)  MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX  |   AUTOANTIBODY, MULTIPLE SCLEROSIS, EAE, IMMUNE SYSTEM 
1dqm:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY  |   ANTIBODY, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM 
3t65:A   (ALA108) to   (ASN209)  S25-2- A(2-8)KDO DISACCHARIDE COMPLEX  |   ANTIGEN-BINDING FRAGMENT, FAB, ANTI-CARBOHYDRATE, ANTI-LPS, ANTIBODY, IMMUNOGLOBULIN, KDO, IMMUNE SYSTEM 
3gi8:L   (ALA115) to   (ASN216)  CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT  |   MEMBRANE PROTEIN, TRANSPORTER, ANTIBODY, CELL MEMBRANE, MEMBRANE, TRANSMEMBRANE, TRANSPORT PROTEIN, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK CONSORTIUM ON MEMBRANE PROTEIN STRUCTURE, NYCOMPS 
2r0z:L   (ALA108) to   (ASN211)  PFA1 FAB COMPLEXED WITH GRIPI PEPTIDE FRAGMENT  |   IMMUNOGLOBULIN; ALZHEIMER DISEASE; AMYLOID, IMMUNE SYSTEM 
2r23:A   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES  |   FAB, ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
2ddq:L   (ALA114) to   (ASN217)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT  |   MONOCLONAL ANTIBODY, 4-HYDROXY-2-NONENAL, IMMUNOGLOBULIN, IMMUNE SYSTEM 
4jfz:L   (THR109) to   (ASN210)  STRUCTURE OF PHOSPHOSERINE (PSAB) SCAFFOLD BOUND TO PSER PEPTIDE  |   IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4jn1:L   (THR115) to   (SER214)  AN ANTIDOTE FOR DABIGATRAN  |   IGG FRAGMENT BINDING DABIGATRAN, IMMUNE SYSTEM 
3u0w:L   (THR109) to   (SER208)  AD RELATED MURINE ANTIBODY FRAGMENT  |   IMMUNOGLOBULIN, ANTIBODY, AMYLOID BETA, ALZHEIMER, IMMUNE SYSTEM 
3u46:L   (THR109) to   (ASN210)  CH04H/CH02L P212121  |   IGG, IMMUNOGLOBLULIN, IMMUNE SYSTEM, HIV-1 ANTIBODIES, V1V2-DIRECTED 
4jzj:L   (THR115) to   (SER214)  CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX  |   RECEPTOR-FAB COMPLEX, CYTOKINE RECEPTOR-IMMUNE SYSTEM COMPLEX 
1r3l:A   (ALA109) to   (ASN212)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+  |   MEMBRANE PROTEIN, POTASSIUM CHANNEL, KCSA-FAB COMPLEX, CESIUM 
3u9p:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT  |   BETA BARREL, TRANSPORT PROTEIN, IMMUNE SYSTEM 
3u9p:M   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT  |   BETA BARREL, TRANSPORT PROTEIN, IMMUNE SYSTEM 
1for:L   (ALA108) to   (ARG210)  STRUCTURE DETERMINATION OF AN FAB FRAGMENT THAT NEUTRALIZES HUMAN RHINOVIRUS AND ANALYSIS OF THE FAB-VIRUS COMPLEX  |   IMMUNOGLOBULIN 
4yue:L   (ALA112) to   (ASN213)  MOUSE IL-2 BOUND TO S4B6 FAB FRAGMENT  |   CHEMOKINE, ANTIBODY, COMPLEX, CYTOKINE/IMMUNE SYSTEM COMPLEX 
1riu:L   (ALA109) to   (GLY212)  ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE  |   ANTI-COCAINE ANTIBODY, FAB, IMMUNE SYSTEM 
1rjl:A   (ALA109) to   (ARG211)  STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831  |   BETA SHEET, ANTIBODY-PROTEIN COMPLEX, IMMUNE SYSTEM 
1fve:A   (THR109) to   (ASN210)  X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING  |   IMMUNOGLOBULIN 
2f58:L   (ALA109) to   (ASN210)  IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE)  |   IMMUNOGLOBULIN, FAB, HIV-1, GP120, V3, IMMUNE SYSTEM 
4yzf:F   (ALA113) to   (ASN214)  CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3  |   IMMUNE SYSTEM, HUMAN MEMBRANE PROTEIN, ANION EXCHANGER, ERYTHROCYTES 
4yzf:J   (ALA113) to   (ASN214)  CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3  |   IMMUNE SYSTEM, HUMAN MEMBRANE PROTEIN, ANION EXCHANGER, ERYTHROCYTES 
1rup:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE (G) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT APS BEAMLINE 19-ID  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM 
4ki5:D   (ALA108) to   (ASN211)  CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99  |   IMMUNOGLOBULIN FOLD, DISCOIDIN FOLD, ANTIBODY, BLOOD COAGULATION FACTOR, ANTIGEN BINDING, BLOOD PLASMA, IMMUNE SYSTEM 
4ki5:F   (ALA109) to   (ASN210)  CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99  |   IMMUNOGLOBULIN FOLD, DISCOIDIN FOLD, ANTIBODY, BLOOD COAGULATION FACTOR, ANTIGEN BINDING, BLOOD PLASMA, IMMUNE SYSTEM 
3hpl:B   (ALA109) to   (ASN210)  KCSA E71H-F103A MUTANT IN THE CLOSED STATE  |   KCSA, E71H, F103A, CLOSED, INACTIVATION, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, IMMUNE SYSTEM-METAL TRANSPORT COMPLEX 
4kjp:D   (ALA108) to   (ALA211)  STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE  |   MEMBRANE TRANSPORTING PROTEIN, TRANPORT PROTEIN, MEMBRANE PROTEIN 
4kjp:F   (ALA108) to   (ALA211)  STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE  |   MEMBRANE TRANSPORTING PROTEIN, TRANPORT PROTEIN, MEMBRANE PROTEIN 
4kk8:D   (ALA108) to   (ALA211)  STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
4kk8:F   (ALA108) to   (ALA211)  STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE  |   MEMBRANE TRANSPORTER, TRANSPORT PROTEIN 
4kmt:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12  |   IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM 
3v0w:L   (GLY109) to   (ARG211)  CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS  |   BETA BARREL, ANTIBODY, FAB, IMMUNE SYSTEM 
4kq3:L   (THR108) to   (SER207)  CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3i75:A   (ALA109) to   (ALA212)  ANTIBODY STRUCTURE  |   ANTIBODY, IGG, IMMUNE SYSTEM 
4kxz:I   (THR110) to   (ARG212)  CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.  |   CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM 
4kxz:L   (THR110) to   (ARG212)  CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.  |   CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM 
4kxz:M   (THR110) to   (GLY213)  CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.  |   CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM 
4kxz:P   (THR110) to   (ARG212)  CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.  |   CYSTEINE KNOT, FAB, VARIOUS GROWTH FUNCTIONS (TGF-BETA), TGF-BETA ANTAGONIST (GC2008), TGF-BETA RECEPTORS, IMMUNE SYSTEM 
4ky1:L   (THR109) to   (GLY212)  HUMANIZED HP1/2 FAB  |   FAB, ANTIBODY, ALPHA4 INTEGRIN, IMMUNE SYSTEM 
3ve0:B   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF SUDAN EBOLAVIRUS GLYCOPROTEIN (STRAIN BONIFACE) BOUND TO 16F6  |   EBOLA, SUDAN, GLYCOPROTEIN, VIRUS SURFACE, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3i9g:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE  |   ANTIBODY, FAB, SPHINGOSINE-1-PHOSPHATE, CALCIUM, IMMUNOGLOBIN, IGG, IMMUNE SYSTEM 
4kze:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF AN RNA APTAMER IN COMPLEX WITH FAB  |   G-QUADRUPLEX, FLUORESCENCE, FLUOROPHORE BINDING, IMMUNE SYSTEM-RNA COMPLEX 
1h0d:A   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F  |   IMMUNE SYSTEM/HYDROLASE, COMPLEX (ANTIBODY/HYDROLASE), RIBONUCLEASE, ANTIBODY 
3vi3:L   (ALA114) to   (ARG216)  CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)  |   BETA PROPELLER FOLD, ROSSMANN FOLD, BETA SANDWICH, FIBRONECTIN RECEPTOR, CELL ADHESION-IMMUNE SYSTEM COMPLEX 
3vi3:E   (ALA114) to   (ASN217)  CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)  |   BETA PROPELLER FOLD, ROSSMANN FOLD, BETA SANDWICH, FIBRONECTIN RECEPTOR, CELL ADHESION-IMMUNE SYSTEM COMPLEX 
3ifl:L   (ALA114) to   (ASN215)  X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12A11) COMPLEX  |   ANTIBODY, AMYLOID BETA PEPTIDE, IMMUNE SYSTEM 
4zpt:B   (ALA109) to   (ASN210)  STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1)  |   VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4zpt:L   (ALA109) to   (ASN212)  STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1)  |   VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4zpv:L   (ALA109) to   (ASN210)  STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)  |   VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4zpv:B   (ALA109) to   (ASN210)  STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)  |   VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1tet:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS  |   IMMUNOGLOBULIN 
1tjg:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE  |   2F5; ANTIBODY; GP41; HIV-1; NEUTRALIZING; MEMBRANE-PROXIMAL, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1tji:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE  |   2F5, ANTIBODY, GP41, HIV-1, NEUTRALIZING, MEMBRANE-PROXIMAL, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
2h2s:D   (ALA108) to   (ASN209)  CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN-  |   CLC; TRANSPORTER; CHLORIDE; ANTIPORT, ION TRANSPORT 
2w9e:L   (ALA108) to   (ARG210)  STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231  |   FAB, PRP, PRION, MEMBRANE, GPI-ANCHOR, LIPOPROTEIN, GOLGI APPARATUS, DISEASE MUTATION, IMMUNE SYSTEM, GLYCOPROTEIN, CELL MEMBRANE 
1hi6:A   (ALA109) to   (ASN210)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE  |   IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIBODY/PEPTIDE), POLYSPECIFICITY, CROSSREACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1 
4zxb:B   (ALA114) to   (ASN217)  STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN, IRDELTABETA CONSTRUCT, IN COMPLEX WITH FOUR FAB MOLECULES  |   RECEPTOR TYROSINE KINASE EXTRACELLULAR DOMAIN ANTIBODY FRAGMENTS, HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX 
3iu3:B   (THR106) to   (SER205)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN  |   IL-2RA, CD25, BASILIXIMAB, SIMULECT, THERAPEUTIC ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, MEMBRANE, RECEPTOR, SUSHI, TRANSMEMBRANE, IMMUNE SYSTEM 
3iu3:D   (THR106) to   (GLY209)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN  |   IL-2RA, CD25, BASILIXIMAB, SIMULECT, THERAPEUTIC ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, MEMBRANE, RECEPTOR, SUSHI, TRANSMEMBRANE, IMMUNE SYSTEM 
3iu3:L   (THR106) to   (ARG208)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN  |   IL-2RA, CD25, BASILIXIMAB, SIMULECT, THERAPEUTIC ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, MEMBRANE, RECEPTOR, SUSHI, TRANSMEMBRANE, IMMUNE SYSTEM 
3iu4:L   (THR109) to   (ARG211)  ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3  |   ANTIBODY, GANGLIOSIDE, IDIOTYPE, IMMUNE SYSTEM 
1tqb:C   (ALA109) to   (ASN210)  OVINE RECOMBINANT PRP(114-234), VRQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY  |   PRION, ANTIBODY, UNKNOWN FUNCTION/IMMUNE SYSTEM COMPLEX 
4zyp:G   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN  |   IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION 
4zyp:I   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN  |   IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION 
4zyp:E   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN  |   IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION 
4zyp:M   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN  |   IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION 
4lmq:L   (THR109) to   (SER208)  DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12  |   IMMUNOGLOBULIN, CELL ADHESION-IMMUNE SYSTEM COMPLEX 
4lvo:B   (ALA110) to   (ARG212)  CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX WITH ADDED CACL2  |   ALPHA BETA, ENZYME-PRODOMAIN COMPLEX, ROSSMANN FOLD, SERINE PROTEASE, CALCIUM IONS, PRODOMAIN, PARASITOPHOROUS VACUOLE, HYDROLASE- INHIBITOR-IMMUNE SYSTEM COMPLEX 
2hwz:L   (THR108) to   (SER207)  FAB FRAGMENT OF HUMANIZED ANTI-VIRAL ANTIBODY MEDI-493 (SYNAGIS TM)  |   IMMUNOGLOBULIN, FAB FRAGMENT, IMMUNE SYSTEM 
1u92:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]- DKWQS (CYCLIC)  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1i9r:L   (THR113) to   (ASN214)  STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY  |   BETA-SHEET SANDWICH, IMMUNOGLOBULIN, CYTOKINE/IMMUNE SYSTEM COMPLEX 
1i9r:M   (THR113) to   (ASN214)  STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY  |   BETA-SHEET SANDWICH, IMMUNOGLOBULIN, CYTOKINE/IMMUNE SYSTEM COMPLEX 
1i9r:Y   (THR113) to   (ASN214)  STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY  |   BETA-SHEET SANDWICH, IMMUNOGLOBULIN, CYTOKINE/IMMUNE SYSTEM COMPLEX 
1ikf:L   (ALA109) to   (ASN210)  A CONFORMATION OF CYCLOSPORIN A IN AQUEOUS ENVIRONMENT REVEALED BY THE X-RAY STRUCTURE OF A CYCLOSPORIN-FAB COMPLEX  |   IMMUNE SYSTEM-IMMUNOSUPPRESSANT COMPLEX, FAB-CYCLOSPORIN COMPLEX, CYCLOSPORIN A, IMMUNOSUPPRESSANT 
4m7j:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF S25-26 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO TRISACCHARIDE  |   BETA-SANDWICH, CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM 
3j1s:L   (ALA109) to   (ASN212)  STRUCTURE OF ADENO-ASSOCIATED VIRUS-2 IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY A20  |   EPITOPE, FAB, GENE THERAPY, VIRUS-IMMUNE SYSTEM COMPLEX 
1uwe:L   (THR109) to   (ASN210)  MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9  |   ANTIBODY 
1uwe:U   (THR109) to   (SER208)  MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9  |   ANTIBODY 
1uwe:X   (THR109) to   (SER208)  MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9  |   ANTIBODY 
3wii:M   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A, A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.  |   IMMUNOGLOBULIN FAB FRAGMENT, ANTI-HEPATOCELLULAR CARCINOMA ANTIBODY, THE THIRD FIBRONECTIN TYPE-III DOMAIN (FN3) OF HUMAN ROBO1, IMMUNE SYSTEM 
4mhj:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)  |   H5N1 INFLUENZA VIRUS, EPITOPE, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4mhj:Q   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)  |   H5N1 INFLUENZA VIRUS, EPITOPE, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2itc:B   (ALA109) to   (ASN212)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN SODIUM CHLORIDE  |   VOLTAGE-GATED CHANNEL, TRANSMEMBRANE, IONIC CHANNEL, ION TRANSPORT, K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN 
1jfq:L   (ALA109) to   (ASN212)  ANTIGEN-BINDING FRAGMENT OF THE MURINE ANTI-PHENYLARSONATE ANTIBODY 36-71, "FAB 36-71"  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
1jgl:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF IMMUNOGLOBULIN FAB FRAGMENT COMPLEXED WITH 17-BETA-ESTRADIOL  |   ANTIBODY, FOUR-CENTER HYDROGEN BOND, STEROID, IMMUNE SYSTEM 
3j3z:L   (ALA109) to   (ASN210)  STRUCTURE OF MA28-7 NEUTRALIZING ANTIBODY FAB FRAGMENT FROM ELECTRON CRYO-MICROSCOPY OF ENTEROVIRUS 71 COMPLEXED WITH A FAB FRAGMENT  |   EV71, ENTEROVIRUS, HFMD, STRAIN-SPECIFIC EPTITOPE, VP1-145, IMMUNE SYSTEM 
3wsq:L   (THR110) to   (ASN211)  STRUCTURE OF HER2 WITH AN FAB  |   KINASE, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
3x3f:L   (THR109) to   (SER208)  TRAIL-R2 EXTRACELLULAR REGION COMPLEXED TO A FAB FRAGMENT FROM HUMAN AGONIST ANTIBODY KMTR2  |   TRAIL-R2, AGONIST ANTIBODY, APOPTOSIS-IMMUNE SYSTEM COMPLEX 
2jix:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR  |   IMMUNE SYSTEM, RECEPTOR, TRANSMEMBRANE, RECEPTOR SOLUBLE DOMAIN, ANTIBODY, RECEPTOR-IMMUNE SYSTEM COMPLEX 
1kcu:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF ANTIBODY PC287  |   ANTI-PEPTIDE ANTIBODY, IMMUNE SYSTEM 
4nwt:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF THE ANTI-HUMAN NGF FAB APE1531  |   BETA SANDWICH, HUMAN BETA NERVE GROWTH FACTOR, IMMUNE SYSTEM 
5cd5:D   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF AN IMMATURE VRC01-CLASS ANTIBODY DRVIA7 FROM A CHINESE DONOR BOUND TO CLADE A/E HIV-1 GP120 CORE  |   VRC01, GP120, HIV-1, ANTIBODY, IMMUNE SYSTEM 
1xgt:A   (ALA109) to   (ASN212)  STRUCTURE FOR ANTIBODY HYHEL-63 Y33L MUTANT COMPLEXED WITH HEN EGG LYSOZYME  |   HYHEL-63, 2.1A CRYSTAL STRUCTURE, Y33L MUTANT, IMMUNE SYSTEM 
1l7i:L   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4  |   IG DOMAIN, FAB FRAGMENT, IMMUNE SYSTEM 
5chn:L   (THR115) to   (ASN216)  FAB FRAGMENTS OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 5M16  |   ANTIBODY, IMMUNE SYSTEM 
5chn:B   (THR115) to   (SER214)  FAB FRAGMENTS OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 5M16  |   ANTIBODY, IMMUNE SYSTEM 
2ny2:C  (THR2111) to  (SER2210)  HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C, T257S, S334A, S375W, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B  |   HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1lo4:L   (ALA114) to   (ASN217)  RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9  |   FAB, CATALYTIC ANTIBODY, RETRO-DEILS-ALDERASE, IMMUNE SYSTEM 
5cp3:A   (ALA114) to   (ASN215)  CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES IN COMPLEX WITH SULFATHIAZOLE  |   SULFATHIAZOLE, ANTI-SULFONAMIDES ANTIBODY, ANTIGEN-BINDING FRAGMENT, COMPLEX, IMMUNE SYSTEM 
2zch:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY  |   HUMAN PSA, KALLIKREIN RELATED PEPTIDASES, ANTIBODIES, PROSTATE CANCER, GLYCOPROTEIN, HYDROLASE, POLYMORPHISM, PROTEASE, SECRETED, SERINE PROTEASE, ZYMOGEN, IMMUNE SYSTEM 
2zck:L   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF A TERNARY COMPLEX BETWEEN PSA, A SUBSTRAT-ACYL INTERMEDIATE AND AN ACTIVATING ANTIBODY  |   HUMAN PSA, ANTIBODIES, KALLIKREIN RELATED PEPTIDASES, PROSTATE CANCER, GLYCOPROTEIN, HYDROLASE, PROTEASE, SECRETED, SERINE PROTEASE, ZYMOGEN, IMMUNE SYSTEM 
4oly:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54R IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE  |   VRC07 ANTIBODY, PASSIVE TRANSFER, NEUTRALIZATION, IN VIVO PROTECTION, AUTOREACTIVITY, LENTIVIRAL INFECTION, ENHANCED POTENCY, HIV-1 GP120, VRC07-G54R, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1mcb:B   (PRO113) to   (PRO212)  PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS  |   IMMUNOGLOBULIN 
1y18:L   (THR109) to   (SER208)  FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1y18:A   (THR109) to   (SER208)  FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1y18:C   (THR109) to   (SER208)  FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
1y18:E   (THR109) to   (SER208)  FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CHIMERIC FAB, HAPTEN COMPLEX, IMMUNE SYSTEM 
3kj4:L   (ALA114) to   (ASN217)  STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY  |   NOGO RECEPTOR ANTAGONIST ANTIBODY, LRR, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, GPI-ANCHOR, LEUCINE-RICH REPEAT, LIPOPROTEIN, MEMBRANE, RECEPTOR, IMMUNE SYSTEM 
2zuq:B   (ALA134) to   (ASN237)  CRYSTAL STRUCTURE OF DSBB-FAB COMPLEX  |   DISULFIDE BOND, MEMBRANE PROTEIN, FAB, E. COLI, CELL INNER MEMBRANE, CELL MEMBRANE, CHAPERONE, ELECTRON TRANSPORT, MEMBRANE, OXIDOREDUCTASE, REDOX-ACTIVE CENTER, TRANSMEMBRANE, TRANSPORT, OXIDOREDUCTASE/IMMUNE SYSTEM COMPLEX 
2zuq:E   (ALA134) to   (ARG236)  CRYSTAL STRUCTURE OF DSBB-FAB COMPLEX  |   DISULFIDE BOND, MEMBRANE PROTEIN, FAB, E. COLI, CELL INNER MEMBRANE, CELL MEMBRANE, CHAPERONE, ELECTRON TRANSPORT, MEMBRANE, OXIDOREDUCTASE, REDOX-ACTIVE CENTER, TRANSMEMBRANE, TRANSPORT, OXIDOREDUCTASE/IMMUNE SYSTEM COMPLEX 
1mie:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393  |   CATALYTIC ANTIBODY, ESTER HYDROLYSIS, ESTEROLYTIC, FAB, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1mrd:L   (ALA109) to   (ARG211)  PREPARATION, CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES  |   IMMUNOGLOBULIN 
5d6c:A   (THR109) to   (ASN210)  STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT  |   STAPHYLOCOCCUS AUREUS WALL TEICHOIC ACID ANTIBODY MRSA, IMMUNE SYSTEM 
5d6c:L   (THR115) to   (SER214)  STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT  |   STAPHYLOCOCCUS AUREUS WALL TEICHOIC ACID ANTIBODY MRSA, IMMUNE SYSTEM 
1yef:L   (GLY109) to   (ASN212)  STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH SUBSTRATE ANALOGUE  |   CATALYTIC ANTIBODY 
1yeh:L   (GLY109) to   (ASN212)  STRUCTURE OF IGG2A FAB FRAGMENT  |   CATALYTIC ANTIBODY, IMMUNOGLOBULIN C REGION 
3ks0:J   (PRO112) to   (PRO211)  CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4  |   ELECTRON TRANSFER, EPITOPE, DOMAIN MOBILITY, FLAVOCYTOCHROME B2, ANTIBODY, FAB, HEME DOMAIN, ELECTRON TRANSPORT, FLAVOPROTEIN, FMN, HEME, METAL-BINDING, MITOCHONDRION, OXIDOREDUCTASE, RESPIRATORY CHAIN, TRANSIT PEPTIDE, TRANSPORT 
1n0x:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE  |   ANTIBODY-PEPTIDE COMPLEX, PEPTIDE DIMER, IMMUNE SYSTEM 
1n0x:M   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE  |   ANTIBODY-PEPTIDE COMPLEX, PEPTIDE DIMER, IMMUNE SYSTEM 
3aaz:B   (THR114) to   (SER213)  CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY  |   ANTIBODY ENGINEERING, HUMANIZATION, HWO-2 FAB, IMMUNE SYSTEM 
3aaz:L   (THR114) to   (ASN215)  CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY  |   ANTIBODY ENGINEERING, HUMANIZATION, HWO-2 FAB, IMMUNE SYSTEM 
1ymh:C   (ALA109) to   (ASN212)  ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W  |   ENGINEERING OF CRYSTAL CONTACTS, PPL-FAB COMPLEX, IMMUNE SYSTEM 
5dd6:L   (ALA109) to   (SER208)  CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES  |   HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM 
5dd6:B   (ALA109) to   (SER208)  CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES  |   HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM 
1ynl:L   (ALA109) to   (ASN210)  IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETERNERS: CRYSTAL STRUCTURE OF NC6.8 CO- CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647  |   TRIETHYL AMINOMETHANE SULFONYL ACID, SWEETENER COMPOUND, SC45647 AND NC174, IMMUNE SYSTEM 
5dfv:F  (ALA2001) to  (ASN2104)  CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04  |   HELICAL BUNDLE, CELL ADHESION, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM 
4py8:J   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF FAB 3.1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ  |   HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, MEMBRANE FUSION, NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1zls:L   (THR109) to   (SER208)  FAB 2G12 + MAN4  |   HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN-SWAPPING, IMMUNE SYSTEM 
5e2u:L   (THR114) to   (SER213)  STRUCTURE OF ANTI-TAU AT8 FAB IN THE PRESENCE OF PHOSPHOPEPTIDE  |   IMMUNE SYSTEM 
4q9r:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF AN RNA APTAMER BOUND TO TRIFLUOROETHYL-LIGAND ANALOG IN COMPLEX WITH FAB  |   G-QUADRUPLEX, FLUORESCENCE, FLUOROPHORE, RNA-IMMUNE SYSTEM COMPLEX 
2a6k:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR  |   IMMUNOGLOBULIN FOLD, FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM 
5en2:B   (ALA109) to   (ASN212)  MOLECULAR BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF NEW WORLD HEMORRHAGIC FEVER MAMMARENAVIRUSES  |   IMMUNOGLOBULIN, GLYCOPROTEIN, VIRUS, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5eoc:L   (ALA113) to   (ASN216)  CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I  |   COMPLEX, MONOCLONAL ANTIBODIES, HCV, IMMUNE SYSTEM 
5eoc:M   (ALA113) to   (ASN214)  CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I  |   COMPLEX, MONOCLONAL ANTIBODIES, HCV, IMMUNE SYSTEM 
5esq:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5esq:C   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5euk:A   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5euk:C   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5f3b:B   (THR109) to   (SER208)  STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY  |   MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
5f3b:F   (THR109) to   (SER208)  STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY  |   MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
3c09:L   (THR108) to   (SER207)  CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR  |   CELL SURFACE RECEPTOR, GLYCOPROTEIN, ANTIGEN, ANTIBODY COMPLEX, FAB FRAGMENT, ANTITUMOR, DRUG IMMUNE SYSTEM-TRANSFERASE COMPLEX, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
4r2g:I   (PRO109) to   (PRO209)  CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4  |   PROTEIN-PROTEIN COMPLEX, IGG, ANTI-HIV ANTIBODIES, GP120, IMMUNE SYSTEM 
5fec:L   (THR105) to   (SER204)  CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120  |   ANTIBODY, IMMUNE SYSTEM, HIV-1 
5fec:B   (THR105) to   (SER204)  CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120  |   ANTIBODY, IMMUNE SYSTEM, HIV-1 
4r4h:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF NON-NEUTRALIZING, A32-LIKE ANTIBODY 2.2C IN COMPLEX WITH HIV-1 ENV GP120  |   HIV-1 ATTACHMENT GLYCOPROTEIN GP120, VIRAL PROTEIN-IMMUNE SYSTEM- INHIBITOR COMPLEX 
3naa:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF FAB15 MUT5  |   ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM 
4r97:B   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
3cfd:L   (ALA109) to   (ASN212)  PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN  |   IMMUNOGLOBULIN, PURPLE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM 
3cfd:A   (ALA109) to   (ASN212)  PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN  |   IMMUNOGLOBULIN, PURPLE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM 
3cfe:L   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10  |   IMMUNOGLOBULIN, PURPLE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM 
3cfe:A   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10  |   IMMUNOGLOBULIN, PURPLE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM 
4rgn:C   (ALA109) to   (ASN212)  STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES, 14G8 AND 6D3  |   NEUTRALIZING ANTIBODY, STAPHYLOCOCCAL ENTEROTOXIN B, TOXIN-IMMUNE SYSTEM COMPLEX 
4rgn:L   (ALA109) to   (ASN212)  STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES, 14G8 AND 6D3  |   NEUTRALIZING ANTIBODY, STAPHYLOCOCCAL ENTEROTOXIN B, TOXIN-IMMUNE SYSTEM COMPLEX 
3o2d:L   (THR108) to   (SER207)  CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY  |   IMMUNOGLOBULIN FOLD, HIV-1 PRIMARY RECEPTOR, T CELL CORECEPTOR, MONOCLONAL ANTIBODY, MEMBRANE, IMMUNE SYSTEM 
3o6k:L   (ALA114) to   (ARG216)  CRYSTAL STRUCTURE OF ANTI-TAT HIV FAB'11H6H1  |   ANTIGEN-BINDING SITE, U-SHAPED GROOVE, IMMUNE SYSTEM, TAT HIV 
4s1q:L   (THR111) to   (ARG213)  CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY, 45-VRC01.H03+06.D- 001739, IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE  |   HIV-1, NEUTRALIZING ANTIBODIES, VRC01-LINEAGE, ANTIBODY MATURATION, EVOLUTIONARY RATE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4tpr:L   (ALA114) to   (ASN217)  STRUCTURE OF TAU5 ANTIBODY FAB FRAGMENT  |   IMMUNE SYSTEM, MONOCLONAL ANTIBODY 
3ogc:B   (ALA109) to   (ASN212)  KCSA E71A VARIANT IN PRESENCE OF NA+  |   VOLTAGE-GATED CHANNEL, ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN 
4d9l:L   (PRO109) to   (THR209)  FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697  |   IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM 
4d9q:D   (THR109) to   (SER208)  INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D  |   FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4d9q:L   (THR109) to   (SER208)  INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D  |   FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3or7:B   (ALA109) to   (ASN212)  ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I  |   INACTIVATION, ALPHA-HELICAL, POTASSIUM CHANNEL, IMMUNE SYSTEM- TRANSPORT PROTEIN COMPLEX 
3dvn:A   (THR111) to   (ASN212)  CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU2.16 BOUND TO K63-LINKED DI- UBIQUITIN  |   DI-UBIQUITIN, FAB FRAGMENT, ANTIBODY, NUCLEUS, PHOSPHOPROTEIN, RIBOSOMAL ROTEIN, IMMUNE SYSTEM 
3dvn:L   (THR111) to   (ARG213)  CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU2.16 BOUND TO K63-LINKED DI- UBIQUITIN  |   DI-UBIQUITIN, FAB FRAGMENT, ANTIBODY, NUCLEUS, PHOSPHOPROTEIN, RIBOSOMAL ROTEIN, IMMUNE SYSTEM 
5hdq:L   (ALA109) to   (ASN210)  MNTC CO-STRUCTURE WITH MAB 305-78-7  |   TRANSPORT PROTEIN, MONOCLONAL ANTIBODY, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4dn4:L   (THR111) to   (SER210)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CNTO888 FAB AND MCP-1 MUTANT P8A  |   ANTIBODY CHEMOKINE, IMMUNE SYSTEM 
5hys:L   (THR113) to   (SER212)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM 
5hys:B   (THR113) to   (SER212)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM 
5hys:D   (THR113) to   (SER212)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM 
5hys:F   (THR113) to   (SER212)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM 
5i1a:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i1a:A   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i1k:L   (THR110) to   (SER209)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-20  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3pho:A   (ALA112) to   (ASN213)  CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, CARBOHYDRATE-BINDING PROTEIN 
3piq:D   (PRO109) to   (PRO208)  CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1  |   MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM 
3piq:F   (PRO109) to   (PRO208)  CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1  |   MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM 
5id0:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5id0:C   (THR109) to   (GLY212)  CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5iq9:B   (PRO110) to   (ALA208)  CRYSTAL STRUCTURE OF 10E8V4 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE.  |   IMMUNOGLOBULIN, MPER, ANTIBODY, IMMUNE SYSTEM 
5iq9:L   (PRO110) to   (PRO209)  CRYSTAL STRUCTURE OF 10E8V4 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE.  |   IMMUNOGLOBULIN, MPER, ANTIBODY, IMMUNE SYSTEM 
5itf:A   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT  |   IMMUNE SYSTEM 
5itf:C   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT  |   IMMUNE SYSTEM 
5ivz:A   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT  |   IMMUNE SYSTEM 
5ivz:C   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT  |   IMMUNE SYSTEM 
3qcu:L   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)  |   ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM 
3qcu:M   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)  |   ANTIBODY, LYSOPHOSPHATIDIC ACID BINDING, IMMUNE SYSTEM 
3qg7:L   (ALA109) to   (ARG211)  STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM QUENCHING ANTIBODY  |   IMMUNOGLOBULIN FOLD, ANTIGEN RECOGNITION, AIP4, SECRETED, IMMUNE SYSTEM 
3r06:A   (ALA109) to   (ASN210)  CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT  |   ANTIBODY, ANTI-CD3EPSILON, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM 
3r06:C   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT  |   ANTIBODY, ANTI-CD3EPSILON, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM 
3r06:E   (ALA109) to   (ASN212)  CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT  |   ANTIBODY, ANTI-CD3EPSILON, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM 
3r06:L   (ALA109) to   (ARG211)  CRYSTAL STRUCTURE OF ANTI-MOUSE CD3EPSILON ANTIBODY 2C11 FAB FRAGMENT  |   ANTIBODY, ANTI-CD3EPSILON, T-CELL RECEPTOR, SIGNALLING, IMMUNE SYSTEM 
4fqq:A   (PRO110) to   (PRO209)  CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB  |   IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM 
5jsa:F   (THR109) to   (ARG211)  UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128  |   HIV-1 TRIMER, UFO, SOSIP, VACCINE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4g6k:L   (THR109) to   (GLY212)  CRYSTAL STRUCTURE OF THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB IN ITS UNBOUND STATE  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, CYTOKINE, INTERLEUKINE-1BETA 
4g7y:L   (THR109) to   (ARG211)  CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.8 A)  |   MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE 
4g80:B   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A)  |   MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE 
4g80:D   (THR109) to   (ASN210)  CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A)  |   MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE 
4g80:H   (THR109) to   (SER208)  CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A)  |   MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE 
5kvf:L   (ALA109) to   (ASN212)  ZIKA SPECIFIC ANTIBODY, ZV-64, BOUND TO ZIKA ENVELOPE DIII  |   ZIKA VIRUS, ENVELOPE PROTEIN, VIRAL PROTEIN, STRUCTURAL GENOMICS, ANTIBODY, CSGID, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5kzc:L   (THR111) to   (ASN212)  CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01  |   HIV, ENV, GP120, NEUTRALIZING ANTIBODY, N-LINKED GLYCAN, IMMUNE SYSTEM 
5kzc:D   (THR111) to   (ASN212)  CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01  |   HIV, ENV, GP120, NEUTRALIZING ANTIBODY, N-LINKED GLYCAN, IMMUNE SYSTEM 
5th2:A   (THR109) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5th2:C   (THR109) to   (ASN210)  CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM